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2RÉSUMÉ 
L’imagerie par spectrométrie de masse est une technique sans marquage permettant la détection 
et la localisation de protéines à partir de coupes de tissus. Afin de repondre à des problematiques 
biologiques, le nombre de protéines identifiées doit etre amelioré. Une stratégie consiste à realiser 
une  micro-jonction liquide sur des regions particulieres des coupes de tissus afin d’extraire les 
peptides issus de la digestion in situ des protéines. Plus de 1500 protéines ont identifié sur une 
zone de 650µm, correspondant à environ 1900 cellules. Une corrélation entre ces données avec 
celles générées par MSI a augmenté le nombre de protéines localisées. Afin d’obtenir dans le 
même temps, la localisation et l’identification de protéines, une méthode consiste à realiser la 
microdissection de l’ensemble de la coupe après l’avoir déposée sur une lame recouverte de 
prafilm. Parafilm-Assisted Microdissection (PAM) a également été appliquée à l’etude de 
l'expression différentielle de protéines dans des tumeurs de prostate. Les résultats identifiés 
glutamate oxaloacétate transférase 2 (GOT2) en tant que biomarqueur de protéine candidate 
impliquée dans le métabolisme du glucose, en plus de celles qui ont déjà été indiqué 
précédemment. Réunis ensemble, ces méthodes MS d'analyses directes fournissent un moyen 
robuste d’étude de protéines dans leur état natif afin de fournir des indications sur leur rôle dans 
des systèmes biologiques. 
 
Mots clés : spectrométrie de masse, imagerie, protéomique, micro jonction liquide, 
microdissection assistée par parafilm, cancer de la prostate 
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3SUMMARY 
 
Mass spectrometry-based methods for direct tissue analysis, such as MS imaging, are label-free 
techniques that permit the detection and localization of proteins on tissue sections. There is a 
need to improve the number of protein identifications in these techniques for them to 
comprehensively address biological questions. One strategy to obtain high protein IDs is to 
realize liquid microjunction on localized regions of tissue sections to extract peptides from the in 
situ digestion of proteins. More than 1500 proteins were identified in a 650µm spot, 
corresponding to about 1900 cells. Matching these IDs with those from MSI increased the 
number of localized proteins. In order to achieve simultaneous identification and localization of 
proteins, a method consisting of microdissecting entire tissue sections mounted on parafilm-
covered slides was developed. Spectral counting was then used to quantify identified proteins, 
and the values were used to generate images. Parafilm-Assisted Microdissection (PAM) was also 
used to examine the differential expression of proteins on prostate tumors. Results identified 
glutamate oxaloacetate transferase 2 (GOT2) as a candidate protein biomarker involved in 
glucose metabolism, in addition to those that have already been reported previously. Taken 
together, these direct MS analysis methods provide a robust means of analyzing proteins in their 
native state and are expected to provide insights to their role in biological systems. 
 
Keywords: mass spectrometry, imaging, proteomics, liquid microjunction, parafilm-assisted 
microdissection, prostate cancer 
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1INTRODUCTION 
Biological processes are highly dynamic and involve millions of molecules of various 
physicochemical properties and functions. In order to have a relatively fine picture of their 
mechanisms we need to first be able to monitor the variation in terms of abundance of the 
molecules in time and space. This means that we need to at least first perform a large scale 
identification of these biomolecules, and quantify and localize them in the time course of the 
biological process. These first intention studies are generally performed to highlight the main 
features differentiating the studied physiological or physiopathological process from a normal 
situation. When studying physiopathological mechanisms, information about the changes in 
signaling pathways is expected. Omics is nowadays the related term used in general to refer to 
these large scale analyses which are classified according to the family of biomolecules to be 
studied due to the different methodologies and technologies they are relying on. Omics is thus a 
broad terminology including, genomics, transcriptomics, metabolomics, lipidomics and 
proteomics as main research fields. Omics techniques will give information on the modification 
of cell signalization and will help to determine markers of the physiological/physiopathological 
process as well as provide a better understanding of the mechanisms. These large scale analyses 
are generally followed by more focused studies in order to decipher precise signalization 
pathways which are required to obtain a more precise knowledge on the cascade of events, 
including specific modifications carried by the molecules, as well as their interactions and 
translocation into the cells requiring thus various methodologies including structural biology 
techniques such as NMR, X-Ray and a large panel of microscopy technologies. Various families 
of biomolecules act in synergy to maintain cell homeostasis and allow cell-to-cell communication 
in a normal function or in response to an external stimulus. Ideally, to obtain a complete picture 
we should need to perform systematic biology by correlating the data coming from the different 
Omics. Since this is a huge task, researches are generally focused on one family of biomolecules, 
although more and more researchers are trying to integrate several large analyses together 
(Weckwerth 2008; Griffiths and Wang 2009). Taking the problem from one side, proteins are one 
of the families of biomolecules that can be studied in order to understand physiopathological 
mechanisms. Large scale protein analyses are referred to as proteomics analyses as introduced in 
the mid 90’s by Wilkins and coll (Wilkins, Pasquali et al. 1996).  
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Proteomics analyses rely on a panel of technologies but among them Mass Spectrometry (MS) 
plays a central role. Indeed, the development of soft ionization sources such as matrix-assisted 
laser desorption/ionization (MALDI) and electrospray ionization (ESI) in the mid 80’s have 
paved the way for the establishment of MS as a tool for the analysis of molecules of biological 
importance (Yamashita and Fenn 1984; Karas, Bachmann et al. 1987). With these sources it is 
now easy to generate ions from high molecular weight compounds of high polarity (Karas and 
Hillenkamp 1988; Fenn, Mann et al. 1989), thus expanding the range of biological molecules that 
can be analyzed by MS from small metabolites, to most notably proteins. In a way, MS has 
revolutionized the field of proteomics by permitting large scale analysis (McDonald and Yates 
2002; Yates, Ruse et al. 2009). Instrumental developments in the field of MS combined to 
improvements in separation methods such as liquid chromatography (LC (Zhao and Lin ; 
Ishihama 2005) and developments of bioinformatic tools (Swan, Mobasheri et al. ; Eng, 
McCormack et al. 1994; Fenyo and Beavis 2008) have greatly contributed to this achievement. 
Currently thousands of proteins can be identified from a single experiment using shotgun 
strategies (Geiger, Velic et al. 2013; Picotti, Clement-Ziza et al. 2013). In these strategies 
extracted proteins are altogether submitted to enzymatic digestion. After purification of the 
digestion peptides, they are conventionally separated using LC on-line coupled to the MS 
instrument. This strategy relies on the capacity of the instrument to record MS and MS/MS data 
from the solution eluted from the LC system. MS spectra provide access to the mass of the 
digestion peptides while MS/MS will give structural information on the primary sequence of 
these peptides. The measured masses of the proteolytic peptides and the mass collected from the 
structural analysis are then combined to be compared and matched with a protein or gene 
sequence database, and the protein identification is assigned based on the accuracy of the match. 
This identification process depends on the unequivocal assignment of ions, and parallel 
developments in instrumental design in terms of mass accuracy and resolving power led to 
improvements in the identification (Scigelova, Hornshaw et al. 2011). Increase in the duty cycle 
of instruments also greatly improves the number of identification by allowing to record more 
structural information (Liu, Huttenhain et al. 2013). Crucial to the development of MS-based 
proteomics is the parallel improvement in the classical analytical methods of sample preparation. 
For instance, the improvement of chromatographic separation allowed the refinement of protein 
purification protocols that are tailored to the demands of the protein of interest. Development of 
high-throughput and less cumbersome instruments permitted the interfacing of more and more 
methods with MS, and paved the way for incorporation of multi-dimensional preparative 
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procedures in an effort to decrease the complexity of samples and increase the identification 
potential. Currently, Shot-Gun strategies allow fast access to the identification and relative 
quantification through label free quantification methods to thousands of proteins (Wisniewski, 
Dus et al. 2013) at various levels (from whole body, organs, cells down to cell compartments or 
vesicles) in various biological complexes allowing now to study molecules of lower abundance 
with important biological functions such as chemokines or cytokines (Meissner and Mann 2014). 
 
However, in spite of all these improvements in proteomics, one crucial dimension is lacking, 
which is the information about the evolution of protein abundances with respect to their 
localization. This information is not required when working on body fluids, but becomes crucial 
when studying tissues, such as solid tumors. In fact, most large scale proteomics analyses are 
performed on whole organs or regions of organs. This only provides access to averaged 
information and renders difficult the identification of proteins that are highly localized to a 
restricted area (even though they are in relatively high abundance) due to dilution of the total 
amount of proteins. Such approaches thus do not show the variation in abundance of the proteins 
in a specific micro-environment, which can be primordial, for example in the early development 
of pathologies. Various strategies were developed to circumvent these difficulties. One instance 
involves collection of a specific type of cells. Cell sorting can be carried out by various means 
including Flow Cytometry, but the most popular ones are based on Laser Capture 
Microdissection (LCM, (Emmert-Buck, Bonner et al. 1996)). In LCM, cells are sorted based on 
their morphologies, which were pre-determined by histological staining. In the beginning LCM 
was shown to be relatively laborious since it was difficult to collect a large number of cells 
sufficient for gel based strategies. The advent of shotgun strategies based on nanoflow LC 
systems and nanoESI ion sources, and requiring much less amount of material, has greatly helped 
to the improvement of these strategies (Thakur, Rejtar et al. 2011). However, even if LCM 
coupled to shotgun analysis is nicely working this strategy still presents certain limitations such 
as the number of cells to be collected (most of the time about 50,000 cells) and the morphological 
phenotyping-based cell selection criterion in place of molecular phenotyping. Moreover, 
obtaining numerous cells entails having to collect them from various tissue sections in which the 
micro-environment can greatly vary. 
 
In contrast, MS Imaging (MSI) strategies provide direct access to the 2D-distribution of 
molecules without pre-fractionation or purification of samples (Jungmann and Heeren 2012). 
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This greatly simplifies the sample preparation and stresses on the importance of analyzing 
proteins in the context of their localization. By doing so, MSI allows for the ability to 
discriminate different types of tissues in the same organ, and permits the non-subjective 
identification of deseased areas in contrast to normal ones. This simple and straightforward 
approach permitted the identification of tumor regions in otherwise normal tissues, for example, 
and demonstrated the potential MSI as a diagnostic tool that can be developed for future use by 
clinicians in the hospital setting. In this regard, MALDI MSI has shown to be the more powerful 
and versatile of the various MSI modalities due to the wide range of molecules accessible to the 
MALDI ion source (Fournier, Wisztorski et al. 2008). MALDI MSI is applicable to a large 
variety of endogenous molecules including proteins as well as exogenous ones such as drugs, 
abiotics or xenobiotics. MSI has shown to be very powerful in obtaining the localization of 
known compounds; one of the best illustrations is the imaging of drugs and their metabolites in 
whole body animals. MSI can effectively replace whole body autoradiography (WBA), which 
uses radiolabeled drugs and does not allow the metabolites to be imaged (Solon, Schweitzer et al. 
2010). Alone or combined to multivariate statistical analysis, MSI can also be used as a tool for 
cell phenotyping and finding markers of physiological or physiopathological processes. This 
approach is often used for clinical studies of pathologies such as cancer, where imaging has 
shown significant applications in tissue classification and biomarker discovery (Franck, Arafah et 
al. 2009). In spite of its success in recent years, there are still limitations that need to be addressed 
in MSI. Perhaps the biggest issue is the crucial need to improve its sensitivity especially in 
detecting less abundant molecules. This remains especially true for proteins that are more 
difficult to detect due to their physico-chemical properties. In particular, higher mass proteins 
(Mw >30,000 Da) are clearly not detected when using conventional sample preparation and only 
most soluble proteins of the lowest Mw are observed (Franck, Longuespee et al. 2010). Thus, for 
proteins the number of compounds that can be imaged is relatively limited compared to other 
molecule families such as lipids. Moreover, direct imaging often results to localization of the 
most abundant proteins. Although this is not an issue by itself, nonetheless, abundant proteins 
impose a limit to the number of biomarkers that can be discerned by MSI by hindering the 
identification of the less abundant ones. More detailed information on physiopathological 
mechanisms requires the identification of these low abundance proteins, especially if they are 
involved in signalization pathways implicated in the disease. Identification of imaged proteins is 
one of the other great challenges for MALDI MSI in these untargeted approaches. These two 
difficulties have led to the development of On Tissue Bottom-Up strategies (Lemaire, Desmons 
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et al. 2007; Franck, Arafah et al. 2009). Here, proteins are in situ digested in a controlled manner 
to generate peptides which should be easier to detect and identify while avoiding their 
delocalization. Direct protein identification is a challenge since most ion activation methods do 
not allow fragmentation of intact species due to internal redistribution on all the degrees of 
freedom of the energy transferred by means of ion activation. This is circumvented by on tissue 
digestion of proteins. Though resolving part of the problem, on tissue digestion can increase 
sample complexity by increasing the number of peptide species, and again due to ion suppression 
effects, only digestion peptides coming from most abundant proteins are predominantly observed. 
Many groups, including ours, have attempted to address this issue by developing peptide 
derivatization to increase their propensity for fragmentation (Franck, El Ayed et al. 2009), 
incorporating washing and abundant protein depletion strategies into the imaging protocol, 
designing novel matrices to improve protein ionization from single to multi-charged species, 
using different methods to digest the proteins in situ, and so on. Nonetheless, the results of these 
approaches are limited, and the challenge to be able to detect, analyze and identify proteins of 
low abundance in their native environment on tissue remains a daunting task.  
 
It is thus mandatory for the understanding of physiopathological mechanisms to elucidate 
prognostic and diagnostic biomarkers and their targets, and to be able to identify and image a 
much larger number of proteins. Clearly there is currently a need to fill the gap between the 
potential of conventional proteomics strategies and the potential of MS imaging to bring the 
localization of the molecules. This was the first goal of my PhD project. In this work, I present 
different strategies to demonstrate alternative ways to address the limitation of protein detection 
on tissue, as well as other developments I have tried to address in the course of three years of 
study. The first part focuses on the development of a strategy using the liquid microjunction 
extraction to be able to extract proteins on a localized region on a tissue section. The liquid 
microjunction extraction is considered as one of the ambient surface sampling techniques. In this 
published work, as much as 1500 proteins were identified in a region as small as 650 µm, roughly 
corresponding to 1900 cells. We were able to discriminate two regions on a rat brain tissue 
section based on these protein identifications and managed to correlate these results on the 
regions identified by hierarchical clustering analysis following a MALDI MSI experiment. As 
such, we have started to incorporate the liquid microjunction extraction strategy into our MSI 
platform and used it in further studies in our group. This localized extraction strategy is presented 
as an alternative to on-tissue cell collection done using laser capture microdissection (LCM) and 
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related strategies, which could sample homogeneous cell populations but at the expense of losing 
localization due to limited number of cells in the sampling region, and which still also suffers 
from poor protein identification yield in spite of the cell population enrichment. Although the 
strategy presently cannot sample homogeneous cell populations given the current size of the 
microdigested and microextracted area attainable, nonetheless, it can be used to examine cell 
populations in the context of their microenvironment. The ideal situation, in retrospect, would be 
to sample proteins of individual cells in the context of their tissue localization, as we expect the 
protein expression to change in a similar manner as has been demonstrated for metabolites even 
for cells of the same population (Zenobi 2013). Concordance with this idea, a chapter on the 
recent results of the continuation of the work on this subject is presented, focusing on decreasing 
both the size of the microextracted and microdigested areas. This consists of the use of alternative 
means to create a smaller liquid microjunction and the direct coupling of this method to nanoLC-
MS. Although a similar set-up has already been previously reported, the current one was 
designed specifically for a proteomic approach and aimed for the sampling of even smaller 
regions, and results of its comparison with the conventional off-line liquid microjunction 
nanoLC-MS approach is discussed. 
 
In the second part, I present the parafilm-assisted microdissection method. Here, an alternative 
approach dealing with the limited protein identification problem is shown. This consists of 
mounting a tissue specimen on a parafilm-covered slide, excising regions from the tissue, and 
subjecting them individually to conventional shotgun proteomics MS analysis. Furthermore, the 
published work explores the possibility of generating molecular images from the protein 
identifications, using the quantitative values of the spectral counts of peptide assignments. With 
this approach, we were able to identify and localize high and low abundance proteins, and are 
currently working towards the refinement of this strategy in order to improve the resolution of the 
images. An application of the PAM method on prostate tumors is then presented. Here, we 
examined fresh frozen tumor sections, excised regions of interest, and subjected them to 
proteomics MS analysis. Here I demonstrate that using the PAM approach allows for the 
identification and quantification of protein expression levels. The importance of this in regard to 
prostate cancer is that the data can be used to detect changes in the regulation of proteins, and 
eventually biological pathways, as the prostate undergoes pathological changes.  
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In summary, this work is largely divided into two categories: development of MS-based methods 
for on-tissue protein identification, and linking these methods with quantification and use this to 
be able to map protein distribution across the tissue. In addition, application of on-tissue protein 
identification and quantification strategies in the context of prostate cancer for the discovery and 
development of candidate biomarkers is also presented. 
Hypothesis 
Current MS-based methods for the direct analysis of proteins on tissue, such as MS imaging, 
suffer from poor detection, identification and quantification of proteins thereby warranting the 
development of alternative approaches that could circumvent these inherent limitations. One way 
is to improve the number of protein identifications by localized microextraction on discreet 
regions of the tissue section. Restricting microextraction on discreet regions could improve the 
identification of proteins of low abundance by limiting the amount of abundant proteins co-
extracted, compared for example when extraction was performed on the entire organ or tissue 
section. These protein IDs could then be used for back-correlation with MSI data to increase the 
number of protein assignments that have been localized. Another way is to perform simultaneous 
identification and localization of proteins in a single approach, without sacrificing the high 
number of protein identifications. This can be achieved by dividing a tissue section into 
millimeter-sized portions that can then be individually subjected to shotgun MS. The spectral 
counts of the proteins identified can then be used to reconstruct the image of the tissue section 
and map their spatial distribution.  
Objectives 
Develop alternative methods to ameliorate MSI protein identification strategies. 
This can be achieved by developing a localized protein extraction method based on the liquid 
microjunction approach. The approach is similar in principle to the generation of protein ID 
databases that are then used for matching with peaks in MSI spectra. In contrast though, the 
protein database will be obtained from localized regions on the tissue section. This will be done 
by performing in situ tryptic digestion on those regions, followed by extracting the peptides using 
the liquid microjunction approach, then subjecting the extracts to shotgun nanoLC MS. 
 
Develop quantification-based imaging strategies to directly correlate protein identification 
data with localization information. 
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Simultaneous identification, quantification and localization of proteins on tissue sections can be 
realized by obtaining millimeter-sized pieces of the tissue and subjecting each piece individually 
to shotgun nanoLC MS. Label-free quantification of the identified proteins can then be done by 
spectral counting, and the relative quantification data used to generate the image of the tissue by 
noting the positions where the tissue pieces have been excised from the section. The tissue pieces 
can be obtained from the tissue section by mounting the latter on a parafilm-covered slide and 
excising the pieces using a scalpel. Parafilm is a relatively inert material that can act as a support 
for the tissue during cutting of the pieces. 
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the sampling of charged analytes actually begins. The ionized species are then transported to the 
mass analyzer where their resolution in terms of m/z occurs. In tandem MS experiments, 
additional fragmentation of ions detected after m/z separation can be performed and the resultant 
MS/MS spectra can be used for analyte identification in the post-analysis step. After detection, 
the analysis can yield spectra for precursor or product ion scans, MS/MS spectra, as well as MS 
images constructed from the mapping of ion density on the selected or entire region of the sample 
section. Note that direct MS analysis methods are at the frontline of the scheme and thus are 
important in determining the outcome of the entire analysis. 
 
The major advantage of direct on-tissue protein analysis in contrast to classical MS-based 
methods is the minimization or total elimination of complicated fractionation procedures that 
tend to introduce artifacts to the sample with each subsequent purification step (Huang, Cheng et 
al. 2011). By doing the analysis directly on tissue, it is possible to analyze proteins in their native 
state and in the presence of their interaction partners, thus providing a more realistic view of the 
binding of these proteins compared when their interactions are studied in solution. The point by 
point examination of tissue surfaces typical of direct tissue analysis methods allows the mapping 
of protein distribution across the whole tissue, permiting the localization of proteins.  
Ambient MS 
Ambient MS-based methods are those that employ direct tissue sampling under ambient 
conditions of temperature and pressure. Their development is mainly driven by the need for mass 
spectrometers that are capable of performing on the spot analysis of real-world samples thus 
giving access to this technology to everyday applications, such as for instance, in the 
determination of pesticide content in food products or, detection of substances of abuse or of 
stimulants in race animals and athletes, to name a few. This is possible by liberating the analysis 
from constraints presented by difficulties of introducing the sampling surface into the vacuum, 
including sample size and analyte volatility. In these methods, there is a great emphasis in the 
examination of samples that are preserved in their native state with minimal or no interference 
due to the analysis. Their use in proteomics is limited to the identification or quantification of 
highly abundant endogenous proteins, and proteome-wide discoveries involving these methods 
still have to be demonstrated.  
 
A total of 42 ambient MS-based methods are currently reported in literature (Table 1, (Badu-
Tawiah, Eberlin et al. 2013)). Several reviewers have classified them into various categories 
based on the similarities and differences in their mode of sampling the surface (Figure 2). It is 
not our current objective to provide a comprehensive review of these methods, but rather to 
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highlight major surface sampling principles in order to emphasize our choice of approaches used 
in this work. 
 
 
Figure 2. Overview of ambient MS-based methods. 
Venter & Cooks’ classification of ambient MS-based methods based on the mode of sample 
extraction and transport to the mass spectrometer inlet. Reprinted from (Venter, Nefliu et al. 
2008), Copyright (2008) with permission from Elsevier. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  31 
Table 1. Ambient MS methods as recently reviewed by Badu-Tawiah and Cooks, 2013.  
 
 
Reproduced with permission. For references, see (Badu-Tawiah, Eberlin et al. 2013). 
 
 Method name Acronym Agent Characteristics
1 Desorption electrospray ionization DESI Sprays
Imaging capabilities, reactive mode, small (<500 Da) 
and large molecules
2 Easy ambient sonic-spray ionization EASI Sprays Imaging capabilities, small (<500 Da) molecules
3 Desorption ionization by charge exchange DICE
Sprays, chemical 
ionization
Small (<500 Da) molecules
4
Transmission mode desorption electrospray 
ionization
TM-DESI Sprays Reactive mode
5 Nanospray-desorption/electrospray ionization Nano-DESI Sprays
Imaging capabilities, small (<500 Da) and large 
molecules
6 Probe electrospray ionization PESI Sprays
Imaging capabilities, small (<500 Da) and large 
molecules
7 Liquid microjunction-surface sampling probe LMJ-SSP Sprays
Imaging capabilities, reactive mode, small (<500 Da) 
molecules
8 Paper spray PS Sprays Reactive mode, small (<500 Da) and large molecules
9 Direct analysis in real time DART Plasmas Small (<500 Da) and large molecules
10 Low-temperature plasma probe LTP Plasmas Reactive mode, small (<500 Da) molecules
11 Flowing atmospheric pressure afterglow FAPA Plasmas Small (<500 Da) molecules
12
Desorption atmospheric pressure chemical 
ionization
DAPCI Plasmas Small (<500 Da) molecules
13 Desorption corona beam ionization DCBI Plasmas Small (<500 Da) molecules
14 Dielectric barrier discharge ionization DBDI Plasmas Small (<500 Da) molecules
15
Electrospray-assisted laser desorption 
ionization
ELDI Lasers, sprays
Imaging capabilities, small (<500 Da) and large 
molecules
16 Laser ablation electrospray ionization LAESI Lasers, sprays Imaging capabilities, small (<500 Da) molecules
17
Laser-assisted desorption electrospray 
ionization
LADESI Lasers, sprays
Imaging capabilities, small (<500 Da) and large 
molecules
18 Laser desorption electrospray ionization LDESI Lasers, sprays
Imaging capabilities, small (<500 Da) and large 
molecules
19
Laser-induced acoustic desorption-
electrospray ionization
LIAD-ESI Lasers, acoustic, sprays Small (<500 Da) and large molecules
20
Neutral desorption extractive electrospray 
ionization
ND-EESI Sprays Reactive mode, small (<500 Da) molecules
21
Radiofrequency acoustic desorption and 
ionization
RADIO Sprays, acoustic Small (<500 Da) molecules
22 Atmospheric pressure solids analysis probe ASAP Heat, plasmas Small (<500 Da) molecules
23
Infrared laser ablation metastable-induced 
chemical ionization
IR-LAMICI
Lasers, chemical 
ionization
Small (<500 Da) and large molecules
24
Rapid evaporative ionization mass 
spectrometry
REIMS Chemical ionization Heating, small (<500 Da) molecules
25
Desorption atmospheric pressure 
photoionization
DAPPI Chemical ionization Photons as proton source, small (<500 Da) molecules
26
Beta electron-assisted direct chemical 
ionization
BADCI Chemical ionization
Beta particles as proton source, small (<500 Da) 
molecules
27 Extractive electrospray ionization EESI Sprays Reactive mode, small (<500 Da) and large molecules
28
Remote analyte sampling transport and 
ionization relay
RASTIR Sprays Small (<500 Da) and large molecules
29
Laser ablation flowing atmospheric-pressure 
afterglow
LA-FAPA Plasmas Small (<500 Da) molecules
30 Surface activated chemical ionization SACI Plasmas Small (<500 Da) molecules
31 Single-particle aerosol mass spectrometry SPAMS Lasers Small (<500 Da) molecules
32 Laser diode thermal desorption LDTD Lasers, plasmas Small (<500 Da) molecules
33
Helium atmospheric pressure glow discharge 
ionization
HAPGDI Plasmas Small (<500 Da) molecules
34 Surface acoustic wave nebulization SAWN Acoustic Small (<500 Da) molecules
35 Ultrasonication-assisted spray ionization UASI Acoustic Small (<500 Da) and large molecules
36
Atmospheric pressure-thermal 
desorption/electrospray ionization
AP-TD/ESI Heat, sprays Small (<500 Da) molecules
37 Microplasma discharge ionization Microplasma Plasmas Small (<500 Da) molecules
38
Atmospheric pressure thermal desorption 
ionization
APTDI Heat Small (<500 Da) molecules
39
Desorption electrospray/metastable-induced 
ionization
DEMI Sprays, plasmas Small (<500 Da) molecules
40 Switched ferroelectric plasma ionizer SwiFerr Plasmas Small (<500 Da) molecules
41 Laser electrospray mass spectrometry LEMS Lasers, sprays Small (<500 Da) and large molecules
42 Plasma-assisted desorption ionization PADI Plasmas Small (<500 Da) molecules
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Thermal Desorption/Ionization Methods 
Ambient MS-based methods can be divided into several major categories based on the 
mechanism by which they extract samples from the surface and transport them to the inlet of the 
mass spectrometer (Figure 2). Thermal desorption/ionization-based methods are those that 
employ a heating mechanism to convert molecular species from the condensed phase in the 
sample surface into the vapor phase. This is traditionally followed by secondary ionization 
effected through the use of a corona discharge (atmospheric pressure chemical ionization, (APCI 
(Van Berkel, Pasilis et al. 2008)), or atmospheric pressure surface analysis probe, (ASAP (Ellis, 
Brown et al. 2013)). The mode by which heat is used to convert condensed phase material into 
gas phase, the manner of ionization, or both, can be varied thus leading to methods based on the 
TD-APCI principle. In laser diode thermal desorption (LDTD), the heated gas is replaced by an 
infrared (IR) laser that sequentially fires at the back of the sample surface, heating it until the gas 
phase molecules are ejected from the sample surface (Lohne, Andersen et al. 2012). In direct 
analysis in real-time (DART), heated He gas is converted into metastable atoms, and serves both 
to desorb material into gas phase and ionize them (Gross 2014). In plasma-assisted 
desorption/ionization (PADI), the He gas is initially made to pass between two electrodes, one of 
which is covered by a dielectric layer. As the gas flows, alternating voltage is applied to the two 
electrodes, generating plasma composed of metastable He, ions, radicals and electrons. The 
plasma jet is made into contact with the sample surface for desorption/ionization to occur. 
Molecular ionic species are generally formed using the method, although in some instances 
fragment ions can also be observed (Ratcliffe, Rutten et al. 2007). Lastly, in desorption 
atmospheric pressure photoionization (DAPPI), a microchip nebulizer delivers the heated solvent 
into the sample surface (Haapala, Pol et al. 2007; Luosujarvi, Arvola et al. 2008). This is then 
followed by ionization using an ultraviolet lamp in place of the corona discharge. The mechanism 
of ionization is similar with APPI using liquid sample introduction sources. 
Laser Ablation Methods 
Another type of ambient MS-based methods involves the use of a laser to generate an ablation 
plume of gas phase molecules which is then subjected to secondary ionization. Early examples of 
this approach used inductively-coupled plasma (ICP) as a means for secondary ionization (Van 
Berkel, Pasilis et al. 2008), making it useful in geology-type applications that demand elemental 
analysis of samples. Laser ablation has also been coupled with APCI-type ion sources. One 
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example uses a CO2 laser to effect desorption of neutral molecules, followed by APCI ionization 
to analyze trypsinized proteins on SDS-PAGE gels (Coon, Steele et al. 2002). But perhaps the 
most widespread examples of this type of ambient MS-based method is when it is coupled with 
the ESI source. One method, termed laser ablation electrospray ionization (LAESI, (Nemes and 
Vertes 2007)), fundamentally accomplishes ESI-like ionization, and follows two phases. During 
the first phase, a strong 1µs pulse at 2940 nm excites the –OH vibration in water present in the 
sample, resulting to the creation of a hemispherical plume that initially expands and eventually 
collapses due to pressure exerted by the atmosphere during the second phase, lasting 300 µs. The 
explosion ejects secondary particles composed of a mixture of molecules, clusters and ablated 
particulate matter, which then coalesce with the charged droplets of the ESI source. A variant 
consists of using a 337-nm nitrogen laser operating at 20 µJ per pulse, the focused laser spot size 
of which is 100 µm x 150 µm with the laser beam incident angle at 45 (Shiea, Huang et al. 
2005). 
 
The main advantage of LAESI-type methods, in addition to high ionization yield, is the 
possibility of producing multiply-charged molecules from laser ablation modes of sampling. This 
limitation is inherent in laser desorption-type sampling where only singly-charged and rarely 
doubly-charged ions are generated. This capability stems from the use of the ESI to induce the 
charging of the ejected particles. As such, protein spectra having multiply-charged envelopes of 
ions similar to those observed in ESI-generated spectra are observed when using laser ablation-
sampled spectra. Reports on top-down analysis of proteins using LAESI have recently appeared 
in literature (Kiss, Smith et al. 2014), and it is expected to find wider applications in proteomics, 
in addition to its established application in the in-depth profiling of small metabolites and in 
particular lipids (Shrestha, Nemes et al. 2010). Its main disadvantage though is the fact that 
ablation using a mid-IR range laser is dependent on the water content of the sample (Ye, Greer et 
al. 2011). Variations in the water content and tensile properties of the sample thus limit the 
replicability of this technique particularly for time-resolved imaging because they grossly affect 
the LAESI ion yield. The use of lower, mid-IR absorbances would also entail the use of 
significantly higher laser fluences in order to ablate biological samples. 
Liquid and Gas Jet Desorption/Ionization Methods 
Methods using liquid or gas jet, on the other hand, are those that rely on the collision of charged 
solvent droplets with the analyte on the surface for sample desorption, followed by charge 
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transfer upon impact. The mechanism of sample desorption in this case can be referred to as a 
liquid film-droplet sputtering process. Exemplified mainly by desorption electrospray ionization 
(DESI) (Takats, Wiseman et al. 2004), this method uses a pneumatically-driven electrospray that 
provides the charged droplets that wet the surface. The wet area is continuously impacted by the 
droplets, causing splashing, jetting, or creation of secondary droplets that may contribute to the 
ejection of the sample in addition to those that have initially been ejected upon impact of the 
spray (Takats, Wiseman et al. 2005). As such, no sample pre-treatments are used prior to its 
injection to the mass spectrometer, although it has also been demonstrated that the system can be 
coupled to an auxilliary chromatograhic set-up for use in more sensitive sample detection (Zhang, 
Yuan et al.). As in conventional ESI, a high voltage, typically 4 kV, is applied to create the 
charged droplets (Bereman and Muddiman 2007). By removing the voltage and increasing the 
nebulizing gas velocity to a sufficient level to permit ejection of analytes, a variation called 
desorption sonic spray ionization (DeSSI) was developed (Haddad, Sparrapan et al. 2006). Since 
no voltage is applied, the ESI source generates a distribution of positive and negative charged 
droplets. Further increasing the liquid flow up to 0.05-0.15 mL/min, among other modifications, 
leads to the another DESI variation called jet desorption/ionization (JeDI). In this case, the jet 
spray continuously erodes the sampling surface to generate gaseous analytes, making it ideal for 
depth profiling studies. Finally, in neutral desorption extractive electrospray ionization 
(NDEESI), both voltage and liquid were eliminated (Chen and Zenobi 2008). Only a moderate 
flow of gas at room temperature is applied on the surface to induce analyte desorption, followed 
by a secondary ESI ionization. 
 
As surface sampling is done under ambient conditions, DESI can easily be applied to any type of 
sample surface, greatly expanding its applicability to diverse real-world problems. Its proteomics 
applications though are limited to the analysis of liquid (Miao and Chen 2009) or spotted protein 
standards (Rao, Celiz et al. 2013; Montowska, Rao et al. 2014) and imaging of the tryptic digests 
of these (Pasilis, Kertesz et al. 2008). It has been reported that the major limitation of DESI is its 
limited sensitivity; for instance, in the analysis of propanolol metabolites, it failed to detect the 
hydroxypropanolol glucoronide metabolite compared when using other ambient surface sampling 
MS methods or MALDI imaging (Kertesz, Van Berkel et al. 2008).  
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Liquid Extraction Surface Sampling/Ionization Methods 
Surface liquid extraction methods are typically liquid-solid microextraction methods that can be 
coupled with any ambient ionization sources such as ESI or APCI (Van Berkel, Kertesz et al. 
2008). The success of these methods is due to their greater extracting efficiency and larger 
surface sampling areas. It has been shown, for instance, that phase II metabolites of propranolol 
were detected using these methods (Van Berkel and Kertesz 2009; Kertesz and Van Berkel 2010; 
Kertesz and Van Berkel 2010), whereas they were unsuccessfully detected using DESI(Kertesz 
and Van Berkel 2010). In these techniques, the extraction of materials from the sample surface is 
independent of ionization by having a liquid solvent in contact with the sample surface so that 
extraction can occur. The solvent may then be introduced directly into the inlet of the mass 
spectrometer, as in continuous type liquid microjunction set-ups, or they can be collected and 
may be subjected to sample pre-treatment steps, as in discrete type ones. Since ionization is 
independent of extraction, the method can be used in conjunction with various types of ambient 
sources, as has been demonstrated in APCI and ESI applications. Examples of the continuous 
mode are the liquid microjunction surface sampling probe (LMJ-SSP, (Van Berkel, Kertesz et al. 
2008)) and the sealing-surface sampling probe (SSSP, (Luftmann 2004)). This mode has been 
demonstrated to be useful for MS imaging, where an ESI source was used in place of the typical 
laser desorption/ionization source (Van Berkel, Kertesz et al. 2008). Alternatively, the solvent 
can be made in contact with the sample surface discretely as single droplets the formation and 
size of which is regulated by a syringe pump, as seen in the liquid extraction surface analysis 
probe (LESA, (Kertesz and Van Berkel 2010)). In this case, the solvent is carried using a 
conductive tip where the droplet is formed and where the subsequent extract is aspirated back to 
be introduced into the electrospray source. This mode is mostly applied in sample profiling, 
where discrete spots within the sample are extracted and the levels of analyte determined and 
compared for each sampling region. 
 
Because of the independence of sample extraction from ionization, liquid extraction surface 
sampling techniques permit the further treatment of samples with coupled devices prior to 
introduction to the mass analyzer. In essence, this does not belong to the realm of ambient surface 
sampling anymore, however, the use of these samplers as microextraction devices is very 
tempting especially if the whole system is fully automated (Van Berkel, Sanchez et al. 2002; 
Kertesz, Ford et al. 2005). This has been shown, for instance, by coupling the LMJ-SSP device 
with a high performance liquid chromatography (HPLC) system (Kertesz and Van Berkel 2010). 
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Sealing-Surface Sampling Probe 
Much of the development of the current commercially available SSSP type configuration stems 
from the efforts of Luftmann (Luftmann 2004 20) to design a sampling probe for the automated 
extraction and analysis of TLC plates. SSSP works by enclosing the sample surface using a probe 
with a circular cutting edge that goes through the surface deep into the TLC backing aided by a 
frame press. This seals the surface of interest and somehow creates a partial vacuum that aids in 
the extraction of the sample. Solvent flows into the probe through an inlet capillary connected to 
an HPLC pump that regulates the flow, and comes into contact with the surface so that extraction 
can take place. The solvent then exits the probe thru an outlet capillary connected to the ion 
source for introduction to the mass analyzer. The typical diameter of the sampling head is 2 and 4 
mm. In another design, the sampling head is elliptical (2 x 4 mm) so that it adapts more to the 
shape of the TLC spots (Morlock and Jautz 2008). The pump can be switched from standby 
mode, where solvent flows directly to the ion source, to sampling mode, where the solvent enters 
the probe and sampling occurs, or to docking mode, where the probe can be cleaned 
automatically using pressurized air (Aranda and Morlock 2007; Luftmann, Aranda et al. 2007).  
 
As previously mentioned the SSSP system is currently designed for analysis of samples spotted 
on TLC plates, although it is imminent that this can also be applied to analogous surfaces 
especially those that are porous. Thus it may also be applied to systems utilizing polymer or 
metallic supports. The only limitations are that it is only restricted to samples where the pressure-
aided sealing mechanism is possible, and that the pressure to be used for sealing must be 
optimized for each surface being used to avoid leakage of the extracting solvent, although 
modifications have been implemented to avoid this problem (Alpmann and Morlock 2006). 
Liquid Microjunction Surface Sampling Probe 
The LMJ-SSP system is mainly developed by Van Berkel and co-workers (Van Berkel, Sanchez 
et al. 2002), although prototypes of this device have been previously reported (Modestov, Srebnik 
et al. 2001; Wachs and Henion 2001). This probe consists of a capillary inserted inside a bigger 
one so that the space between them is used as an inlet connected to a solvent reservoir. Solvent 
enters and fills this space until the excess goes out of the capillary and comes into contact with 
the sampling surface. In this so-called wall-less ‘microjunction’ formed between the solid sample 
surface and the liquid, extraction occurs as the analytes with preferential affinity to the solvent 
polarity migrate to the liquid interphase and leave the sample by concentration gradient-driven 
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diffusion. The hollow portion of the inner capillary of the probe serves as the outlet line and is 
connected to the ion source. The resulting extract enters this line because of a self-aspirating 
mechanism driven by the pneumatic flow of the nebulizing gas towards the source.   
 
The LMJ-SSP device has found applications in extraction of spots from hydrophobic TLC plates 
(Van Berkel, Sanchez et al. 2002; Ford, Deibel et al. 2005), drugs obtained by solid phase 
extraction cards (Wachs and Henion 2003), affinity-captured proteins (Van Berkel, Ford et al. 
2006), and it has also been used for the imaging of inks on paper (Kertesz, Ford et al. 2005). In 
the latter case, resolution was achieved at 0.5 mm, the size of the probe. By modifying and 
automating the adjustment of the microjunction formation, LMJ-SSP in discrete sampling mode 
was used for high-throughput analyses of drugs (Van Berkel and Kertesz 2009). This also 
lessened the need for technical expertise in adjusting the probe-to-sample distance which is 
crucial to microjunction formation, and thus enables the automatic probing of a sample surface 
with varying thicknesses as in whole body tissue section for example. Problems in sample carry-
over was observed, however, and it was suggested to perform a blank run in between samples to 
ensure complete cleaning of the probe prior to the next analysis. Coupling with other post-
treatment devices, such as an HPLC set-up, was also recently accomplished using the LMJ-SSP 
(Kertesz and Van Berkel 2010). This can be very important with regard to future advances in 
ambient sampling because this allows clean-up of complex sample matrices that may hinder 
efficient sample detection when they are introduced directly to MS. 
Liquid Extraction Surface Analysis 
Further exploration of the discrete ambient surface sampling as an alternative to the continuous 
type led to the design of LESA (Kertesz and Van Berkel 2010). The principle is that the 
formation of the wall-less microjunction does not have to be restricted with the use of probes as 
in the case of LMJ-SSP. In fact, the microjunction can be formed simply by putting into contact a 
solvent droplet with the sampling surface, a function that can also be achieved using disposable 
pipette tips. After extraction, the extract is aspirated by means of a plunger mechanism using the 
same tip and then delivered into the electrospray head for ionization. With this system, flexibility 
is offered on the modulation of the size of the microjunction formed and variation of extraction 
time to suit a particular analysis. Currently, LESA has been demonstrated on the quantitation of 
drugs on dried blood spots (DBS), profiling of total drug distribution on whole body tissue 
sections, and extraction and quantitation on MALDI spots (Kertesz and Van Berkel 2010). It has 
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also recently been used for the direct and rapid identification of intact hemoglobin variants from 
DBS samples used for the neonatal screening of sickle cell and other hemoglobin-related diseases 
(Edwards, Creese et al. 2011). LESA has also been used to correlate results obtained from MS 
imaging experiments (Marshall, Toteu-Djomte et al. 2010). Although imaging investigations 
using LESA have yet to be reported, the possibility of using this technique for imaging has been 
implied. 
 
Much of the developments in LESA have been obtained through the use of the TriVersa 
NanoMate system marketed by Advion Biosciences. Using the Advanced User Interface (AUI), 
Van Berkel and Kertesz (Kertesz and Van Berkel 2010) were able to use the NanoMate platform 
to perform LESA procedures. The TriVersa NanoMate is actually a coupling device used for 
automated delivery of infused samples for ESI MS analysis. It uses a robotic arm to pick up 
specially designed conductive tips and uses them to aspirate the sample by attaching the open end 
into a disposable nano-electrospray chip. The chip contains 384 electrospray emitters created 
using a deep reactive ion etching chemical process (Schultz, Corso et al. 2000). These nozzles 
provide long and stable sprays and eliminate sample-to-sample carry-over by the use of new 
nozzles for individual analyses. In addition, the TriVersa NanoMate platform offers portability 
and adaptability with a variety of compatible mass spectrometers. As such, prior to the 
development of the LESA mode, this device has already seen various applications in the analysis 
of lipids (Stahlman, Ejsing et al. 2009), metabolites (Giavalisco, Hummel et al. 2008), proteins 
and protein-related fields like post-translational modifications, non-covalent interactions, and top-
down proteomics (Zhang, Van Pelt et al. 2003), antibodies and glycosylation (Ge, Rybakova et 
al. 2009), and others (Stumpo and Reinhold 2010). 
 
The NanoMate system has three modes of operation: 1) infusion mode, 2) fraction collection and 
3) LESA. In the infusion mode, the device allows for the direct introduction of samples into the 
ESI emitter, as previously described. The fraction collection mode is used to interface the device 
(and the coupled mass spectrometer) to a liquid chromatography (LC) set-up. In this mode the 
eluant coming from the LC system is transported to the NanoMate through a microcapillary 
tubing connected to a tee. The tee is connected to the mandrel and to the nanospray adapter, so 
that simultaneous collection of the eluant at constant time segments (through the mandrel) is 
possible while a portion is being electrosprayed. The resulting MS spectra can thus be correlated 
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with the collected eluants and, depending on the interfaced LC set-up, with other detection 
systems such as a UV detector for example. 
 
In LESA mode, the NanoMate system works as follows. The robotic arm picks up the conductive 
tip, aspirates the solvent from a reservoir and dispenses it on a specific location on the sample 
surface. It then aspirates back the extract and attaches the tip to an ESI chip nozzle for 
electrospraying. In fact, there is very little difference in the mode of operation as in the usual 
infusion mode, except that the solvent is allowed to flow out of the conductive tip and be in 
contact with the surface first before introducing to the electrospray emitter. 
 
Crucial to the optimization of LESA using the NanoMate platform are the distance of the tip 
relative to the sampling surface, the kind and amount of solvent used for microjunction 
formation, the hydrophobicity and matrix of the surface to be analyzed, the contact time between 
the solvent and the surface during the extraction process, the number of extraction repeats used 
for sampling, as well as the parameters used for the generation of the electrospray. The first three 
conditions determine the quality of the microjunction created, ie., its size, shape and recovery. 
Depending on the application, the size is of particular importance because it determines the 
spatial resolution that can be achieved when using LESA. The contact time and number of 
extractions, on the other hand determine the extent of the extraction and thus has particular 
importance in quantitation applications (sample recovery, repeatability of measurements, and 
method feasibility). Whereas the electrospray parameters such as the capillary voltage and gas 
pressure, as well as the MS parameters, determine the overall quality of the spectra being 
generated. 
MS Imaging 
MS imaging is a direct surface sampling method that allows the mapping of analyte distribution 
based on their peak intensities in the mass spectra collected throughout the entire sample surface. 
This involves the use of a sampling source, typically a laser or secondary ions, that rasters on the 
surface to desorb/ionize material. For each point on the surface, mass spectra and coordinates are 
simultaneously obtained, and then processed so that each point will correspond to a pixel in the 
molecular image. As such, a single pixel can contain a multititude of information from the peaks 
corresponding to analytes contained within the sample, spanning a wide range of biomolecule 
families like small molecule metabolites, lipids, peptides and proteins. The major strength of this 
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approach is the simultaneous analysis of these components in a one-shot analysis, with minimal 
sample preparation steps. The generation of molecular maps allows for their spatial localization 
approaching subcellular resolution. Fundamentally a non-targeted, multiplexed approach, MS 
imaging allows for the detection of changes across the sample due to its high data acquisition 
capability. In contrast to traditional approaches such as whole body autoradiography, analytes are 
detected from the image based on their characteristic mass-to-charge (m/z) ratios and without the 
use of radioactive labeled compounds. 
 
Figure 4. MSI workflow. 
Tissues are obtained after sacrificing the organism and dissecting the organs; they are then kept 
viable by storage at cryogenic temperature or fixation. Micrometer-thin sections can be obtained 
from the tissue by cryosectioning, and these are mounted on conductive glass slides. To prevent 
analyte delocalization, the tissue is dried under vacuum. Matrix is then deposited and once dry, 
the sample is irradiated point by point while the laser is rastering across the entire section. For 
each point, spectra are recorded, and the ion distribution for each m/z peak is mapped using the 
point coordinates (pixels) during data processing and image reconstruction. (Reprinted from 
(Franck, Arafah et al. 2009) with permission from the American Society for Biochemistry and 
Molecular Biology). 
 
A typical MSI experiment is outlined in Figure 4. By means of cryosectioning, micrometer-thin 
sections are obtained from tissue specimens that have either been frozen, formalin fixed and 
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paraffin-embedded, or preserved by other means and mounted on a slide. Point by point 
collection of spectra is then performed by rastering across the section, generating a grid of points 
that are then converted into spatial coordinates once the spectral acquisition step is done. Finally, 
the image is generated by displaying the intensity of an ion at the selected m/z value. The quality 
of the generated image can be assessed in terms of three figures of merit, two of which are 
coming from MS (Pol, Strohalm et al. 2010). Mass accuracy refers to the agreement of an ion’s 
measured mass (or m/z) with its theoretical mass (expressed in parts per million units) and is 
dependent on the type of mass analyzer used (Rompp and Spengler 2013). This parameter is 
crucial particularly for peptide/protein identification in proteomics experiments because of the 
multitude of isobaric peptides that can exist in a complex sample that could lead to false positive 
identifications. Mass resolution or resolving power, on the other hand, refers to the minimum 
difference by which two ions can be discerned from each other (Smith, Kilgour et al. 2013). This 
is usually obtained by dividing the m/z value with the full width at half maximum (FWHM) of 
the ion peak (Marshall and Hendrickson 2008). This parameter is important in spatial localization 
because low-resolution images can generate false distributions especially if the individual 
isobaric ions produce distinct distributions themselves. The third figure of merit, spatial 
resolution, is a microscopy imaging parameter defined as the minimum distance between two 
objects that can be used to discern them from each other. In MSI, spatial resolution can be 
determined as the center-to-center distance between two sampling regions assuming that each 
sampling region corresponds to a single pixel in the image (Rubakhin, Jurchen et al. 2005).  
 
The mass accuracy, resolutive power and spatial resolution requirements of an MSI experiment 
depend on the type of analyte being examined. Mass accuracy and resolutive power rely heavily 
on instrumental capability, especially the kind of mass analyzer used. Whereas, spatial resolution 
is dependent on the quality of preparation of the sample and all the other steps prior to analysis in 
the mass spectrometer.  
 
In regard to instrumentation, current mass analyzers can be categorized into three groups, with 
the Fourier transform ion cyclotron resonance (FTICR) possessing the highest resolutive 
capability of up to 3,000,000 FWHM (Smith, Kiss et al. 2013), followed by the orbitrap mass 
analyzers (resolution up to 240,000 FWHM, (Michalski, Damoc et al. 2012)) and the time-of-
flight (TOF), ion trap, or any of the hybrids (usually containing two mass analyzers and a 
  43 
collision cell such as triple-quadrupole, quadrupole-TOF, and TOF-TOF, with resolutive power 
typically between 1,000-25,000 FWHM). 
 
TOF mass analyzers use a drift tube under vacuum, with the ion source held at one end and a 
microchannel plate detector placed on the other end. The m/z of the ions generated from the 
bombardment of the sample is obtained by measuring the time it takes for the ion to travel thru 
the field-free drift tube until they hit the detector (Cotter 1992). Initially all the ions that enter the 
drift tube have ideally the same kinetic energies, thus, the time it takes for each ion to hit the 
detector will be dependent on its mass with the lighter ions reaching first and the heavier ones 
going last. As such, TOF mass analyzers theoretically have no mass limit, although 
measurements only up to m/z 200 kDa have been reported for proteins. MSI is commonly 
performed using TOF mass analyzers  because of the broad mass range afforded by these 
instruments, their rapid acquisition rate, and their compatibility with vacuum-based ion sources 
(Suckau, Resemann et al. 2003).  
 
Quadrupole mass analyzers transmit ions by a filtering mechanism using oscillating electrical 
fields to selectively stabilize or destabilize ion trajectories as the ions pass through a radio 
frequency quadrupole field produced by 4 parallel rods (Miller and Denton 1986). Changing the 
potentials of the rods allows for the selective passing of a certain m/z range, allowing the ejection 
of qualified ions either continuously or in discrete successive pulses. Variations of this 
configuration such as in triple-quadrupoles allows for further discernment of ions (Yost and Boyd 
1990). They are initially filtered in the first quadrupole, then enter a collision cell where 
additional fragmentation is performed, then pass through a second filter in the third quadrupole, 
which only selectively transmits fragments of the ion that has been subjected to fragmentation in 
the collision cell.  
 
In contrast to quadrupoles which transmit ions by filtering them according to m/z, ion traps "trap" 
packets of ions in a three-dimensional space defined by a ring electrode between two endcap 
electrodes (Paul 1990). Varying the radio frequency potential (supplemental oscillatory excitation 
voltage) of the endcap electrodes allows for the destabilization of the orbits of the ions, so that 
those with low masses get ejected from the z-axis on to the detector, while the rest remain in orbit 
inside the trap. As the space of the trap is defined, only a limited range of m/z can be trapped at a 
time. Hence the working m/z range of ion traps is typically below 4000 Da, though interfacing it 
  44 
with ion sources capable of producing multiple-charged ions makes it applicable to larger 
molecules such as proteins.  
 
FTICR mass analyzers (Marshall, Hendrickson et al. 1998) measure mass using the image current 
the ion generates as it accelerates in a spiral trajectory held by a static magnetic field  and pushed 
by a rapidly varying radio frequency electric field (Penning trap). As they do so, they form part of 
a circuit and detectors specifically placed at fixed positions in space record the electrical signal 
over time, generating the periodic signal. The frequency of the cycling of the ion is dependent on 
its m/z, and a Fourier tranformation deconvolution of the signal leads to this value. Repetitive 
measurement of the ion signal thus provides high sensitivity and resolutive power in this mass 
analyzer. Orbitrap mass analyzers, on the other hand, trap ions in an oscillating electric field 
produced by a central electrode working at constant voltage and outer electrodes at varying 
voltages (Zubarev and Makarov 2013). As in FTICR instruments, the image of the ion current 
generated as it oscillates back and forth on the central electrode is recorded and subjected to 
Fourier tranformation to obtain the m/z value.  
 
As previously mentioned, spatial resolution is a microscopy factor dictated by the quality of 
sample preparation as well as the steps prior to introduction of the sample to the mass 
spectrometer. Degradation begins immediately upon procurement of biological samples as they 
often contain proteolytic enzymes that are activated once exposed to suitable conditions. As such, 
biopsy samples are frozen in liquid nitrogen and stored in -80C to retard the proteolytic activity 
of these enzymes (Norris and Caprioli 2013). Rat brain samples prepared this way have been 
reported to be viable for one year, after which, degradation starts to become significant. Another 
method is to crosslink the proteins on the tissue using formaldehyde followed by embedding in 
parafilm (Maes, Broeckx et al. 2013) . This is the most common method of storing biopsy 
material for archiving, as the fixed sample can be stored at room temperature for years because 
the extensive crosslinking induced by formaldehyde hinders the enzymatic activity of the proteins 
on the tissue (Scicchitano, Dalmas et al. 2009). Once the samples have been procured, care in 
their handling during sectioning must also be done. For frozen samples, an abrupt increase in 
temperature during cryosectioning can lead to melting of the tissue and codensation of moisture 
on the surface, not only hastening enzymatic degradation but more importantly causing 
delocalization of the components. Also, the thickness of the sections could play a role in the 
sensitivity or the applicability of the ionization method that will be used. As a guide, the average 
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cell size between 10-20 µm is used depending on the tissue specimen, and single cell layers are 
generally prefered for imaging work (Ye, Greer et al. 2011).  
 
Once the tissue sections have been prepared, the succeeding preparation steps are dependent on 
the type of ionization source that will be used. This can either be vacuum-dependent or ambient 
type. 
Vacuum-Dependent Sources 
Vacuum-dependent ion sources are those that necessitate the use of a vacuum system in order to 
function. The vacuum is essential because it is important that the ions produced do not collide 
with the background gases as they enter the detector, otherwise they lose their kinetic energies. 
The vacuum is also a means to prevent contamination by background gases that can be adsorbed 
during measurment.  
Secondary Ion MS 
In its simplest form, SIMS uses a primary beam of ions placed at a specific angle to the sample 
surface so that the collision of the ions with the sample produces a plume of secondary ions that 
are then collected and analyzed in the mass spectrometer (Pol, Strohalm et al. 2010). The ion 
beam can be generated using  liquid metal ions, such as gold, Ga+, Bi+ or In+ (Ye, Greer et al. 
2011), or by electron ionization of noble gases such as 40Ar+ or Xe+, oxygen (16O-, 16O2
+, 16O2
-), 
ionized molecules (SF5
+) and fullerene (C60
+), or by surface ionization (133Cs+). As these primary 
ions possess high energies, their bombardment of the sample cause damage on the primary area 
of impact, thus making SIMS a hard ionization technique. The resultant high energy secondary 
ionization leads to the formation of very small fragments which are actually remnants of the 
analytes that were not on the direct path of the beam. SIMS works best at the low mass range, 
with a mass limit of m/z <4000. The size of the analyte that is ionized depends on the ion beam 
that is being used; large cluster ions such as SF5
+ and C60
+ are able to expel larger fragments from 
samples and thus these ion beams find particular biological applications notably for the analysis 
of lipids and small metabolites (Fletcher, Lockyer et al. 2007; Jones, Lockyer et al. 2007). 
Currently it is still difficult to analyze proteins using SIMS mainly because the ion beams 
mentioned are inefficient to expel such large molecular assemblies, though in some instances it 
might be possible to eject fragments of these proteins at low ion yields (Figure 5 (Komatsu, 
Murayama et al. 2008)). Resampling of the same area on the sample permits the use of SIMS in 
depth profiling studies (Debois, Brunelle et al. 2007); however, the chemical damage induced by 
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the ion bombardment restricts depth profiling up to submicron levels, known as the “static limit” 
of the analysis. 
 
Figure 5. TOF-SIMS imaging of Human serum albumin (HSA) film sample. 
(a) optical image of HSA film spotted with trypsin droplets using a modified BJ printer. (b) Ion 
images of digested fragment peptide ion peaks. (c) Gathered ion image of all digested fragment 
peptide ion images. (d) Ion images of non-digested material (siloxane molecule and gold). 
(Reprinted from (Komatsu, Murayama et al. 2008), with permission from Elsevier). 
 
SIMS operating in static mode (Pol, Strohalm et al. 2010) currently offers nanometer resolution, 
the highest resolution possible for any MSI technique. This is made possible by pulsing the 
fluence of the primary ion beam, thus keeping it at a very low level thereby effectively reducing 
the area being sampled as well. The consequence of this though is the relatively low ion yield, 
leading to a much lower signal sensitivity. On the other hand, in dynamic SIMS, a higher energy, 
continuous primary ion beam is used, so that bombardment of the sample surface leads to its total 
destruction. As a consequence, more ions per pixel are produced and even smaller fragments are 
generated compared when using low energy ion beams.  
 
In essence, no additional sample preparation steps are necessary for a SIMS analysis. Optional 
methods can improve the sensitivity of the MS acquisition depending on the application being 
pursued. For instance, a method called freeze fracturing can be done in order to lyse cells without 
disrupting the localization of their components by growing them on a conductive surface 
sandwiched with another one, freezing them in liquid nitrogen, and pulling apart the two pieces 
together (Roddy, Cannon et al. 2002). Freeze drying in liquid propane (Lanekoff, Phan et al. 
2013) or crosslinking the cellular components with formaldehyde prior to analysis (Xia and 
Castner 2003) can also be done to preserve the localization of the components. For the analysis of 
  47 
trypsinized proteins, it has been reported that the use of a liquid matrix containing trifluoroacetic 
acid enhances the sensitivity of the SIMS experiment (Nygren and Malmberg 2010). 
Matrix-Assisted Laser Desorption/Ionization 
MALDI is a soft-ionization technique that serves as the method of choice for detecting 
biomolecules directly from sample surfaces. In MALDI, the sample surface is coated with a 
matrix that serves as the primary energy absorbing compound (Karas, Bachmann et al. 1987). 
The surface is then irradiated with a laser beam passed the limit of the fluence threshold. Most of 
the energy from the incident laser beam is absorbed by the matrix, although some of it will 
eventually be transfered to the analytes on the sample surface, triggering their desorption and 
ionization. Eventually a plume of charged molecules, their alkali metal adducts, as well as neutral 
species is created on the irradiated surface, and the charged species are accelerated from the 
source towards the mass analyzer by application of an electric field. The resultant ionization 
generally produces singly charged species although sometimes doubly charged species can also 
be observed especially for larger molecules (Karas, Gluckmann et al. 2000; Karas and Kruger 
2003). Conventional vacuum-based MALDI sources use UV lasers such as the N2 or frequency-
tripled neodymium-doped yttrium aluminium garnet (Nd:YAG) lasers operating at 337 nm and 
355 nm respectively. The more recent development called atmospheric pressure MALDI (AP 
MALDI), a variation of this source that can operate without the need for a vacuum, runs on an IR 
laser operating at 2940 nm and takes advantage of the vibration of water molecules on biological 
samples in order to induce their desorption, but provides less sensitive detection (Li, Shrestha et 
al. 2007).  
 
The matrix is of paramount importance in MALDI (Burton, Watson et al. 1997; Lietz, 
Gemperline et al. 2013). They are usually aromatic compounds that absorb energy at the 
aforementioned wavelengths preventing the premature degradation of the analytes prior to 
desorption and energy transfer steps (Li, Inutan et al. 2012). Also, during the process of 
deposition, matrix solvents extract the analytes from the surface and inhibit proteolytic activity of 
the enzymes present by denaturing them. The organic solvent is eventually evaporated by drying 
the slide under vacuum, leaving a homogeneous coating of matrix crystals on the surface doped 
with the analytes. When already in gas phase, the matrix acts in concert with the acid usually 
added to the solvent as a reservoir of protons that initiates and maintains proton, cation and 
electron tranfer processes eventually resulting in the formation of singly-charged species. Often 
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the choice of matrix determines the outcome of a MALDI analysis in terms of the type of analyte 
(Figure 6). Lipids are best detected using 2,5 dihydroxybenzoic acid (DHB), for example, while 
peptides and and proteins are best detected using α-cyano-4-hydroxy cinnamic acid (HCCA) and 
sinnapic acid (SA), respectively (Norris and Caprioli 2013). As these analytes usually occur at 
distinct mass ranges, typical MALDI analysis workflows usually also limit the mass range of 
analysis to focus on the particular type of analyte for enhanced sensitivity. Specialized matrices 
are also available for more specific kinds of analyses. For instance, the liquid ionic matrices 
derived from stoichiometric mixtures of aniline with the aforementioned matrices work best in 
the MS imaging of analytes on biological tissue samples (Meriaux, Franck et al. 2010). In-source 
decay fragmentation methodologies used in top-down proteomics MS specifically use 1,5-
diaminonaphthalene to induce direct fragmentation of proteins (Sellami, Belgacem et al. 2012).  
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Figure 6. The choice of matrix depends on the analyte to be detected in MALDI MSI. 
Images obtained from two consecutive rat brain sections. Top: imaging of lipids using DHB. 
Below: imaging of intact proteins using SA. In both panels, the upper left image next to the scale 
is the composite of the three m/z mapped. 
 
For imaging, the matrix can be deposited to the sample surface by various means (Franck, Arafah 
et al. 2009; Rompp and Spengler 2013). The method used determines the size of the matrix 
crystals that are formed; for improved resolution it is desirable to have smaller, more uniform 
crystallization because the size of the crystal affects the size of the pixel, whereas for improved 
analyte extraction yield (and therefore, detection sensitivity) it is necessary to increase the 
exposure of the analyte surface to the matrix solution to facilitate the process (inadvertently 
creating larger matrix crystals). Matrix deposition can be effected by manual spotting using a 
micropipette. This can provide efficient co-crystallization of analyte with the matrix, although 
this is generally avoided in imaging because of the delocalization of the analyte within the entire 
pool of the matrix solvent in addition to poor reproducibility of the spotting. Manual spraying can 
also be done using a pneumatic sprayer to spray coat the entire section, but for consistent results, 
automated devices are generally preferred (Sugiura, Shimma et al. 2006). Among these, the 
ImagePrep device is very popular because it is capable of controlling the deposition chamber 
temperature, as well as tightly regulating the quality of spraying, amount of matrix deposited, and 
drying intervals between spraying. ImagePrep exposes the sample section to a matrix aerosol 
generated by vibrational vaporization. Other devices work based on other modes of sample 
deposition, such as electrospraying (Wei, Nolkrantz et al. 2004), sublimation (Hankin, Barkley et 
al. 2007) and microspotting (by acoustic deposition or ink jet spotting). Electrospraying and 
sublimation methods work best for analytes that do not need to be co-crystallized with the matrix 
(such as lipids) because there is no or very little amount of solvent used during the deposition. On 
the other hand microspotting generally leads to micrometer-sized spots (150 µm diameter), with 
analyte diffusion determined by the size of the microspot. The loss of spatial resolution in 
microspotting is compensated for by the more efficient extraction and co-crystallization of the 
analyte and this method finds particular use in protein MS imaging. 
 
Apart from matrix deposition, additional sample preparation steps are necessary for an effective 
MALDI-based imaging analysis. Depending on the analyte of interest, steps such as washing and 
interfering analyte depletion, in situ enzymatic digestion, and signal enhancement by chemical 
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derivatization, can be incorporated in the imaging workflow to improve the data generated. 
Washing or depletion (Grey, Chaurand et al. 2009) is done by incubating the tissue section in 
solvents that liberate components selectively. The selectivity of the wash depends on the 
chemical properties of the component that needs to be removed. For example, in the MS imaging 
of proteins, it is necessary to delipify tissue sections using organic solvents (Lemaire, Wisztorski 
et al. 2006). The amphoteric property of proteins renders them resistant against organic solvents 
and as such, they are retained on the tissue after the wash. Whereas doing the reverse, ie, wash 
with aqueous solvent to remove proteins, might not necessarily enhance lipid detection; they may 
serve to deplete the tissue of abundant proteins and salts that can otherwise mask the signal of the 
less abundant ones during the MS analysis. This has been observed in the analysis of integral 
membrane proteins in the eye lens, for example, where the depletion of crystallins by repeated 
washing with water exposes aquaporins (Grey, Chaurand et al. 2009). Enzymatic digestion is a 
means to generate peptides for bottom-up MS imaging strategies (Groseclose, Andersson et al. 
2007); further details about protein identification using this strategy will be discussed later. 
Direct enzymatic digestion of a tissue section can be done by depositing the proteolytic enzyme 
using the same devices used for matrix deposition. As the enzyme will also be present on the 
tissue during MS analysis, care should be taken to minimize its signals by regulating the amount 
and concentration of the enzyme deposited, and by dissolving them in buffers that can be 
tolerated by the mass spectrometer. In cases where identification of the protein directly on tissue 
is necessary, chemical modifications that can orient the fragmentation of this protein to a specific 
ion series thereby enhancing the overall quality of the MS/MS spectrum generated can be done 
by treating the tissue with specific reagents prior to MS analysis (Figure 7 (Franck, El Ayed et 
al. 2009)). These reagents can be deposited using the same devices previously described. In all 
cases, it must be noted that the overall spatial resolution of the image of the treated sample will 
be influenced by all the sample treatments used, and as such, the choice of the washes or the 
deposition of proteolytic enzymes or derivatization agents must be carefully regulated to avoid 
delocalization of the analytes.  
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Figure 7. N-terminal derivatization improves on-tissue MS/MS identification of peptides. 
MALDI MS spectra recorded after (a) enzymatic digestion followed by N-
(succinimidyloxycarbonylmethyl)tris(2,4,6-trimethoxyphenyl)phosphonium bromide (TMPP) 
derivatization and (b) enzymatic digestion. (c) Images of the digestion peptide at m/z 726 and its 
corresponding TMPP derivative at m/z 1299, showing an identical distribution for both ions. 
MALDI MS/MS spectra recorded from a rat brain tissue section in the same area after on-tissue 
trypsin digestion with and without TMPP derivatization (d and e, respectively). (f) Identification 
results from the databank using R. norvegicus taxonomy. Reproduced with permission from 
(Franck, El Ayed et al. 2009). Copyright (2009) American Chemical Society. 
 
Ambient Sources 
Several ambient ion sources have been used for MS imaging applications. Of these, the most 
extensively used are DESI (Eberlin, Ferreira et al. ; Wiseman, Ifa et al. 2006; Laskin, Heath et al. 
2011) and LAESI (Nemes and Vertes 2007; Nemes and Vertes 2010). The major advantages of 
this type of imaging are that even lesser sample preparation steps are needed and ionization can 
be effected using ESI. As such, it is possible to generate multiply-charged ions which can be very 
useful if tandem MS analysis such single-reaction monitoring type imaging would be required. 
Their limitation though, is the low spatial resolution attainable, currently at about 180-200µm for 
DESI (Ye, Greer et al. 2011). (Spatial resolution as low as 40m has been reported (Kertesz and 
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Van Berkel 2008), but its wider applications have yet to be demonstrated.) By eliminating the 
need for vacuum, ambient sources futher extend the applicability of MS imaging to real world 
situations. This however, presents its own unique challenges to MS imaging. For instance, it may 
not be fully possible to eliminate contamination due to the environment of the sample, paticularly 
if this environment cannot be controlled. Another challenge is the desorption, ionization and 
transmission of the analytes. Ambient sources are typically placed in front of the inlet of the mass 
spectrometer, with the desorbed analytes simply drawn into the inlet by virtue of gas flow into 
the capillary. Whereas in contrast, vacuum-based sources have been reported to have a maximum 
ion transmission of about 50%, in spite of more efficient and carefully controlled ion collection 
methods. It is highly doubtful that ambient sources are capable of matching this yield, although 
perhaps liquid extraction surface sampling type sources might be able to overcome this limitation 
by making multiple extractions on the same region prior to injection to the mass spectrometer. 
Figures 8 and 9 show examples of ambient MS imaging of proteins.  
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Figure 8. Top-Down LAESI-MS Imaging of intact proteins in a mouse lung section. 
Optical (G), selected ion images (A, C, E) and selected isotope images (B, D, F) obtained using 
LAESI FT-ICR MS. The MS images show the distribution of the ions at m/z 822 (15.6 kDa: A, 
B), 827 (5 kDa: C, D) and 883 (15.6 kDa: E, F). (Reproduced with permission from (Kiss, Smith 
et al. 2014), Copyright (2014) John Wiley and Sons). 
 
 
Figure 9. DESI-MS imaging of a binary combination of cytochrome C and BSA standards 
printed on Permanox surfaces.  
Left shows the layout of the spotting. (Reprinted from (Rao, Celiz et al. 2013) with permission 
from Springer Science and Business Media). 
Identification and Quantification of Proteins On Tissue by MS 
Direct identification of proteins on tissue remains one of the key challenges in direct tissue 
methods of MS analysis. As such, it becomes the bottleneck of these methods aimed at the 
discovery of novel protein biomarkers for example, as understanding the biology of a disease and 
design of putative therapeutic drugs rely heavily on the identity and nature of these biomarkers. 
In contrast to small molecule metabolites, drugs, lipids and endogenous peptides, whose 
identification and quantification can be established using tandem MS and related techniques 
(SRM and so on), proteins present unique challenges owing to their significantly larger molecular 
masses. For instance, it is more difficult to fragment them using conventional fragmentation 
methods especially in the MALDI setting which yields singly-charged ions. An added 
complication is the existence of numerous protein isoforms and the presence of post-translational 
modifications. The former complicates an otherwise rather simple bottom-up analysis by 
demanding more identified peptides per protein ID in order to discern them better from their 
isoforms; in most instances particularly if the sample matrix is complex, it is already difficult to 
find one peptide for a low abundance protein. The latter on the other hand complicates the 
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MS/MS spectrum of a fragmented peptide by introducing masses not typically observed in that 
peptide’s fragmentation pattern.  
 
For a long time, MS developments have solely been improved for the qualitative assessment of 
specific proteins on samples. However, increasing applications demanding for the examination of 
protein expression levels necessitate the development of quantification strategies to monitor the 
changes of these levels especially in instances when the organism under study is being subjected 
to stress in disease states. These quantification strategies stress the importance of protein 
expression changes and relate these changes with each other so that an integrative view 
encompassing an entire protein network can be examined. As such, these strategies are therefore 
focused on the quantification of proteins en masse, in contrast to conventional methods aimed at 
detecting and quantifying only one or a few set of proteins. 
Peptide Mass Fingerprinting 
Peptide mass fingerprinting (PMF) is a method used to make protein ID assignments using mass 
spectra (Henzel, Billeci et al. 1993; James, Quadroni et al. 1993; Pappin, Hojrup et al. 1993; 
Yates, Speicher et al. 1993). An isolated protein is prepared either intact or digested, and 
subjected to ionization then mass analysis, so that the generated spectrum contains m/z peaks 
corresponding to the sequential fragmentation of the protein both along the N- and C-terminals. 
The mass peaks are tabulated and compared with pre-existing protein databases constructed from 
the theoretical fragmentation of a protein (termed in silico digestion) whose sequence has been 
determined from translation of the genome database. The specific sequence of the amino acids in 
a protein yields specific sequential fragmentation and this pattern is used to discern proteins from 
each other. After interrogation, a list of putative protein IDs is obtained and decisions on the 
protein ID assignment is based on the statistical confidence of the m/z alignment. 
 
The strength of this approach is that it does not necessitate the use of the more rigorous de novo 
peptide sequencing method which is the traditionally used method for protein sequencing. 
However, it is important that the database used for spectral alignment must have a comprehensive 
protein list. Also, the method is very prone to error if the sample analyzed is impure. The 
presence of other proteins in the sample could interfere with the PMF generated by introducing 
artifact peaks that will decrease the confidence of the protein alignment. Also, not all proteins 
behave in exactly the same way and some do not yield very good PMFs. This can be due to poor 
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fragmentation or the presence of amino acids that tend to absorb incident ionizing energies more 
compared to others. To address this issue, it might be necessary to use chemical derivatization so 
that only a specific ion series containing intense and more or less complete fragmentation peaks 
will appear in the mass spectrum thus greatly improving unambiguous protein assignment.  
 
A special means to generate protein PMFs is by analysis of the intact proteins directly using top-
down approaches (Catherman, Skinner et al. 2014). Fragmentation of intact proteins is induced 
by subjecting them to other kinds of fragmentation mechanisms instead of the convential 
collision induced dissociation (Schey, Anderson et al. 2013; Kiss, Smith et al. 2014). In a 
MALDI-based platform, this can be achieved by spraying the tissue surface with 1,5-DAN and 
subjecting it to in-source decay (ISD, (Calligaris, Villard et al. 2011)). ISD is a phenomenon that 
occurs when the laser fluence is increased 15-20% above the analyte’s threshold so that in the 
process proton transfer happens between the matrix molecules and the analyte’s backbone C=O. 
This leads to fragmentation following either a radical pathway (forming c- and z- ion series) or a 
thermal pathway (forming x-, y- and a-, b- ion series). In electrsopray platforms, electron transfer 
dissociation (ETD, (Syka, Coon et al. 2004)) or electron capture dissociation (ECD, (Zubarev, 
Kelleher et al. 1998)) can be used to do top-down MS. Such methods uilize ion/electron or 
ion/ion interaction mechanisms to dissociate gas phase ions into their fragments (Hart-Smith 
2014). The ions receive electrons to produce radical cations that initiate the fragmentation 
process. However, in contrast to CID, the fragmentation does not follow the typical energy 
redistribution that leads to the dissociation of the weakest bonds, but rather follows those similar 
to ISD. The success of these top-down approaches have been demonstrated in a variety of 
systems, the greatest advantage being that PTMs are retained and can be analyzed. However, they 
still remain somewhat restricted to single-protein or simple mixture analysis, although recent 
developments in separations will make these approaches a viable alternative to digestion-based 
ones. 
Tandem MS 
Tandem MS methods are those where a precursor ion from an initial full MS analysis is subjected 
to further fragmentation in order to create product ions in a subsequent MS/MS analysis (Figure 
10 (Louris, Wright et al. 1985)). The prototypical example of this is with the use of the triple 
quadrupole mass analyzer previously described, where the second quadrupole acts as a collision 
chamber where CID-type dissociation can occur (Yost and Enke 1977; De Hoffmann 1996). The 
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As such, their use in proteomics allowed for a deeper probing of the proteome never before 
realized. 
 
NanoLC-interfaced orbitrap mass spectrometers generally yield thousands of MS/MS spectra in a 
single chromatographic run. Individual inspection of these spectra is tedious, and bioinformatics 
methods to address this issue have been developed through the years. The tenet of protein 
identification in these methods can be explained as follows. Consider a peptide sequence shown 
in Figure 11, where it is shown that it can fragment in a variety of ways to yield different types 
of ion series during MS/MS. The most dominant of this is the b-ion series, where the ions are 
formed from amide bond cleavage on the C-terminal end of the peptide (Hunt, Yates et al. 1986). 
In an ideal situation, the sequence of the original peptide can be derived simply from calculating 
the mass differences of the peaks in a sequential manner from the high mass to the low mass end 
(or vice versa), and comparing these losses to the unique masses of the known amino acids, a 
method known as de novo sequencing (Medzihradszky and Chalkley 2013). However, in the real 
situation, many elements can compound a mass spectrum. For instance, the reverse sequence, the 
y-type ion series, which occurs if the charge is retained on the amine group during fragmentation, 
also appears in the spectrum and has an equal likelihood to appear (Biemann 1990).  Sometimes 
the a-type ion series which are produced during the decarboxylation of the b-type ions can also be 
present. Further compounding the spectrum is the fact that the ion series may be incomplete 
because of variations in peak intensities due to the preference of the fragmentation to certain 
types of mechanisms. 
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Figure 11. Peptide ion series nomenclature. 
The most commonly observed peptide fragments in low energy collisions such as in ion trap, 
triple quadrupole and q-TOF mass spectrometers are the b, y and a ions. b-ions extend from the 
N-terminus while the y-ions extend from the C-terminus. a-ions are produced by decarboxylation 
of b-ions are diagnostic of their presence. c- and z-ions, on the other hand, are produced by 
peptide backbone fragmentation following a non-ergodic process when exposed to electrons of 
near thermal energies. Adapted from (Roepstorff and Fohlman 1984) and (Biemann 1988). 
 
Nonetheless, since the probability of occurrence of the ion series is known, it is actually possible 
to produce a hypothetical spectrum considering all the factors mentioned. This system works if 
there is prior knowledge of the peptide sequence but fails, however, in discovery-driven 
approaches. The alternative approach in this case is to guess every amino acid sequence possible, 
build hypothetical spectra from these, and find the best match (Spengler 2004). Even if this is 
possible, it becomes impossibly difficult after 7-8 amino acids because of the increasing false 
positive rates. Even so, the idea to come up with hypothetical spectra for every possible sequence 
permutation became the basis for subsequent improvement. With the emergence of the whole 
genome sequencing era, it became apparent that the genome sequencing technique can also be 
applied to tandem MS data. Thus, instead of searching all possible peptide sequences, a 
significantly smaller genome database can instead be accessed. This translates to a 10,000 fold 
decrease in the amount of sequences that needs to be examined for a 20-mer set of non-redundant 
amino acid sequences currently available in the National Center for Biotechnology Information 
(NCBI) database.  
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for MALDI MSI this is done by capitalizing on post source decay (PSD, (Spengler 1997)), a 
metastable type of fragmentation that occurs immediately after the ions exit the high field region 
of the source due to the excess internal energy that they possess by colliding with other ions or 
with gas. In MALDI-TOF/TOF instruments, a lift cell is employed in order to accelerate, collect 
and resolve these fragments and provides the MS/MS spectrum depending on the isolated m/z. 
Even so, PSD provides limited MS/MS spectra mainly because PSD fragmentation occurs after 
the analyte ion has left the source, leading to significant ion losses especially for larger m/z 
values (Durrant and Brown 2009). Increasing the laser energy may increase the amount of 
fragments that can be generated, but this is at the expense of losing spectral resolution. A further 
limitation is the innate complexity of the tissue matrix, which induces ion suppression. As such, 
direct MS/MS on tissue is scarcely performed, and often only leads to the identification of 10 or 
so abundant proteins or endogenous peptides. This can be further improved by introducing ion 
mobility to separate isobaric ions (Stauber, MacAleese et al. 2010), nonetheless, the single charge 
ion production of MALDI sources poses a serious drawback to begin with and limits the overall 
efficiency of the fragmentation in this method. 
 
An alternative approach is done by subjecting an adjacent tissue section to protein extraction and 
nanoLC-MS analysis, generating a database of peptide and protein IDs that are then matched with 
the peptide masses obtained from the MSI of the other tissue section (Chaurand 2012; Mascini 
and Heeren 2012). For this approach to be effective, it is necessary to meet two criteria: 1) the 
accuracy of both MSI and LC-MS should be high, in order to avoid false identifications, and 2) 
the peptides in the tissue subjected to LC-MS analysis should be representative of those in the 
tissue subjected to MSI. The first criterion can be met by using high-accuracy instruments in both 
analyses, so that a maximum deviation of <10 ppm can be imposed during matching (Schober, 
Schramm et al. 2011). For MALDI-TOF instruments, such a criterion can be met by adding 
internal calibrants during the sample preparation (Gustafsson, Eddes et al. 2012). The second 
criterion, on the other hand, can be met by using the same sample block for protein extraction in 
both analyses. In addition to imposing a very low maximum deviation value, additional 
confirmatory analysis can also be performed to validate the protein identifications, such as by 
imuunohistochemistry, although such validation can be limited in terms of the number of proteins 
that can be validated due to expense. 
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It must be noted that although the generation of MS/MS databanks for matching with MSI data is 
an attractive means to provide unequivocal protein identifications, the approach does not really 
address the major limitation of MALDI-based approaches in that it is restricted to single charge 
ion production and thus limited protein identification utility (McDonnell, Corthals et al. 2010). 
Moreover, in the absence of reliable tandem MS spectra, correlation is highly dependent on the 
accuracy of the mass spectrometer and validation using complementary methods. Thus, there is 
still an on-going effort to merge the advantages of the two approaches into a single analysis.  
Direct Quantification Methods 
MS-based direct quantification methods pertain to those methods that allow the quantification of 
analytes directly on sample surfaces with minimal sample preparation and at the same time still 
keeping the analyte localization intact. This excludes stable isotope-based methods that entail 
extensive and rigorous sample preparative steps and where analyte localization is typically lost 
during sample processing. Quantification can be absolute or relative, and specific approaches 
have been developed depending on the type of direct MS analysis used. 
 
Peak intensities in a mass spectrum do not necessarily reflect the amount of analyte in a sample, 
although variation in these intensities for the same analyte across multiple samples can be 
indicative of varying abundance (Nikolov, Schmidt et al. 2012). Although peak intensities cannot 
be harnessed directly, their chromatographic traces can be monitored by constructing the elution 
profile of the ion of interest post-acquistion. Each elution profile can be refered to as the feature 
of that ion, and is the sum of all peaks detected in all consecutive mass scans collected at the 
retention time dimension. As such a feature is the three-dimensional representation of the m/z, 
peak intensity, and retention time of an analyte ion. Features can be detected and measured using 
the extracted ion chromatogram (XIC, (Higgs, Knierman et al. 2005)). This method provides a 
simplest means to quantify analyte signal by simply plotting the total intensity of a selected ion 
for a specified m/z window at a given retention time. Here the retention time is the apex of the 
intensity of the feature (Sandin, Teleman et al. 2014). Detection and identification of features can 
be done simultaneously. In label-free methods (ie., quantitative methods that do not require stable 
isotope incorporation) utilizing tandem MS, the scanning MS mode provides the MS1 spectra 
where the XIC is extracted, while the data-dependent MS2 spectra provide the peptide 
identifications (Nahnsen, Bielow et al. 2013). Such feature-based detection methods are the basis 
of such quantification softwares as MaxQuant, Skyline and Spectrum Mill (see (Sandin, Teleman 
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et al. 2014) for the comprehensive list). These methods are extensively used because of the 
accuracy of the quantitative measurements they produce.  
 
Another label-free method, called spectral counting, utilizes the linear relationship between the 
number of tandem MS/MS spectra used for protein identification and the abundance of that 
protein to derive relative quantitative information at the protein level (Neilson, Ali et al. 2011). 
This is possible because increased protein abundance leads to the generation of more tryptic 
peptides during the digestion step, and consequently results in increased protein coverage, 
number of unique peptide identifications, and eventually number of MS/MS spectra used for 
protein identification. Although less accurate than feature detection-based methods, spectral 
counting is more reproducible and provides a broader dynamic range (Zhu, Smith et al. 2009). 
Several improvements were done on this method, one of them corrects for the fact that larger 
proteins essentially generate more spectra compared to smaller ones. The normalized spectral 
abundance factor (NSAF, (Zybailov, Florens et al. 2007)) was defined to account for the 
variations in spectral count due to differences in potein length. Building on the spectral counting 
concept, absolute quantification strategies such as protein abundance index (PAI, (Rappsilber, 
Ryder et al. 2002)) and absolute protein expression (APEX, (Lu, Vogel et al. 2007)) have also 
been developed, among others; they mostly deal with the manner in which peptide spectra are 
being utilized to make quantitative inferences at the protein level. In PAI for example, a ratio of 
the identified peptides over the number of theoretical observable tryptic peptides is computed 
while in APEX, absolute protein concentration per cell is obtained. 
 
In another approach, transitions that occur as one selected peak is subjected to tandem MS 
fragmentation can be followed, and these transitions can actually accurately determine analyte 
quantity. Selected reaction monitoring (SRM) is a targeted approach where precursor-product ion 
transitions are monitored over time to yield chronograms with the retention time and the intensity 
of the specific transition as coordinates (Lange, Picotti et al. 2008). Filtering at the two stages can 
effectively eliminate background ions, resulting in high selectivity. Unlike full scans, an SRM 
scan is conducted only at a narrow m/z range resulting in improved sensitivity and a linear 
response over a wide dynamic range. It is thus ideal for the quantification of less abundant 
components of the sample mixture. 
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In contrast to conventional shotgun proteomics approaches, SRM is a targeted method aimed at 
quantification of pre-selected peptides, the design of which depends on the peptide being 
examined. Prior knowledge of the transitions is necessary for an effective SRM measurement 
(Sandin, Teleman et al. 2014). Specifically, proteins of the desired protein set have to be selected 
and can be done, for example, by subjecting an aliquot of the sample to shotgun LC-MS. Next, 
peptides that provide good MS spectra and uniquely identify these proteins (called proteotypic 
peptides) have to be identified, usually by scanning through the shotgun data previously 
generated or by computational methods (Mallick, Schirle et al. 2007). Then, fragments that 
discriminate one peptide from another and provide optimal intensity during MS/MS have to be 
identified. Rigorous time and effort is needed to conduct a good SRM experiment, nonetheless, te 
meticulousness of this method pays off because once the method has been established, it can 
easily be implemented, used indefinitely, and multiplexed with other SRM methods. 
 
In contrast to the methods previously discussed, MSI-based methods have been developed 
independently mainly because the heterogeneous nature of ionization has its own distinct 
challenges observable only in MSI (Gessel, Norris et al. 2014). A robust quantitative MSI 
method must take into consideration the fact that the analyte MS signal is dependent not only on 
the concentration but also on the efficiency by which the analyte has been ionized and also to its 
extractability from the sample. In matrix-based MSI, variations in matrix crystallization due to 
inhomogeneities present on the tissue further hamper the reproducibility of quantitative methods. 
Because of these limitations, current MSI-based quantification methods are mostly restricted to 
the analysis of drugs that have sufficient ionization yields and whose fragments can easily be 
monitored by SRM experiments if the need arises (Lietz, Gemperline et al. 2013). The most often 
used method nowadays relies on the addition of internal calibrants during the sample preparation 
steps, the MS responses of which are then used to make corrections during analyte concentration 
calculation (Gustafsson, Eddes et al. 2012). Internal calibrants used are usually stable isotope-
labeled variants of the analyte. These are either deposited on the sample section together with the 
matrix, administered to the organism prior to sample procurement, or applied to the surface prior 
to tissue mounting. Varying concentrations of the internal standard on the tissue can be used to 
construct calibration curves that can then be used to deduce the absolute concentration of the 
analyte. Notable applications of this approach have been reported for MALDI MSI and ambient 
source imaging (Pirman, Reich et al. 2012; Vismeh, Waldon et al. 2012; Lanekoff, Thomas et al. 
2014). Another approach, pioneered by Setou’s group in 2010, uses a correction factor to account 
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for the signal intensity variations across different types of tissue (Hattori, Kajimura et al. 2010). 
Building upon this approach, a homologous correction factor called tissue extinction coefficient 
(TEC) can be determined for a specific analyte on various types of tissue and these factor is then 
taken into consideration during the calibration curve construction (Hamm, Bonnel et al. 2012). It 
is to be noted that, at the present, no imaging-based protein quantification strategies have yet 
been developed, owing to the aforementioned challenges. 
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3PART 1 : IMPROVEMENT OF ON-TISSUE IDENTIFICATION 
STRATEGIES FOR MALDI IMAGING : TOWARDS SINGLE-PIXEL 
IDENTIFICATION 
 
Chapter 1 
Article 1 
Development of Liquid Microjunction Extraction Strategy for Improving Protein 
Identification from Tissue Sections 
Authors: Jusal Quanico, Julien Franck, Claire Dauly, Kerstin Strupat, Jocelyn Dupuy, Robert 
Day, Michel Salzet, Isabelle Fournier, Maxence Wisztorski 
Article Status: published in Journal of Proteomics [Volume 79, pages 200-218, 2013] 
Summary: 
Experimental manipulations, including protocol optimization, sample preparation, and data 
gathering, were realized by Mr. Quanico. He also contributed to the design of experimental set-
ups and decision making. In detail, my contributions include: 
1. Implementation and optimization of the liquid extraction surface analysis strategy prior to 
its use in this proteomics analysis, first by coupling on-line with an ion trap MS 
instrument, then by off-line analysis; 
2. Perform all MALDI-MS imaging experiments and MS imaging-related procedures such 
as sample preparation and enzymatic digestion, matrix application, and image acquisition 
and analysis; and 
3. Perform the on-tissue microdigestion and microextraction using the microspotter and the 
developed liquid microjunction extraction protocol, followed by extract handling prior to 
nanoLC-MS analysis. 
4. In terms of writing the manuscript, Mr. Quanico wrote the drafts which were then built 
upon in the subsequent writing of the final manuscript. He also edited the manuscript. 
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Resumé en français 
La technique d’imagerie  par spectrométrie de masse (MSI) MALDI a montré un grand potentiel 
pour la classification moléculaire et l’identification de marqueur de pathologies. Néanmoins, 
l’identification in situ des protéines reste très limitée due à la trop haute complexité des tissus. 
Par conséquent, seules les protéines les plus abondantes peuvent alors être identifiées.Les 
approches protéomiques conventionnelles quant à elles,  permettent l’identification d’un grand 
nombre de protéines aussi bien majoritaires que minoritaires et de façon plus fiable mais la notion 
de localisation est alors perdue. Dans cet article est présenté une approche permettant 
l’identification de protéines d’abondance aussi bien élevée que faible à partir de coupes de tissu, 
tout en conservant la donnée de localisation. Cette techniquerepose sur une stratégie de micro-
extraction par micro-jonction liquide sur des régions de coupes de tissus préalablement digérées à 
la trypsineCette stratégie s’est montrée très efficace pour extraire les peptides de digestion qui, 
après séparation par chromatographie liquide en phase inverse couplée à un instrument HR 
FTMS pour une analyse en mode MS/MS a permis l’identification moyenne de 1500 protéines à 
partir d’une région d’environ 650µm de diamètre correspondant à environ1900 cellules. Cette 
approche peut être facilement intégrée pour une approche de type MALDI-MSI donnant ainsi un 
fort potentiel pour des applications cliniques. 
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ABREVATIONS 
MSI : Mass Spectrometry Imaging ;RPLC : Reverse Phase Liquid Chromatography; LCM: 
Laser Capture Microdissection; ROI: Region of Interest; PCA: Principal Component Analysis; 
HC: Hierarchical Clustering, FFPE: Formalin Fixed and Paraffin Embedded; TOF: Time-of-
Flight; ISD: In Source Decay, ETD: Electron Transfer Dissociation; DESI: Desorption 
Electrospray Ionization; LESA: Liquid Extraction Surface Analysis; DBS: Dried Blot Spot; 
LTQ: Linear ion Trap; MeOH: Methanol; EtOH: Ethanol; HCCA:-cyano-4-hydroxycinnamic 
acid; SA: Sinapinic Acid; ANI: Aniline; HES: Haematoxylin Eosin Safran; ITO: Indium Tin 
Oxyde; Nd:YAG: Neodymium-doped Yttrium Aluminium Garnet; BSA: Bovine Serum 
Albumin; CID: Collision induced Dissociation; FWHM: Full Width at Half Maximum; amu.: 
Atomic Mass unit; FDR: False Discovery Rate; S/N: Signal to Noise; ID: identification; ppm: 
Part Per Million; LMJ-SSP: Liquid Microjunction-Surface Sampling Probe; SSSP: Sealing 
Surface Sampling Probe; CE: Capillary Electrophoresis. 
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SUMMARY 
MALDI Mass Spectrometry Imaging has shown important potential for molecular classification 
and pathology marker discovery. Direct structural analysis from tissue sections has shown 
limitations for protein identification because of the high degree of complexity of tissues. Only 
proteins of major abundance are identified this way. On the contrary, conventional proteomics 
approaches clearly allow for reliable identification of complex protein extracts but does not 
provide fine correlation with protein location in their original context. Here is presented an 
approach to obtain identification of proteins of various abundances while keeping their 
localization within the section. On-tissue trypsin digestion followed by micro-extraction using a 
liquid micro-junction interface is an efficient strategy to extract tryptic peptides and further 
identify the associated proteins off tissues. It was shown that conventional Reverse Phase Liquid 
Chromatography separation on the extracted material followed by MS/MS analysis on a HR 
FTMS instrument enabled the identification 1500 proteins on average with high confidence from 
an area of about 650 μm in diameter, which corresponds to an estimated number of 1900 cells in 
average. The approach can be easily integrated in the MALDI MSI workflow and should provide 
interesting insights for clinical applications. 
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INTRODUCTION 
Identification of molecular components involved in cellular mechanisms and their fine regulation 
is a key point for understanding physiological processes occurring in living organisms. Cell 
dysfunction processes greatly impact signaling pathways by modifications of molecular players. 
In particular, proteins are largely affected by cellular changes. These changes have an impact on 
their regulation (activation/repression of protein synthesis), primary structure (protein cleavage 
by enzymes, post-translational modifications), spatial arrangement and ability to complex with 
other partners (directly related to changes in protein concentrations and primary structure or due 
to changes in the environment such as ionic strength or pH). Over the past 25 years, many efforts 
were given to gain protein structural information and quantification. To date, proteomics offers a 
wide range of high performance strategies, methodologies and instrumentation to reach this goal. 
However, if conventional proteomics offers access to a large number of identified proteins, there 
is increasing evidence suggesting that such strategies lack correlation of the identified proteins to 
their location in their original context (i.e. tissues). For tissues, laser capture microdissection 
(LCM) systems have been developed to collect cells of specific phenotypes based on 
morphological criteria recognition (Craven and Banks 2001; Craven and Banks 2003; Mustafa, 
Kros et al. 2008; Rodriguez, Espina et al. 2008). Currently, for cell collection from tissues, LCM 
is the better suited method. However, LCM remains technically somehow difficult to setup 
whatever the used technology. For proteomics, sample collection is time-consuming because of 
the large number of cells needed to be collected to permit detection given the instrument 
available. Indeed, few thousands up to several dozen thousands might have to be captured for 
proteomics analyses. Studies show a clear correlation of collected cell numbers with the number 
of subsequently identified proteins. Previous studies show identification of about 100-200 
proteins for 500 cells, 500-700 proteins for 5000 cells and 1500-2500 proteins for 50 000-60 000 
cells (Cha, Imielinski et al. 2010; Wang, Xu et al. 2010; Stingl, van Vilsteren et al. 2011; Thakur, 
Rejtar et al. 2011; Wisniewski, Ostasiewicz et al. 2011). However, automatic cell collection, 
through the use of morphological recognition dedicated tools, is not always very reliable and 
manual collection is very time consuming. Additionally, it must also be noted that cell collection 
for LCM is based on morphological criteria and thus does not guarantee that all cells are involved 
in the same physiological processes due to the cells’ local microenvironment and cross-talk. 
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On the other hand, MALDI Mass Spectrometry Imaging (MSI) is a molecular imaging tool that 
can be used to study the spatial distribution of endogenous and exogenous compounds including, 
drugs (Khatib-Shahidi, Andersson et al. 2006; Bouslimani, Bec et al. 2010; Goodwin, Macintyre 
et al. 2010; Goodwin, Scullion et al. 2010; Solon, Schweitzer et al. 2010; Castellino, Groseclose 
et al. 2011; Goodwin, Mackay et al. 2011; Prideaux, Dartois et al. 2011), metabolites (Esquenazi, 
Coates et al. 2008; Miura, Fujimura et al. 2010; Van Dyck, Flammang et al. 2010; Porta, Grivet 
et al. 2011; Lee, Perdian et al. 2012; Sarsby, Towers et al. 2012; Yoshimura, Zaima et al. 2012), 
lipids (Chen, Hui et al. 2009; Djidja, Francese et al. 2009; Chen, Jiang et al. 2010; Rompp, 
Guenther et al. 2010; Colsch, Jackson et al. 2011; Delvolve, Colsch et al. 2011; Veloso, 
Astigarraga et al. 2011), peptides (Hanrieder, Ljungdahl et al. 2011; Meriaux, Arafah et al. 2011; 
Minerva, Boonen et al. 2011) and proteins (Seeley and Caprioli 2008; Grassl, Taylor et al. 2011) 
from both vegetal (Kaspar, Peukert et al. 2011) and animal models. MALDI MSI was found to be 
a powerful technology for many fields of research such as pharmaceuticals (Bonnel, Legouffe et 
al. 2011), biomarker discovery and tracking for various pathologies e.g. brain disorders (Stoeckli, 
Staab et al. 2002; Stauber, Lemaire et al. 2008; Hanrieder, Ljungdahl et al. 2011) or oncology 
(Lemaire, Menguellet et al. 2007; El Ayed, Bonnel et al. 2010; Rauser, Marquardt et al. 2010; 
Willems, van Remoortere et al. 2010; Balluff, Rauser et al. 2011; Le Faouder, Laouirem et al. 
2011; Elsner, Rauser et al. 2012; Meding, Nitsche et al. 2012; Nipp, Elsner et al. 2012). To 
highlight the regulation of molecules with important functions related to a specific biological 
process by a simple MALDI MSI acquisition, these molecules have to be subjected to further 
characterization. For several years, many groups have been developing and improving on tissue 
protein identification strategies. In particular, on tissue Bottom-Up approaches through in situ 
enzymatic digestion have been demonstrated to allow direct identification of proteins from both 
frozen (Groseclose, Andersson et al. 2007) and formalin fixed paraffin embedded (FFPE) 
(Lemaire, Desmons et al. 2007) tissues. In order to maintain localization of peptides throughout 
the digestion process, methodologies were developed to perform enzymatic digestion from 
discrete locations on the tissues using a micro-spotter (Groseclose, Andersson et al. 2007; 
Lemaire, Desmons et al. 2007; Franck, Arafah et al. 2009) or from whole tissue sections with 
micro-sprayer devices (Djidja, Claude et al. 2010; Gustafsson, Oehler et al. 2010). In this bottom-
up approach, tryptic peptides are subsequently analyzed by MS2 and identified upon databank 
interrogation. However, even if MS spectra on each pixel show hundreds of peptides, only few 
proteins are identified (Schober, Schramm et al. 2011) . One of the ways to increase the number 
of protein identifications is the improvement of tryptic peptide detection. This has been done by 
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incorporation of tissue treatments in the strategy, such as washing to minimize ion suppression 
effect (Franck, Arafah et al. 2009) . Moreover, peptides with a very close m/z that enter and get 
fragmented together at the collision cell preventing the identification were separated by the 
inclusion of a gas phase separation using ion mobility (McLean, Ridenour et al. 2007; Djidja, 
Claude et al. 2009; Stauber, MacAleese et al.). In addition, improvement of protein fragmentation 
to aid in identification was also examined by N-terminal derivatization. This orientates the 
fragmentation of tryptic peptides towards a specific ion series, increasing the protein 
identification score (Franck, El Ayed et al. 2009). All these efforts have led to better protein 
identification, however, the less abundant proteins which present significant biological activities, 
in particular pathologies, remain difficult to detect and identify. More recently, on-tissue top-
down strategy (Debois, Bertrand et al. 2010; Zimmerman, Debois et al.) was introduced by 
means of In Source Decay (ISD) (Brown and Lennon 1995; Hardouin 2007) . This method of 
fragmentation is generally well-suited for purified proteins and leads to large sequence 
determination. However, in situ ISD has allowed the detection and identification only of the most 
abundant protein from the pixel analyzed (Debois, Bertrand et al. 2010) due to the high 
complexity of the sample. 
Another strategy consists of combining MALDI-MSI and LC-MS/MS in a single workflow, 
allowing the improvement of protein identification. Basically, proteins are in situ digested, 
fractionated and then extracted prior to nanoLC separation, followed by MS/MS analysis for 
databank interrogation (Stauber, Lemaire et al. 2008). This approach was shown to improve 
protein identification, but since it was performed on a whole or half of a tissue section, 
information about protein localization is lost. This can be regained if back correlation to imaging 
data of tryptic peptides is done, as previously demonstrated for FFPE tissue samples (Lemaire, 
Desmons et al. 2007; Stauber, Lemaire et al. 2008). More recently, intact proteins were extracted 
from tissue prior to fractionation by ultracentrifugation, and, in combination with high resolution 
and accurate mass determination, has allowed the detection of about a hundred proteins (Schober, 
Schramm et al. 2011) . Although in this approach, the localization of proteins is lost, it can be 
regained by correlation with the tryptic peptide signals from the image of an adjacent section. 
The number of identified and localized proteins improved, but the approach continues to be 
limited by ion suppression effect and decreased sensitivity due to dominant signals from the most 
abundant proteins. Localized intact proteins provided by MALDI-MSI can also be identified after 
their extraction from a consecutive section prior to analysis by nanoLC-MS/MS using electron 
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transfer dissociation (ETD) as activation mode. This strategy was used for clinical applications in 
oncology and has lead to the identification of several markers (Rauser, Marquardt et al. 2010; 
Elsner, Rauser et al. 2012; Nipp, Elsner et al. 2012). However, only the highly soluble proteins 
were identified and localized in this manner, and the correlation was not accurate because the 
image was obtained using a MALDI TOF instrument. Moreover, proteins of interest could be 
diluted among the large amount of abundant proteins, especially if the region of interest is small 
compared to the size of the sample. 
There is therefore a crucial need to develop a new strategy that allows protein identification on 
discrete regions of tissue sections, avoiding dilution of low abundant proteins. Recently, surface 
sampling using liquid microjunction was introduced demonstrating liquid-solid micro-extraction 
that can be coupled to any ionization sources (Van Berkel, Kertesz et al. 2008). The success of 
these methods as alternatives to typical ambient surface sampling/ionization sources is due to 
their greater extracting efficiency and larger surface sampling areas. For example, it has been 
shown that metabolites of a drug could be detected using liquid microjunction extraction, 
whereas they were unsuccessfully detected using DESI (Kertesz and Van Berkel 2010). In one of 
these methods called liquid extraction surface analysis (LESA) (Kertesz and Van Berkel 2010), 
the solvent can be made in contact with the sample surface by dispensing in a controlled fashion 
discrete droplets. Molecules extracted can be subjected to further pretreatments including 
desalting and separation steps prior to MS analysis.  
In this paper, a new strategy is presented for protein identification from discrete locations on 
tissue sections determined by hierarchical clustering (HC) (Deininger, Ebert et al. 2008) that can 
be used to classify cell groups according to their molecular content profiles. Proteins are then 
extracted by liquid microjunction using LESA followed by nanoLC-MS/MS analysis. In 
particular, localized on-tissue enzymatic digestion followed by micro-extraction and subsequent 
analysis on an HR (high resolution) ESI MS instrument providing high accurate mass 
measurement was evaluated. This strategy can be integrated within the MALDI MSI workflow in 
order to perform supervised profiling on distinct cell groups having specific molecular profiles. 
This robust and fast new strategy shows to be a good alternative than LCM and leads to 
identification of a larger number of proteins with respect to the number of cells studied. 
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EXPERIMENTAL PROCEDURES 
Chemicals 
All chemicals were of the highest purity obtainable. Water, Formic Acid (FA), trifluoroacetic 
acid (TFA), Acetonitrile (ACN), methanol (MeOH) are purchased from Biosolve B.V. 
(Valkenswaard, the Netherlands). Ammonium bicarbonate (NH4HCO3), Ethanol (EtOH), α-
Cyano-4-hydroxycinnamic acid (HCCA) (puriss), sinapinic acid (SA), aniline (ANI), and 
reagents for HES staining were purchased from Sigma-Aldrich (Saint-Quentin Fallavier, France). 
Trypsin (sequencing grade modified trypsin, porcine) was purchased from Promega 
(Charbonnieres, France). A standard digest of BSA was obtained from Bruker Daltonics (Bruker 
Care Online, Part-No. #217498) and used without any further purification.  
Tissue sample preparation  
Male Wistar rats at adult stage maintained under standard care were used for tissue collection. 
Animals were sacrificed by CO2 gas and brains were dissected. Tissues were subsequently frozen 
into isopentane cooled at -50°C. Samples were then stored at -80°C until required. 10µm rat brain 
tissue sections were obtained using a cryostat CM1510S (Leica Microsystems, Nanterre, France) 
and thaw mounted onto indium-tin oxide (ITO)-coated conductive glass slides (Bruker Daltonics, 
Bremen, Germany). The tissue sections were vacuum-dried in a desiccator for10 min then soaked 
in 70% EtOH, 95% EtOH and chloroform for 30s each prior to vacuum dessication for 5min. The 
sections were then dried and stored at -20°C until use (Longuespee, Gagnon et al. 2013). For 
some sections, after MALDI analysis, the matrix was removed by washing the slides with 70% 
ethanol and the sections were HES-stained. 
MALDI-TOF MSI Experiments 
MALDI matrix was applied using the ImagePrep device (Bruker Daltonics, GmbH), by spraying 
SA/ANI matrix (1 equivalent of aniline (20µl for 5 ml) in 10 mg/ml in 70:30 ACN/H2O, 
0.1%TFA of SA solution).Protein imaging was performed on an Ultraflex II MALDI-TOF/TOF 
instrument (Bruker Daltonics, GmbH) equipped with a smartbeam laser (Nd:YAG, 355nm). 
Protein mass spectra were acquired in linear positive ion mode within a mass range of m/z 3000-
30000. Distance between raster points was set to 300µm and a total of 300 laser shots were 
accumulated at 200-Hz repetition rate for each pixel. Spectra were processed by baseline 
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correction and smoothing using FlexAnalysis 3.2 software (Bruker Daltonics, GmbH). Image 
analysis and data visualization were performed with the FlexImaging 2.1 software (Bruker 
Daltonics, GmbH). 
For statistical analysis, the data set obtained from FlexImaging was loaded into the ClinProTools 
2.2 software (Bruker Daltonics, GmbH) to conduct hierarchical clustering. Unsupervised 
clustering was selected with Euclidean as distance method and ward as linkage method. Results 
of hierarchical clustering were exported to FlexImaging 2.1 software to retrieve the areas with 
different profiles.  
MALDI-Orbitrap MSI Experiments 
Automatic trypsin digestion was performed using a high position accuracy chemical inkjet printer 
(CHIP-1000, Shimadzu Biotech, Kyoto, Japan) (Franck, Arafah et al. 2009). The printed array of 
the CHIP-1000 on the tissue section comprised of spots spaced by 250µm center-to-center. A 
total amount of 40 nL of solution containing 20µg/mL of trypsin in 50mM NH4HCO3 was 
applied on each spot. Five droplets of approximately 100pL were deposited on each spot per 
cycle. One hour was necessary to obtain the final volume and to perform sufficient digestion with 
no additional incubation time. After digestion, HCCA/ANI (1.5 equivalent of aniline (36µl for 5 
ml) in 10mg/mL in 7:3 ACN/ water/ 0.1% TFA of HCCA solution.) was deposited on the same 
positions using the ChIP-1000, with the same parameters used during trypsin deposition. 
MS imaging was conducted using a MALDI linear ion trap – orbitrap hybrid mass spectrometer 
(MALDI LTQ Orbitrap XL, Thermo Fisher Scientific). Spectra were acquired using Xcalibur 
2.0.7 SP1 software (Thermo Fisher Scientific, Bremen, Germany). The LTQ Orbitrap instrument 
was operated in positive ion mode over a high mass range (m/z 800-4000). The instrument was 
equipped with an intermediate pressure (75 mTorr) MALDI source using a nitrogen laser (MNL 
100; Lasertechnik Berlin), providing an output at 337 nm with a maximum energy of 80 μJ per 
pulse and a repetition rate of 60 Hz. The Orbitrap analyzer was used for MS data acquisition with 
a mass resolving power of 30,000 FWHM. Automatic gain control was turned off and other data 
acquisition conditions were as follows: laser power per pulse of 10 μJ, 25 laser pulses per spectra, 
and 2 scans averaged per pixel. Distance between raster points was set to 250µm. Image analysis 
and data visualization were performed with the Imagequest1.0.1 software (Thermo Fisher 
Scientific, Bremen, Germany). 
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On-tissue digestion and direct analysis 
Digestion of a specific area on tissue section was performed using the CHIP-1000 previously 
described. The same parameters were used, except that this time the “fill plane” option was 
selected before trypsin deposition. After digestion, HCCA (10mg/mL in 7:3 ACN/ water/ 0.1% 
TFA) was deposited on the same positions using the CHIP-1000, with the same parameters as 
used during trypsin deposition. Direct tissue analysis was done on the MALDI Orbitrap XL used 
previously for MSI. Around 20 scans per digested point in FTMS mode in the range 600-4000 
with a nominal -mass resolution of 100000 at m/z 400 were acquired.  
Liquid microjunction extraction experiments  
Micro-extraction experiments were performed using the TriVersa Nanomate platform (Advion 
BioSciences Inc., Ithaca, NY, USA), with the Liquid Extraction Surface Analysis (LESA) option 
(Kertesz and Van Berkel 2010). Extraction was performed by creating, on a specific location, a 
liquid microjunction where solid-liquid extraction can occur. The slide with the tissue section 
was mounted on a universal adapter plate and the precise X-Y position of the extraction site on 
the sample surface generated using LESA Points software. In most cases, 2µL of solvent was 
aspirated into the tip and used to extract peptides, with 0.6µl dispensed and made in contact with 
the tissue section for 30s. The solvent was then aspirated and dispensed onto a clean 0.2ml 
Eppendorf vial maintained at 4°C to avoid degradation. Here, unlike the conventional use of the 
microjunction extraction system where the extracted liquid is directly dispensed to the 
microfluidic nanoESI chip of the device; the extracted solution is collected in a tube. This allows 
performing several extraction cycles and pooling all collected solutions in the same vial to 
increase quantity of material collected. Iterations of extraction cycles were performed (3, 5 or 15) 
to determine the optimal number of extractions. Different extraction solvents were tested: ACN: 
0.1% TFA aq (8:2, v/v), MeOH/0.1% TFA aq (7:3, v/v), 0.1% TFA aq, 1% TFA aq and 
EtOH/CH3COOH/water (90:9:1, v/v/v). To determine which is the most efficient, 1µl of standard 
BSA tryptic digest solution was spotted on rat brain tissue sections and on this, micro-extraction 
was performed after the spots have completely dried. Collected extracts were subjected to 
MALDI-TOF analysis using the Ultraflex II instrument in reflector mode with HCCA as matrix, 
and the resulting PMFs were subjected to a MASCOT search algorithm (v2.3.01.241) against the 
SwissProt database (Swissprot_2011_08) using Biotools 3.1 software (Bruker Daltonics, Bremen, 
Germany). The mass tolerance was set to 0.2 Da. Three missed cleavages were allowed in order 
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to account for partial digestion. Cysteine carbamidomethylation was set as a fixed modification 
since the standard solution has undergone cysteine reduction/alkylation and that one tryptic 
peptide is expected to show carbamidomethylation (see product information). Methionine 
oxidation and tyrosine phosphorylation were set as variable modifications.  
LC MS/MS 
After micro-extraction, collected samples were dried under vacuum, reconstituted with 10µl of 
0.1%TFA aq and subjected to solid phase extraction using a C18 Ziptip (Millipore,Saint-Quentin-
en-Yvelines, France), eluted by 80% ACN, and dried under vacuum. Dried samples were 
suspended in water/5% acetonitrile/0.1% formic acid. Samples were separated by online 
reversed-phase chromatography using a Proxeon Easy-nLC system equipped with a Proxeon trap 
column (100 μm ID x 2 cm, Thermo Scientific) and C18 packed tip column (100 μm ID x 15 cm, 
Nikkyo Technos Co. Ltd). Peptides were separated using an increasing amount of acetonitrile 
(5%-40% over 110 minutes) and a flow rate of 300 nL/min. The LC eluent was electrosprayed 
directly from the analytical column and a voltage of 1.7 kV was applied via the liquid junction of 
the nanospray source. The chromatography system was coupled to a Thermo Scientific Orbitrap 
Elite mass spectrometer (ThermoFischer Scientific, France). The mass spectrometer was 
programmed to acquire in a data dependent mode. The survey scans were acquired in the 
Orbitrap mass analyzer operating at 120,000 (FWHM) resolving power. A mass range of 400 to 
2000 m/z and a target of 1E6 ions were used for the survey scans. Precursors observed with an 
intensity over 500 counts were selected “on the fly” for ion trap collision-induced dissociation 
(CID) fragmentation with an isolation window of 2 amu and a normalized collision energy of 
35%. A target of 5000 ions and a maximum injection time of 200 ms were used for CID MS2 
spectra. The method was set to analyze the top 20 most intense ions from the survey scan and a 
dynamic exclusion was enabled for 20 s. 
Tandem mass spectra were processed with Thermo Scientific Proteome Discoverer software 
version 1.3. Spectra were searched against UniprotKB/Swiss-Prot (version January 2012) filtered 
with Rattus norvegicus taxonomy (41604 sequences) using the SEQUEST® algorithm. The 
search was performed choosing trypsin as the enzyme with two missed cleavages allowed. 
Precursor mass tolerance was 10 ppm and fragment mass tolerance was 0.5 Da. N-terminal 
acetylation, tyrosine phosphorylation, methionine oxidation and arginine deamidation were set as 
variable modifications. Peptide validation was performed with the Percolator algorithm. Peptides 
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were filtered based on a q-value below 0.01 which corresponds to a false discovery rate (FDR) of 
1% which is referred in the following sections as “high confidence” identification.  
RESULTS 
On tissue direct identification of proteins by MALDI MSI 
On-tissue identification of localized proteins was performed following the MALDI-MSI bottom-
up approach. Trypsin was first deposited on an area of a control rat brain sagittal tissue section 
using a microspotter followed by depositing HCCA/ANI as matrix. Figure 1 presents the results 
obtained through such a strategy combined to high spectral resolution analysis on a MALDI-LTQ 
Orbitrap instrument. Figure 1a shows the scanned image of the area analyzed on the tissue 
section showing the raster of micro spots. Images extracted from MALDI MSI data collected 
from this region are presented Figure 1b for three ions of distinct m/z at 1198.717 (green), 
1612.950 (blue) and 2141.138 (red) respectively showing highly complementary distributions 
across the area. The tryptic digestion fingerprint MS spectrum extracted in one of the 
morphological region of the analyzed tissue (indicated by a dark circle) on Figure 1b is shown 
Figure 1c. The MS spectrum shows a complex digestion profile dominated by a few tens of 
major ions. The m/z list extracted from this spectrum after deisotoping and exclusion of trypsin 
autolysis ions (m/z 2211.1310; 2283.2016 and 1045.5776) shows the presence of around 350 
monoisotopic ions in the m/z range [800-4000] with a S/N>5. Only 20 of these ions present a 
relative intensity >10% of the base peak, meaning that the 330 remaining ions are observed but 
are too low in intensity to generate MS2 spectra that will lead to any identification of peptide. The 
experimental m/z of these 20 most intense ions were compared to the predicted m/z from in silico 
digestion of Myelin Basic Protein S (accession number P02688). Table 1 in supplementary 
data 1 reports the results of the identification. Out of the top 20 most intense ions, 17 are 
attributed to Myelin Basic Protein S  (P02688) among which 3 correspond to acetylated forms, 3 
to isoforms 3 and 2 possible sodium and potassium adduct ions. The 3 other ions remained 
unidentified. In this approach, only few major proteins are identified although many more ions 
are observed. Similar results were recently published by Schober et al. (Schober, Schramm et al. 
2011) . In their work they showed the possible identification of only 14 peptides belonging to 3 
proteins, respectively Myelin Basic Protein, Tubulin Beta 5 Chain and Actin Cytoplasmic 1. 
Given the limited number of proteins identified directly at the tissue level, a new strategy was 
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developed based on micro-extraction allowing an efficient identification of proteins while 
keeping their spatial delocalization at the tissue level to the minimum. 
LESA micro-extraction optimization 
The device used for micro-extraction allows the deposition of solvents or reagents in a controlled 
manner by creating a liquid microjunction that permits extraction and subsequent uptake of the 
solvent containing the extracted material. The size of the contact area between the dispensed 
solvent and the tissue depends on the nature of the tissue surface, its preparation, and the physico-
chemical properties of the solvent (polarity, hydrophobicity, surface tension). The bottom-up 
approach with on-tissue trypsin digestion followed by extraction of the digested peptides from 
the tissues using the liquid microjunction interface was first explored. Optimization of this 
approach, including the microjunction size, extraction time, number of extraction cycles and 
solvent mixture compositions, were performed using standard BSA spotted on rat brain sections 
and can be found in the Supplementary Data 1. Optimal extraction in terms of sequence 
coverage and peptide ion intensity was obtained using ACN: 0.1%TFAaq (8:2, v/v) as solvent 
and doing five extraction repetitions on the same spot with a contact time of 30 s. This protocol 
was used in all subsequent experiments. 
In order to obtain a fine correlation between protein identification and tissue localization, 
reduction of the micro-extraction size is necessary. This parameter is tightly linked to system 
configuration which presently cannot be changed. The minimum volume of liquid that can be 
properly dispensed from the tip of the LESA is currently 0.6 µL, leading to formation of 
microjunction spots of 1.5-1.7 mm in diameter depending on the solvent and surface properties. 
By assuming that analyzed cells present an average size of 15 µm and are round-shaped, we can 
estimate that micro-extraction will be performed on approximately 10 000-13 000 cells. As it is 
difficult to further reduce the extraction size using the instrument, the size of the digested areas 
was reduced instead. This is possible using a micro-spotting piezoelectric device, which has been 
shown previously to deliver picoliter volumes of trypsin on small areas of tissue surfaces 
(Franck, Arafah et al. 2009). 
Figure 2 presents the obtained results by comparing the full MS spectra recorded from two 
distinct locations on two consecutive tissue sections, after subjecting them to washing to remove 
most abundant lipids and peptides that can be co-extracted with the tryptic peptides. On the first 
section, only micro-extraction was done on the tissue (Figure 2a), whereas on the second section, 
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trypsin digestion was first done followed by micro-extraction (Figure 2b). Micro-extraction 
alone shows an area of the expected size (~1700 µm). On the tissue submitted to digestion by 
micro-spotting prior to micro-extraction, the 670 µm-sized spot corresponding to the enzymatic 
digestion can be observed on the tissue and are highlighted with gray circles (Figure 2b). As 
expected for the tissue first submitted to on-tissue digestion, complex profiles of ions are 
observed in the m/z 700-4000 range with observable differences according to the analyzed region 
of the tissue. On the other hand, on the tissue submitted to micro-extraction without any 
digestion, a low populated mass spectrum profile was observed (only one predominant ion in the 
spectrum, indicating that the peptides observed in Figure 2b were only coming from the digested 
portion of the spot. This is a particularly interesting feature since this allows the indirect 
reduction of the extraction area to a region of 670 µm. By applying the same rough calculation as 
previously (i.e. round shaped cells of about 15 µm diameter in average), the estimated number of 
studied cells can be reduced down to about 1900. 
To further assess the method, a comparison of the MS spectra when the tryptic peptides were 
analyzed on tissue and when they were subjected to micro-extraction in the consecutive section at 
the same position (Figure 3). Straightforward MS/MS interrogation allowed the identification of 
dominant peaks in these spectra coming from peptide fragments of abundant proteins present in 
the rat brain, namely, tubulin, actin, myelin and hemoglobin. When the spectra are zoomed, due 
to the high spectral resolution, signals coming from the less abundant proteins become more 
apparent. However, it is difficult to subject these ions to MS/MS analysis due to low signal 
intensity and complexity (overlapping) that prevent the accurate selection of the precursor ion. 
Comparison of spectra obtained directly on tissues and after micro-extraction shows as expected 
a better S/N ratio for conventional MALDI analysis (an average of the S/N ratio for the 20 more 
intense peaks give 60 for direct tissue analysis and 700 for analysis after extraction). There is also 
a marked difference in the signal intensity and the number of detected peptides (118 peptides for 
on tissue MS and 675 for conventional MS after extraction, Figure 3b). However, it must be 
noted that signals showing the highest intensity are the same in both experiments. This is 
expected because of the additional desalting and concentrating step using a hydrophobic phase 
(C18 ziptip) in addition to the absence of interference coming from the tissue matrix that induces 
poor ionization yields. However, this remains unsatisfactory in terms of protein identification 
because the clear advantage of the developed strategy is to provide a solution that can be 
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subsequently processed by any possible proteomics strategies involving LC separation coupled to 
HR MS. 
On tissue micro-digestion & micro-extraction followed by nanoLC-MS/MS analysis 
Statistical analysis has proven to be a very useful approach to identify regions of different 
molecular content that can be specific to certain biological processes. This is exemplified in 
Figure 4a by the use of Hierarchical Clustering (HC) on the MALDI MSI data collected on a 
control rat brain sagittal tissue section prepared for protein imaging. Across the studied section, 
four distinct regions of specific molecular fingerprint are primarily differentiated. In a complete 
biological investigation, the succeeding step consists of the identification of the regulated 
proteins characterizing each of these regions. For this, on-tissue enzymatic digestion combined 
with micro-extraction on two discrete positions of two of these regions (Figure 4b) as 
determined previously by HC (Figure 4a left) and correlated to HES staining (Figure 4a right) 
was then performed in triplicate on three consecutive sections (S1, S2 and S3) thus, for a total of 
6 samples (3 experiments for each of the position, S1P1, S2P1, S3P1 versus S1P2S2P2 and 
S3P2). Specifically, the two investigated positions are in the thalamic nuclei region (P1) and in 
the cerebellar nucleus (P2) according to the rat brain atlas (Figure 4b right panels). 
The full MS spectra of micro-extracted samples from P1 and P2 are shown Figure 4c. Even 
though these spectra are dominated by the signals from abundant proteins, differences can be 
observed between the two positions. The tryptic peptide extracts were then collected and 
analyzed by online nanoLC coupled to an ESI-orbitrap Elite with high speed and high spectral 
resolution capabilities (see Supplementary Data 1 Figure 2 for the base peak chromatograms). 
An average of 25 000 peptide ions was sequenced in MS/MS and, because of the high mass 
accuracy on the parent ion mass determination and the quality of MS/MS spectra in terms of 
type, number and intensity of fragment ions, many of these peptides led to protein identification. 
Figure 5 presents examples of typical MS/MS spectra recorded during these experiments. 
Because of MS/MS spectra quality and parent ion MW determination accuracy, a large number of 
proteins were unambiguously identified with high confidence. To exemplify the complexity of 
the sample, in Table 1 are listed all the ions with isobaric m/z 1383. Thanks to the efficiency of 
peptide separation, 8 different peptides are found to be corresponding to this nominal m/z with a 
maximum separation of 144 mDa in mass. Here, these peptides appear at distinct retention times. 
Even with high resolution capability of the instrument these peptides would have been very 
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difficult to identify from each other in the direct analysis without the separation dimension. Here, 
on the contrary we obtained high confidence identification for each of the 8 peptides with a good 
accuracy on the mass measurement. 
Overall, the experiments led to the identification of a significant number of proteins for each 
sample and each position (>1000). The identified proteins can be found in the Supplementary 
Data 2, from which it is shown that 1517 proteins were identified for P1 from S1, 1554 proteins 
from S2 and 1582 from S3. Figure 6 presents a Venn diagram showing the number of proteins 
identified for each position across the 3 replicates. 1405 proteins are common to the 3 sections; 
11 are unique to S1P1, 17 to S2P1 and 40 to S3P1. By taking all the experiments for P1 we 
obtained a total of 1658 proteins identified (Figure 6a). For P2, 1289 proteins common to the 3 
sections were identified, 28 being unique to S1P2, 4 to S2P2 and 74 to S3P2, amounting to 1761 
protein. In most cases, less than 5% variation is observed between each position, demonstrating 
reproducibility. For each samples, identified proteins came from about 24500-25500 MS/MS 
recorded (depending on the experiment) and sent for databank interrogation. By merging data 
from the different samples (S1, S2, S3) a comparison of the results from the 2 analyzed positions 
can be made. Merging the 3 replicates and using a filter to select only high confidence 
identification, 1334 proteins from P1 and 1409 proteins from P2 were obtained (Figure 6b). 
Altogether, 1606 protein groups based on 5111 peptides were identified. This demonstrates the 
efficiency of the method, leading to identification of about 1300-1400 proteins with high 
confidence according to the position for an estimated equivalent number of 1900 cells with an 
average diameter of 15 µm. 
Biological significance 
Global analysis on the identified proteins shows that they present various cellular localization and 
molecular functions, and are implied in different biological processes. Figure 7 presents a 
diagram of protein location in the cell for proteins identified from P2 (cerebellar nucleus). Most 
of the identified proteins are cytoplasmic (24.54%) and membrane proteins (18.54%), although to 
a less extent proteins from the nucleus, cytosol, cytoskeleton and mitochondria were also 
identified. Comparison of molecular functions and biological processes of proteins identified 
from P1 and P2 are given in Table 2. Looking at molecular functions specific to P1 or P2, the 
most important variations observed are between catalytic activity, metal ion and nucleotide 
binding. Major significant variations for the biological activities of the identified proteins 
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between the two positions are found for metabolic activity and cell organization/biogenesis and 
development (Table 2). Some tiny changes are also observed for transport, cell differentiation 
and cell communication. The number of proteins identified and involved in metabolomic activity 
is 46% higher in cerebral nucleus than in thalamus/hippocampus region one, whereas the ones 
implicated in cell organization is 9% higher in the latter. 
Back correlation of proteins identified via micro-extraction nanoLC-ESI to MALDI MS 
Imaging data 
The on-tissue micro-extraction method followed by nanoLC-ESI MS/MS analysis allowed for the 
identification of a large number of proteins. The generated data were then used to determine 
whether it would be possible to correlate this data to the MALDI MSI data since from the latter, 
only a few major proteins were identified. Because the mass measurements have been performed 
with high mass accuracy, tryptic peptide assignments observed in MALDI MSI can be directly 
compared with those determined under nanoLC-ESI MS/MS. 
As an example, in the cortex region of the primary motor cortex on a consecutive section, on 
tissue microdigestion was performed with the same conditions as in the MALDI-MSI experiment 
and directly analyzed. Assignment of all tryptic peptide masses observed in the on tissue MALDI 
experiment is summarized in the table presented in Supplementary Data 4. The table gives the 
measured m/z list and the corresponding relative intensities of the observed tryptic peptides, 
which are classified by decreasing intensity. Also given are the m/z of tryptic peptides extracted 
from the nanoLC-ESI experiments, protein IDs (name and accession number), the mass 
difference (in ppm) between the two measurements, and the degree of confidence by which these 
peptides have been identified. From the on-tissue MALDI MSI spectrum extracted in the region 
of interest (Supplementary data 1 Figure 3), 176 tryptic peptides m/z can be extracted. On 
these 176 peptides, 120 can be assigned by correlation to nanoLC-ESI and 56 m/z remain 
unassigned. Of the 120 assigned peptides only 3 are found with low confidence identification. In 
terms of the mass difference in the measured peptides (Table 3), 41 peptides showed a mass 
difference <1 ppm, 34 within 1-2 ppm, 24 within 2-3 ppm, 12 within 3-4 ppm and only 9 
showing a mass difference >5 ppm. By setting up to 3 ppm as a good acceptance for confident 
identification, 82.5% of the peptides were assigned. Data were compiled to group tryptic 
fragments of single proteins (unique accession entry) altogether, and are presented in 
Supplementary Data 1 Table 3. Altogether, 61 proteins with unique entry were identified, 20 of 
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which contain 2 or more peptide hits. If the proteins are grouped as shown Table 4, 45 distinct 
protein families can be reassigned to the MALDI MSI data. The most prevalent protein in the 
analyzed region from the tissue is Tubulin family which is identified with 38 fragments, followed 
by ATP Synthase, Hemoglobin, Myelin Basic Protein S, Sodium/Potassium-Transporting 
ATPase, Actin, Clathrin, Synapsin-1, Fructose-Biphosphate Adolase. However, 56 peptides 
remain unassigned and 18 of them with a relative intensity of more than 5%. This corresponds to 
32.18% of the peptides with no assignment.  
DISCUSSION 
The obtained results demonstrate the power of liquid junction micro-extraction in identifying 
proteins from a section with respect to the location of extracted cells in the considered tissue. 
Previously the use of the liquid microjunction for the extraction and analysis of small molecules 
and lipids has been demonstrated (Eikel, Vavrek et al. 2011; Stegemann, Drozdov et al. 2011; 
Schadt, Kallbach et al. 2012), but the applicability of this technology was never shown for neither 
peptide nor protein analysis and in particular for the identification of proteins in Bottom-Up 
strategies combined to on tissue micro-extraction. 
The combination of on tissue digestion using a microspotter followed by micro-extraction offers 
many advantages regarding the analysis of proteins. This strategy allows an efficient control of 
the digestion by accurate delivery of the trypsin-containing droplets, leading to the reduction of 
the digested region by half, compared when the digestion was done by LESA alone. In contrast to 
a bottom-up MSI strategy where the digestion is not as efficient due to the quick drying of the 
trypsin solution between each successive deposition, here, the digestion efficiency has greatly 
improved because the droplet is maintained during the entire incubation. Micro-extraction of 
tryptic peptides is more advantageous than intact proteins considering that the extraction of the 
latter required in most of the cases the use of lysis buffer containing detergents and chaotropes. 
These solutions cannot be handled by a microspotter because it requires their aspiration from the 
surface afterwards. Although it is possible to use LESA for this purpose, the high viscosity of the 
solutions prevents them from being accurately dispensed or aspirated in the current configuration.  
Other ambient surface sampling techniques that are based on the solid-liquid extraction principle, 
such as the liquid microjunction surface sampling probe (LMJ-SSP) and the sealing surface 
sampling probe (SSSP) have been reported (Van Berkel, Kertesz et al. 2008). These methods 
operate in continuous mode. The sample surface is perpetually in contact with a probe that rasters 
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across the surface and as extraction occurs, the extracts are continuously delivered to the ESI 
source. Whereas this mode can be advantageous in surface scanning and ultimately, ESI imaging 
(Blatherwick, Van Berkel et al. 2011), the time of contact between the solvent and the surface is 
short and only a single pass on each position is being performed. As such, this method has low 
detection and at the moment is only restricted to small molecules. On the other hand, the liquid 
junction micro-extraction is a discontinuous extraction method. This is advantageous in 
increasing extraction yields by allowing the repetition of extractions on the same position. 
Moreover, this method permits the collection of extracts, enabling them to be further processed 
by means of conventional analytical strategies, e.g. various fractionation and/or separation 
methods (LC, CE, gel electrophoresis) and various MS instruments including non ambient MS 
sources like MALDI. This increases sample processing time but makes the complex mixture 
more amenable to MS analysis thereby increasing the number of molecules detected and 
identified.  
The obtained results demonstrate that using this strategy, about 1500 proteins can be identified 
with high confidence and good reproducibility for a given position. Here we have shown that 
currently micro-extraction through liquid microjunction is achieved on a spot with a minimum 
size of about 1.5-1.7 mm in diameter using the conventional setup of the instrument. For an 
average cell diameter of 15 µm, this corresponds to a range of 10 000-12 000 cells. To improve 
correlation, the sampling area was decreased down to a spot of 670 µm in diameter corresponding 
to about 1900 cells. From this region, high confidence identification of an average of 1500 
proteins was obtained. Currently, shotgun proteomics can lead to the identification of up to about 
5000 unique proteins (Walther and Mann 2011) as extracted from organs or specific regions of 
organs. However, global extractions if efficient in the number of identified proteins do not allow 
correlation to specific type of cells in their specific tissue micro-environment. Over the past 
years, LCM combined to proteomics strategies has been demonstrated to present a high potential 
for identification of proteins from specific cell phenotypes (Besson, Pavageau et al. 2011; Gozal, 
Dammer et al. 2011). In 2010, Wang et al (Wang, Xu et al. 2010) examined the correlation 
between the number of protein identifications with the decreasing number of LCM-processed 
cells. In their strategy they were able to identify 167, 237, 491 and 619 proteins from 500, 1 000, 
2 500 and 5 000 collected cells, respectively. Similar results were shown by Stingl et al in 2011 
(Stingl, van Vilsteren et al. 2011). Protein identification performed out of 2000 epithelial or 
stromal micro-dissected cells led to an average of 366 identified protein-groups. Recently, 
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Wisniewski et al (Wisniewski, Ostasiewicz et al. 2011) demonstrated the possible identification 
of 1500 proteins from 1000 and 2500 from 10 000 HeLa cell cultures. From LCM micro-
dissected mouse liver tissue sections, they obtained the identification of 3600-4400 proteins out 
of 20 000 laser capture cells. Thakur et al (Thakur, Rejtar et al. 2011), meanwhile, have identified 
about 1700 proteins from 10 000 initially collected cells of primary and metastatic breast cancer 
tissues by combination of SDS-PAGE separation and LC-MS/MS for an equivalent of 1 000 cells 
injected. In the present study we assume to have analyzed about 1900 cells (15 µm diameter) 
from 670 µm spots and identified an average of 1500 proteins. This demonstrates the interest of 
the present strategy which has a clear potential for protein identification with fine correlation to 
their micro-environment.  
The biological significance of the data obtained points out the presence of specific protein 
signatures between the two brain localizations which are in line with their biological role in the 
brain. Cerebellar nucleus is known to modulate the outputs of other brain areas and to calibrate 
precision and timing of movements. The thalamic nucleus is involved in relaying information to 
and from the cerebral hemispheres, and is also involved in motivation, eating, drinking, 
defecation, and copulation. The high number of proteins identified in the cerebellar nucleus is in 
line with its high consumption of glycogen and its involvement in oxidative stress. On the other 
hand, the high expression level of proteins involved in cell organization can be explained by the 
great number of connections and cell projections occurring in thalamic nuclei. This is in line with 
the higher level of proteins implicated in cell communication, cell differentiation and regulation 
identified in this region compared to the cerebellar nucleus region. Altogether, the data confirm 
that specific protein signatures rely on the brain area and their canonical biological functions to 
the brain functioning. 
Finally, the nanoLC-ESI data were correlated to those obtained from MALDI MSI. High spectral 
resolution and high mass accuracy measurements given by the FT instrument allow the 
assignment of the peptides observed on tissue from the tryptic digestion by simple m/z 
correlation. The good correlation of the data allows indirect back identification and subsequently 
protein distribution in tissues. A non-negligible number of peptides were not assigned from 
nanoLC-ESI data though. First, the MALDI MSI data were collected from a tissue section 
adjacent to the one used for micro-extraction experiments. Therefore, it is possible that not 
exactly the same type of cells were targeted, taking into account the heterogeneity of cell 
phenotypes in the brain. The observed discrepancy can also be due to the different ion production 
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source used (ESI vs. MALDI) in the 2 experiments. In fact, it is well-known that MALDI and 
ESI generally provide complementary data (Baeumlisberger, Rohmer et al. 2011) in terms of 
observed peptides because of the very different physico-chemical processes by which ions are 
formed in these two sources. The number of unassigned peptides could be decreased if the micro-
extracted tryptic peptides are analyzed using the same MALDI-LTQ Orbitrap where the MALDI-
MSI experiment was performed. However, in this configuration, low energy activation can only 
be obtained leading to a poor fragmentation yield coming from singly-charged peptides and, 
subsequently, poor MS/MS spectra. This implies that the correlation assignment can be 
ameliorated but this will be at the expense of protein identifications. An alternative would be the 
parallel analysis of the micro-extracted tryptic peptides in the MALDI-TOF/TOF instrument 
providing higher energy activation and therefore probably better protein identifications. 
However, the back correlation will suffer due to the lack of accurate mass measurement obtained 
from the MALDI-TOF.  
Taken altogether, a workflow was designed allowing both imaging and classification of tissue 
regions leading to protein identifications and finally, back correlation to the MALDI MSI data 
(Figure 8).  
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CONCLUSION& PERSPECTIVES 
Here, it was demonstrated that micro-extraction using the liquid microjunction is an efficient 
strategy for protein identification from tissue sections. An approach for micro-extraction on a 
well-controlled area (670 µm diameter), allowing fine correlation of identified proteins to their 
original location in the tissue, was established. This was achieved by performing on tissue 
digestion using micro-spotting followed by micro-extraction using the liquid microjunction 
interface. By applying such a strategy in combination with conventional shotgun analysis for 
simplification of the complex extract using RPLC separation with on-line coupling to high 
spectral resolution ESI FTMS, identification with high confidence of about 1500 proteins for an 
equivalent of about 1900 cells was obtained. This is largely in the range of what is currently 
achieved using LCM followed by proteomics analysis. This method demonstrates to be robust, 
fast and efficient and can be automated. This method was incorporated into the MALDI MSI 
workflow, by analyzing collected MALDI MSI data using statistical tools to determine cells that 
present a similar molecular content. This classification was then used to determine ROIs which 
were used on the tissue digestion and micro-extraction strategy to further identify the proteins 
present in these specific regions. For example in clinics, MALDI MSI will allow for 
classification of the cells according to their role in the physiopathological process compared to 
normal ones, and the proposed strategy presented here will lead to the identification of the 
proteins in these different regions. Even if the strategy has shown great potential, there are many 
further developments needed to be performed. First, the separation of micro-extracted tryptic 
digest can be improved, not only by the use of 1D RPLC separation but also by other methods, 
such as 2D LC or capillary electrophoresis (CE). In order to obtain complementary data, the 
extracts can be subjected to parallel MS analysis using ESI and MALDI sources. In order to 
improve the correlation of identification data to protein location, the reduction of both digested 
and extracted area will be investigated. This can be obtained through several means. Decreasing 
the volume of trypsin and extraction solution is one possibility. This can be achieved by 
mounting specific tips on the liquid microjunction extraction system and is to be tested on short 
term. Finally, it was observed that the number of proteins unique to a specific position is low 
(197 for P1 and 272 for P2) in comparison to all identified proteins. There are certainly numerous 
proteins that are present in both positions but have differential regulation that can be highlighted 
by implementing a quantification strategy such as stable isotope labeling (Brewis and Brennan 
2010). Finally, the extraction of small, soluble intact proteins followed by their separation will 
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also be explored in order to obtain their identification using top-down strategies including ETD 
or ISD in the case of ESI or MALDI analysis respectively.  
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TABLES 
Table 1: Efficiency of Liquid Microjunction extraction combined to nanoLC MS and 
MS/MS analysis to identify isobaric ions. Summary of all ions showing nominal m/z 1383 with 
their corresponding retention time (RT), peptide sequence from identification by databank 
interrogation, mass difference (M) between experimental measurement and theoretical mass and 
identification probability (PEP) 
 
Table 2: Molecular and biological processes of identified proteins using Liquid 
Microjunction extraction workflow for 2 different tissue regions.Comparison between 
position 1 (P1: thalamic nucleus) and position 2 (P2: cerebellar nucleus) of proteins identified 
with high confidence a) molecular functions and b) associated biological processes. In red are 
indicated molecular functions or biological processes showing the most pronounced difference 
comparing position 1 and 2. 
 m/z RT (min) Sequence ΔM [ppm] PEP 
1383.58135 60.43 GGAEQFMEETER -2.35 3.2146E-03 
D4AC23, RCG55994, isoform CRA_c, [D4AC23_RAT] 
1383.61296 52.03 GASQAGMTGYGMPR -1.08 2.0589E-04 
P37805, Transgelin-3, [TAGL3_RAT] 
1383.64470 70.25 EMLGLYTENEGK -1.03 6.6262E-03 
F1LRV4, Heat shock 70 kDa protein 4, [F1LRV4_RAT] 
1383.66802 83.72 ImNTFSVmPSPK 2.35 1.4294E-03 
Q3KRE8, Tubulin beta-2B chain, [TBB2B_RAT] 
1383.67253 36.22 AALPAGEGESPEGAK -1.89 1.6774E-03 
F1LPP0, Amphiphysin_1, [F1LPP0_RAT] 
1383.69267 75.34 SVPEMDPAATIPR -0.79 7.2579E-2 
D4A6C9, Tom1l2, [D4A6C9_RAT] 
1383.70513 104.26 IFDAVGFTFPNR -0.37 8.6078E-06 
O35095, Neurochondrin, [NCDN_RAT] 
1383.72539 61.47 LYQSATQAVFQK -0.97 1.4450E-03 
Q08602, Geranylgeranyl transferase type-2 subunit alpha, [PGTA_RAT] 
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Table 3: Mass accuracyin m/z assignment for back correlation of Liquid Microjunction 
extraction data to MALDI MSI.Number of peptides with respect to the m/z accuracyin the 
assignment of peptides identified from the nanoLC-ESI-LTQ-orbitrap to the MALDI-LTQ-
orbitrap MS Imaging data. 
 
 
Table 4: List of protein families identified by back correlation of Liquid Microjunction 
extraction data to MALDI MSI.Number of peptides found and corresponding percentage with 
respect to the total number of observed peptides in the MALDI MS Imaging spectra sorted 
against each protein family identified by correlation of mass between nanoLC-ESI-LTQ-orbitrap 
and MALDI-LTQ-orbitrap on tissue data. 
 M/Z precision (ppm) Number of peptides 
<1ppm 41 
1ppm<x<2ppm 34 
2ppm<x<3ppm 24 
3<x<4ppm 12 
>5ppm 9 
 
a) M ole cula r 
Function 
P 1 
Thalamic 
nuclei 
P2  
Cerebellar  
nuc leus 
Binding 31% 24% 
Catalytic  Activ ity  22% 24% 
Metal Ion Bind ing 11% 13% 
Nucleotid e Binding  9% 12% 
E nzyme Reg ulator 
A ctivit y 5% 5% 
Transp orte r A ctivit y 5% 5% 
DNA Binding 4% 1% 
Signal Transducer 
A ctivit y 3% 4% 
Receptor Activity  3% 2% 
RNA B inding 2% 3% 
S tructural Mole cule 
A ctivit y 2% 4% 
Transcription 
Regulator Activity  
2% 2% 
Motor Activ ity  1% 1% 
 
b) Biological  
Proce sses 
P 1 
Tha lamic 
nuc lei 
P2 
Cerebellar  
nuc leus 
Regu lation 19% 20% 
Metabolic 13% 28% 
Tran sport 12% 11% 
Cell organization / 
Biogene sis 11% 1% 
Re sponse to 
S timulus  10% 9% 
Deve lopme nt 8% 6% 
Cell Differentiation 5% 6% 
Cell Comm unication 5% 6% 
Cell Death 5% 4% 
Cell Proliferation 3% 2% 
Cellular 
Ho meostasis 2% 1% 
Cellular Comp onent 
move ment 
2% 1% 
Reproduction 2% 2% 
De fense  Respo nse 2% 2% 
Cell Divis ion  1% 2% 
Coagu lation 1% 0% 
Cell Growth 1% 1% 
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Protein family 
Number of peptides 
fragments matching / 
protein family 
% peptides / total 
number of peaks 
Not assigned 56 32.18 
Tubulin 38 21.84 
ATP Synthase 10 5.75 
Hemoglobin 6 3.45 
Myelin Basic Protein S 5 2.87 
Sodium/Potassium-transporting ATPase 5 2.87 
Actin 4 2.30 
Clathrin  4 2.30 
Synapsin-1 4 2.30 
Fructose-biphosphate aldolase 3 1.72 
Cytochrome c oxydase  2 1.15 
Dihydropyrimidinase-related protein 2 1.15 
Heterogeneous nuclear ribonucleoproteins A2/B1 2 1.15 
Histone 2 1.15 
Phosphoglycerate kinase 1 2 1.15 
Adenylate kinase 1 0.57 
Anaphase Promoting Complex 1 0.57 
ATP synthase-coupling factor 1 0.57 
B-Cell receptor-associated protein 1 0.57 
Brain Acid Soluble Protein 1 0.57 
Breast Carcinoma-amplified sequence 1 homolog 1 0.57 
Calcium/Calmodulin-dependent protein kinase 1 0.57 
Complexin-1 1 0.57 
Excision repair cross-complementing rodent repair 
deficiency 
1 0.57 
Glutamine synthase 1 0.57 
GlutathioneS-transferase omega-1 1 0.57 
Glyceraldehyde-3-phosphate dehydrogenase 1 0.57 
Heat Shock Protein HSP 90-alpha 1 0.57 
Hepatocyte Growth Factor-regulated tyrosine kinase 
substrate 
1 0.57 
Isoform 2 of MAGUK p55 subfamily 1 0.57 
Leucine Rich repeat and IQ domain-containing protein 3 1 0.57 
Malate dehydrogenase 1 0.57 
Microtubule-associated protein 1 0.57 
Mitogen-Activated protein kinase 8 interacting protein 3 1 0.57 
Neurofilament heavy polypeptide 1 0.57 
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Protein bassoon 1 0.57 
Purkinje Cell protein 4 1 0.57 
Pyruvate kinase isozymes M1/M2 1 0.57 
Rab GDP dissociation inhibitor alpha 1 0.57 
Similar to Dystrophia myotonica WD repeat-containing 
protein 
1 0.57 
Sodium-dependent neutral amino acid transporter 
SLC6A17 
1 0.57 
Stathmin 1 0.57 
UDP-glucose pyrophosphorylase 2 1 0.57 
Vesicle associated membrane protein 2B 1 0.57 
Vesicle -fusing ATPase 1 0.57 
Hydroxysteroid dehydrogenase-like protein 2 1 0.57 
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FIGURES 
 
Figure 1: MALDI-LTQ-orbitrap MSI after on tissue trypsin digestion by micro-spotting. 
MALDI MSI sequence performed on a control rat brain sagittal tissue section in the cerebellum 
region on a MALDI-LTQ-orbitrap instrument after on tissue trypsin digestion and matrix 
deposition by micro-spotting. Images were acquired with a raster of 250 µm a) Scanned imageof 
a part of the tissue section showing the analyzed region corresponding to the pitch of micro-spots. 
b) Reconstructed composited molecular image based on the signals of ions at m/z 
1198.717(green), 1612.950 (blue) and 2141.138 (red). c) MALDI MS spectrum recorded in the 
positive mode in the orbitrap analyzer extracted from a specific area of the analyzed tissue 
(indicated by a dark circle on Figure 2b). 
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Figure 2: On tissue Liquid Microjunction extraction of trypsin digested or undigested 
regions. Comparison of MALDI-TOF MS spectra recorded in the linear positive mode from 2 
consecutive rat brain sagittal tissue sections at two distinct locations in two regions (1, 2) of the 
tissue after micro-extraction in the optimized conditions for tryptic digestion peptides a) micro-
extraction of non digested areas and b) micro-extraction after on tissue digestion on 300 µm 
spots. Black circles delimit the micro-extraction areas which are about 771 µm diameter and red 
circles define the position of the 300 µm trypsin digestion spots.  
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Figure 3: Direct on tissue versus conventional MALDI after Liquid Microjunction 
extraction analysis of trypsin digested regions. Comparison of the MS spectra recorded on an 
MALDI-LTQ-orbitrap instrument in the positive mode from 2 adjacent sagittal tissue sections of 
control rat brain at the same location (in the cerebellar nucleus region i.e. P2 position) after on 
trypsin digestion by 1 µL enzyme deposition using a micropipette and subsequent a) direct tissue 
analysis and b) after micro-extraction using liquid microjunction and conventional MALDI 
analysis. Mass Spectra are normalized against the same intensity scale. 
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Figure 4: MALDI MSI molecular classification of tissue section. a left) Resultant image of 
the statistical analysis using Hierarchical Clustering (HC) showing areas of the section with 
different molecular signature. MALDI.a right) Haematoxylin Eosine (HE) staining of the same 
tissue section. The white circles represent the position of micro-extraction, position 1 is in the 
thalamic nucleus and position 2 is in cerebellar nucleus. b) Optical picture of the tissue section 
used for micro-extraction. Left: picture after trypsin digestion by micro-spotting in 2 distinct 
positions (P1, P2) and Right: picture after the micro-extraction step. c) Maps extracted from the 
rat brain atlas (sagittal view, lateral 0.9 mm panel) showing the regions used for extraction. Top, 
zoomed view of the panel on the cerebellum region showing that digestion/extraction was 
performed in the cerebellar nucleus and Bottom, zoomed view of the thalamic / hippocampus 
regions indicating that extraction was performed in the thalamic nuclei. c) MALDI-MS orbitrap 
spectra recorded in the positive full FT scan mode after micro-extractionfor position 1 (d) and for 
position 2 (e). 
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Figure 5: Extraction yields obtained through Liquid Microjunction extraction are sufficient 
to provide high quality MS/MS spectra. MS/MS spectra recorded in the positive mode during 
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the nanoLC-ESI-LTQ-orbitrap experiment for position 1 (thalamic nucleus) by selection of a) 
parent ion [M+2H]2+ at m/z 942.4595 (retention time 105.08 min) peptide attributed to Alpha 
Internexin,  b) parent ion [M+2H]2+ at m/z 1078.0271 (retention time 73.33 min) peptide 
attributed to Neuromodulin and c) [M+2H]2+ at m/z 571.3007 (retention time 35.24 min) peptide 
attributed to Sphingosine 1-Phosphate Receptor 5. Peptides were activated by CID. Both 
fragmentation and detection was performed in the LTQ analyzer of the instrument. 
 
Figure 6: Number of identified proteins using Liquid Microjunction extraction workflow 
for 2 different tissue regions. Venn diagram representation of the number of proteins identified 
from position 1 (thalamic nucleus) and position 2 (cerebellar nucleus). Experiments were 
performed in triplicates from 3 consecutives tissue sections. On each replicate P1 and P2 were 
extracted and analyzed. a)Comparison for a specific position of the number of identified proteins 
from each sample(all confidence identification criterion). b) Global representation with merged 
data of the replicates for each position (high confidence identification criterion); 1137 proteins 
are identified from both position 1 and position 2, 197 proteins are unique to position 1 and 272 
to position 2 for a total of 1606 proteins groups of proteins identified in total originating from 
5111 high confident peptides. 
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Figure 7: Cellular localization of identified proteins using Liquid Microjunction extraction 
workflow for 2 different tissue regions. Diagram plotting the relative distribution (%) of 
identified proteins according to their cellular location. 
  103 
 
Figure 8: Markers discovery workflow. General workflow for markers discovery combining 
MALDI MSI and On tissue extraction-Off tissue analysis identification strategy.  
 
SUPPLEMENTARY INFORMATION 
Optimization of micro-extraction of on tissue digested peptides 
The micro-extraction parameters were first optimized in order to maximize the amount of 
peptides extracted. This includes the extraction time, the number of extraction cycles, and the 
type of solvent. Extraction time is an important parameter but cannot be varied on a large range. 
Long contact time (1 min or more) generally leads to evaporation of the liquid at the 
microjunction interface and too short times (15 s) do not provide efficient extraction. A good 
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compromise for contact time is 30 s. Thus, it is more efficient to increase the number of 
extraction cycles than the extraction time. Different mixtures of solvents were tested to determine 
which provides the highest extraction yield. For these experiments we used a model protein (here 
Bovine Serum Albumin, BSA) digested in solution and deposited at a specific location on a rat 
brain section. 1 µL of trypsin-digested BSA solution was spotted on the tissue leading to an area 
of approximately 1.5 mm in diameter onto the tissue. After evaporation of the solution, micro-
extraction was performed using solvents of varying compositions and repeated 5 times. 
Conventional solvents used for peptide extraction from tissue sections were initially tested, as 
mentioned in the Experimental section. After extraction the solutions were analyzed by 
conventional MALDI-TOF MS analysis and data were compared (Supplementary Data 1 Table 
2). Globally the tested solutions were relatively efficient allowing for the observation of a number 
of BSA tryptic peptides. Only data for ACN: 0.1% TFAaq (8:2, v/v), MeOH/0.1% TFAaq (7:3, 
v/v) and 0.1% TFAaq are compiled in Supplementary Data 1 Table 2 because those were the 
solvent mixtures providing the better extraction yields based on the number of tryptic peptides 
observed and sequence coverage. All the solvent mixtures successfully extracted the BSA tryptic 
peptides enabling its identification based on the PMF, but with different scores and variation in 
the sequence coverage and the number of fragments. The use of 0.1% TFAaq enabled the 
detection of 32 fragments corresponding to a sequence coverage of 52.4%. Using 
MeOH/0.1%TFAaq (7:3, v/v) improved the detection to 65.1% with 37 fragments. Finally ACN: 
0.1%TFAaq (8:2, v/v) gave a better sequence coverage (73.6%) with 45 fragments. Similar 
results were obtained by extraction of a second model protein (Lysozyme C) digest spotted on 
tissue sections (data not shown). It must also be noted that some peptides are only specifically 
extracted by certain solvents. It can be therefore interesting to use different solvents successively 
during extraction to maximize the extraction efficiency. 
The number of extraction cycles (n) was then examined. In this case, the experiments were 
performed on tryptic peptides from consecutive sagittal rat brain. On the same location for each 
section, 2 µL trypsin was spotted manually using a micropipette and incubated for 1h. After 
trypsin digestion, the sections were subjected to micro-extraction using n=3, 5 and 15 extraction 
cycles with ACN: 0.1%TFAaq (8:2, v/v), and the extracts subjected to MALDI-TOF MS 
analysis. The spectra quality was compared for n=3, 5 or 15 extraction cycles (Supplementary 
Data 1 Figure 1). Adequate spectra were obtained n=5 or 15 extractions, as determined by the 
increase of the S/N ratio of peaks. This effect is illustrated in the zoom on the ion at m/z 1340 
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presented in the inset. Globally, the number of extracted peptides increased with the number of 
extraction cycles up to a maximum of 5 cycles and remained constant above this threshold. 64 
peaks were detected in the MALDI TOF spectrum for the 3 extraction cycles, 84 for the 5 cycles 
and 80 for the 15 cycles, respectively. An increase in the intensity of ion signals from n=3 to 5 
was also observed. For n=5 and 15, few significant differences were observed between the two 
spectra. As 15 extractions is time-consuming, the number of extraction cycles was fixed to 5. 
Taking into account all these parameters, a workflow for tryptic peptide extraction was designed 
using ACN: 0.1%TFA aq (8:2, v/v) as solvent and five extraction repetitions on the same spot 
with a contact time of 30 s. 
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Supplementary Data 1 Figure 2 reports the base peak chromatograms for P1 compared to P2 
extracted from the collected data. If a similar trend is observed between the two chromatograms, 
it should be noted that some differences could already be observed for the 2 positions.  
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Supplementary Data 1 Figure 3: On tissue MALDI MS spectrum used for back correlation 
of Liquid Micro-junction extraction data from direct tissue MALDI MS. MALDI-LTQ-
orbitrap MS spectrum recorded in positive mode from a sagittal control rat brain tissue section 
after on tissue micro-digestion using micro-spotting in the cortex region of the primary motor 
cortex. Spectrum was recorded directly from the tissue section and shows the presence of 176 
monoisotopic ions corresponding to tryptic peptides. 
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Supplementary Data 1 Table 1: Most of the top 20 tryptic peptides observed in MALDI 
MSI after on tissue digestion are attributed to Myelin Basic Protein S. List of the top 20 ions 
extracted with respect to their intensity from MS spectrum shown Figure 2c after deisotoping and 
exclusion of trypsin autolysis ions with a S/N>5 on the m/z range 800-4000. Experimental m/z 
are compared to the predicted m/z from in silico digestion of Myelin Basic Protein from 
databank. Out of 20, 15 of these ions are attributed to various forms of Myelin Basic Protein. 
Table give the corresponding peptide fragments, the mass precision and the modifications present 
on the protein sequence.  
Measured m/z 
On tissue 
measurement 
Calculated m/z 
In silico digestion 
Peptide fragment 
DM 
(ppm) 
Modifications 
 
2141.1377 2141.1138 104-121 11.16 
 
1067.51196 1067.5017 138-146 9.61 Isoform 3 
1745.85718 1745.8387 11-26 10.59 
 
1502.78662 1502.771 91-103 10.39 
 
1800.86584 1800.8452 138-154 11.46 
 
2179.09424 2179.0696 104-121 11.30 [M+K]+ ion 
2163.10767 2163.0960 104-121 5.30 [M+Na]+ ion 
2826.44702 2826.4176 138-163 10.41 2x Acetyl 
1508.82007 1508.804 2-14 10.65 2x Acetyl 
1099.60681 1099.5967 2-10 9.19 2x Acetyl 
1680.87622 1680.8564 132-146 11.79 Isoform 3 
1339.72192 1339.7076 33-44 10.69 
 
2512.33472 2512.3055 101-121 11.63 
 
1909.94104 1909.9198 138-154 11.12 Isoform 3 
2402.25928 2402.2323 33-54 11.23 
 
1838.81995 unassigned 
   
1540.74219 unassigned 
   
1105.46729 unassigned 
   
1460.73218 1460.7168 104-115 10.53 
 
1024.56270 1024.5534 122-131 9.08 
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Supplementary Data 1 Table 2: Efficiency of Liquid Micro-junction extraction for tryptic 
peptides according the extraction solvent. Evaluation of digest peptides extracted using micro-
junction micro-extraction for 3 different solvent compositions respectively ACN: 0.1% TFA in 
water (8:2, v/v), MeOH /0.1% TFA in water (7:3, v/v) and 0.1% TFA in water alone. A volume 
of 2 µL solvent was charged in the tip and 0.6 µL pushed out to create the micro-junction for 
each of the tested solvent mix. The number of extraction cycle was fixed to n=5. The up taken 
solution was then use for conventional MALDI-TOF analysis using HCCA as matrix. Table 2 
summarize the m/z of the different digestion peptides observed, the position in the protein 
sequence of the digestion peptide for each condition and provide the databank interrogation 
(Mascot) score, the sequence coverage and the number of detected digestion fragment observed.  
Calculated m/z 
In Silico digestion 
Peptide 
fragment 
ACN/0.1% TFA 
(8:2 v/v) 
MeOH/0.1% TFA 
(7:3 v/v) 0.1% TFA 
689.3352 236 - 241 x   
898.4982 483 - 489 x x  
927.5078 161 - 167 x x x 
1138.5353 499 - 507 x x x 
1163.6822 66 - 75 x x x 
1195.5683 223 - 232 x x x 
1249.6661 35 - 44 x x x 
1283.7548 361 - 371 x x x 
1305.75 402 - 412 x x x 
1349.5784 24-34   x 
1399.7376 569 - 580 x x  
1419.7466 89 - 100 x x x 
1439.8673 360 - 371 x x x 
1443.6998 286 - 297 x x  
1479.851 421 - 433 x x x 
1502.5195 375-386  x  
1511.7353 438 - 451 x x  
1519.6849 360-371   x 
1532.6815 298 - 309 x x x 
1554.5584 387 - 399 x x x 
1567.6411 347 - 359 x x  
1576.6614 139 - 151 x x x 
1624.8262 24 - 36 x   
1639.9965 437 - 451 x x x 
1673.8249 118 - 130 x x x 
1724.8834 469 - 482 x x  
1733.9083 156 - 167 x x  
1740.8667 469 - 482 x   
1747.7752 184 - 197 x x x 
1749.738 267 - 280 x x x 
1809.7696 156-168   x 
1880.8521 508 - 523 x x x 
1901.8012 123 - 138 x x x 
1907.8541 529 - 544 x x x 
1927.7362 581 - 597 x x x 
1964.8838 452 - 468 x x x 
2019.9224 139 - 155 x x x 
2028.032 421 - 437 x x x 
2044.9885 168 - 183 x x x 
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2205.0811 168 - 183 x   
2211.104 2-19 x x x 
2247.9843 267 - 285 x x x 
2458.2007 319 - 340 x x  
2492.2818 45 - 65 x   
2541.1978 118 - 138 x x x 
2612.1846 264 - 285 x   
2670.3188 2-23 x  x 
2826.4231 2-24 x   
3511.7386 310 - 340 x   
Mascot Score 191 156 106 
Sequence coverage (%) 73.6 65.1 52.4 
Numbers of fragments 45 37 32 
 
 
Supplementary Data 1 Table 3: List of individual proteins identified by back correlation of 
Liquid Micro-junction extraction data to MALDI MSI. Proteins assignment for the MS 
Imaging spectra in the ROI using mass correlation in between measured peptides after on tissue 
micro-extraction by nanoLC-ESI-LTQ-orbitrap and for MALDI direct tissue analysis. For each 
identified proteins that right column give the number of peptides assigned in the MALDI MS 
Imaging data. 
 
Proteins Assession 
number (Uniprot) Proteins name 
Number of peptides 
fragments matching / 
protein 
Not assigned 56 
Q6P9T8 Tubulin beta -2C Chain 12 
P68370 Tubulin Alpha-1A Chain 9 
P85108 Tubulin Beta -2A Chain 8 
P10719 ATP Synthase Subunit Beta, Mitochondrial 6 
P02688 Myelin Basic Protein S 5 
P11442 Clathrin heavy chain 1 4 
P01946 Hemoglobin Subunit Alpha-1/2 4 
P09951 Synapsin-1 4 
Q4QQV0 Tubulin Beta-6 4 
P60711 Actin Cytoplasmic 1 3 
F1LP05 ATP Synthase Subunit Alpha 3 
P47942 Dihydropyrimidinase-related protein 2 2 
P05065 Fructose-biphosphate aldolase A 2 
P02091 Hemoglobin Subunit Beta-1 2 
A7VJC2 Heterogeneous nuclear ribonucleoproteins A2/B1 2 
P16617 Phosphoglycerate kinase 1 2 
P06685 Sodium/Potassium-transporting ATPase subunit aplha-1 2 
P06686 Sodium/Potassium-transporting ATPase subunit aplha-2 2 
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P689897-2 Isoform 2 of Tubulin Beta-5 chain 2 
P62738 Actin, aortic smooth muscle 1 
Q6P2A5 Adenylate kinase 1 
D4A205 Anaphase Promoting Complex Subunit 2 1 
Q06647 ATP synthase subunit O, mitochondrial 1 
P21571 ATP synthase-coupling factor 6, mitochondrial 1 
Q6AY58 B-Cell receptor-associated protein 31 1 
F1LNN9 Brain Acid Soluble Protein 1 1 
Q3ZB98 Breast Carcinoma-amplified sequence 1 homolog (fragment) 1 
P08413 Calcium/Calmodulin-dependent protein kinase type II subunit 1 
P63041 Complexin-1 1 
P00406 Cytochrome c oxydase subunit 2 1 
P11951 Cytochrome c oxydase subunit 6C-2 1 
D3ZZZ1 Excision repair cross-complementing rodent repair deficiency, complementation group 6 (Predicted) 1 
P09117 Fructose-biphosphate aldolase C 1 
P09606 Glutamine synthase 1 
Q9Z339 GlutathioneS-transferase omega-1 1 
P04797 Glyceraldehyde-3-phosphate dehydrogenase 1 
P82995 Heat Shock Protein HSP 90-alpha 1 
Q9JJ50 Hepatocyte Growth Factor-regulated tyrosine kinase substrate 1 
P43278 Histone H1.0 1 
P15865 histone H12 1 
D3ZAA9 Isoform 2 of MAGUK p55 subfamily member 2 1 
Q6AYL8 Leucine Rich repeat and IQ domain-containing protein 3 1 
O88989 Malate dehydrogenase, cytoplasmic 1 
F1MAQ5 Microtubule-associated protein 1 
D4AD98 Mitogen-Activated protein kinase 8 interacting protein 3 1 
P16884 Neurofilament heavy polypeptide 1 
O88778 Protein bassoon 1 
P63055 Purkinje Cell protein 4 1 
P11980 Pyruvate kinase isozymes M1/M2 1 
F1LNN9 Rab GDP dissociation inhibitor alpha 1 
F1M3D2 Similar to Dystrophia myotonica WD repeat-containing protein 1 
P06687 Sodium/Potassium-transporting ATPase subunit aplha-3 1 
P31662 Sodium-dependent neutral amino acid transporter SLC6A17 1 
P13668 Stathmin 1 
Q5XIF6 Tubulin Aplha-4A Chain 1 
Q4QRB4 Tubulin Beta-3 chain 1 
P69897 Tubulin Beta-5 chain 1 
F1LQ84 UDP-glucose pyrophosphorylase 2 1 
F1LRP6 Vesicle associated membrane protein 2B 1 
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Q9QUL6 Vesicle -fusing ATPase 1 
Q4V8F9 Hydroxysteroid dehydrogenase-like protein 2 1 
 
 
Additional supplementary data (Supplementary Data 2, 3 and 4) can be found in the online 
version of the article at: http://dx.doi.org/10.1016/j.jprot.2012.11.025
Chapter 2 
On-Line nanoLC-MS Coupling of Liquid Microjunction Microextraction 
It was mentioned previously that the correlation of protein identification data to localization can 
be further improved by reducing the digested and extracted areas. To this end, a different 
approach is being pursued. It is to be noted that the liquid microjunction extraction can also be 
realized using other methods (Kertesz and Van Berkel 2010; Van Berkel and Kertesz 2013). In 
fact, any instrumentation capable of dispensing and aspirating microliter quantities of solvent is 
suitable for this purpose. In a past example, an HTC PAL autosampler (LEAP Technologies Inc., 
Carrboro, North Carolina) was interfaced with an LC-MS instrument for liquid handling during 
the extraction step. This way, propanolol and some of its metabolites were quantified on mouse 
whole body sections (Kertesz and Van Berkel 2010).  
Materials and methods 
Liquid Microjunction Instrumentation 
Figure 14 shows another  example, where a Spark 920 FAMOS autosampler (LC Packings 
Dionex, now Thermo Scientific, Bremmen, Germany) was interfaced with an EASY-nLC 1000 
system (Thermo Scientific, Bremen, Germany) that was coupled to an LTQ orbitrap XL MS 
instrument. In this set-up, the syringe of the autosampler is connected to the valve S of the 
EASY-nLC device, and it replaces the tubing that connects the valve to the autosampler pump. A 
100-m capillary replaced the tubing in position 1 of the valve and this capillary is connected to 
the robotic arm that collects the sample from the autosampler vials. A cut falcon tube open at 
both ends covers the tissue section on one end and acts as a support on the other by preventing 
the piercing needle from completely descending towards the bottom of the sample plate.    
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Table 2. Programming sequence used to enable liquid microjunction extraction on the 
FAMOS autosampler. 
Step Command*  Volume  Location  Speed  Height  
1 Valve Position  Load  
2 Aspirate  2 L  Reagent A  1  10  
3 Wait  20 s  
4 Aspirate  0 L  Reagent A  1  10  
5 Dispense  0.2 L  Sample  1  16  
6 Wait  5 s  
7 Dispense  0 L  Sample  1  15  
8 Wait  15 s  
9 Aspirate  0.2 L  Sample  1  15  
10 Wait  5 s  
11 Aspirate  0 L  Sample  1  15  
12 Dispense  0.2 L  Reagent B  1  1  
13 Wait  5 s  
14 Dispense  0 L  Reagent B  1  1  
15 Repeat  4X  Steps  2-14  
16 Aspirate  13 L  Reagent B  3  1  
17 Wait  10 min  
18 Aspirate  0 L  Reagent B  1  1  
19 Valve Position  Inject  
20 Needle Wash  50 L  
*Commands are the functions that the autosampler executes. Location refers to the position of the 
robotic arm. Reagents A and B refer to positions of the solvent bottles located behind the sample 
plate, while Sample refers to the sample plate where the glass slide is mounted. The Sample 
location can be assigned depending on the type of sample plate used (96- or 384-well plates), and 
the position of extraction made precise by further adjusting manually. Speed and Height refer to 
the rate at which the syringe pump moves and the distance of the capillary from the bottom of the 
sample plate when it is being extended from the piercing needle.  
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nanoLC-MS 
The EASY-nLC, on the other hand, was set-up as follows. The configuration was set to One-Way 
Contact Closure, and the data acquisition was started once the contact has been established. A 
method file was created and loaded in the EASY-nLC, independent of the chromatographic 
parameters that are being set in the Xcalibur method file. This method file instead dictates the 
pre-column and column equilibration volumes, flow rates and maximum pressure in the pumps in 
addition to the chromatographic parameters. Pre-column equilibration was set to 3 L and the 
analytical column equilibration to 2 L. The LTQ Orbitrap MS parameters, meanwhile, were still 
set using the Xcalibur method file. A spray voltage of 2 kV was used to generate the precursor 
ions, and scans were performed with a range of 300-1600 m/z. The LTQ orbitrap was operated in 
data acquisition mode performing MS/MS of the top 6 most intense ions from each survey scan. 
The resolving power of the Orbitrap mass analyzer was set to 60,000 FWHM at m/z 500 and a 
normalized collision energy of 35 % with an isolation window of 2 amu was used for the CID 
fragmentation of precursors whose intensities are over 500 counts. For the MS/MS, a target of 
5000 ions and a maximum injection time of 200 ms were used. The dynamic exclusion was set to 
30 s. 
Data Analysis 
 
Raw files obtained from nanoLC-MS were processed using Proteome Discoverer version 
1.4.0.288 (Thermo Fisher Scientific, Bremmen, Germany). The protein identifications were 
obtained using the following parameters for the interrogation : Peptide Mass tolerance : ± 10 
ppm, Fragment Mass tolerance : 0.6 Da, Max. Delta Cn = 0.05, Dynamic Modification : 
Oxidation/+ 15.995 Da (methionine), Enzyme : trypsin, 2 miscleavages, Protein FDR = 0.01. The 
searches were performed using the UniprotKB/Swiss-Prot database (version January 2012) 
filtered with Rattus norvegicus (41604 sequences) taxonomy using the SEQUEST HT algorithm. 
Raw files were also converted to *.mgf using MSConvert (Chambers, Maclean et al. 2012) and 
submitted to Mascot search as needed. For the Mascot searches, the following parameters were 
used : Taxonomy : other mammalia, Database : Uniprot, Enzyme : trypsin, 2 miscleavages, No 
fixed modifications, Variable modification : oxidation of methionine, Peptide tolerance : ± 
10ppm, MS/MS tolerance : 0.6 Da, Peptide Charge : 2+, 3+ and 4+, Instrument : ESI-Trap and 
with the decoy search activated. 
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Results 
Examination of BSA Standard 
The performance of the configuration was evaluated using various samples. In the first instance, 
0.5 L of 10 -4 M BSA in 50 mM bicarbonate buffer was spotted on glass slides and dried in the 
vacuum. The spots were extracted 5x with 0.1% FA dispensed at 0.2 L each time and then 
collected and injected separately. Each extract was separated using a 30-min gradient, and the 
acquired *.raw files were converted to .mgf and submitted to Mascot interrogation. Results show 
successful identification of BSA, with the Mascot scores and Peptide matches decreasing as the 
number of extractions is increased (Table 3). Examination of the extracted ion count of a selected 
peptide signal (m/z 722.32679) shows that after only three extractions, 99.7% of the peptide ion 
count has already been detected. 
 
Table 3. Identification of BSA standard for each extraction using the FAMOS autosampler. 
 
Evaluation of Method on Rat Brain Section 
In the examination of rat brain tissue sections, the size of the microjunction was first optimized to 
determine the minimum volume of solvent that can be dispensed which would provide the 
smallest sampling area possible. This was done as follows. First, the 10-m tissue sections were 
soaked in 70% and 95% EtOH then in CHCl3 for 30 s each and dried. Then 0.2, 0.3 or 0.4 L of 
0.1 % FA was dispensed at approximately the same position on the three consecutively cut 
sections. 0.2 L is the smallest volume that can be dispensed by the autosampler syringe. 
Because of the small internal diameter of the capillary that dispenses the liquid on the tissue 
surface (100 m), a waiting time of 5 s was set to allow the full release of the solvent before it 
touches the tissue surface. This in turn causes the droplet to become larger than the internal 
Extraction # Mascot
Score
Peptides 
Matched
% Sequence 
Coverage
Peak Area 
(m/z 722.32679)
1st 2729 141 62 98423539
2nd 849 57 50 11109431
3rd 787 41 47 2311063
4th 438 23 34 371891
5th 39 4 5 ND
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diameter of the capillary. Unpublished accounts of other TriVersa Nanomate users suggested that 
the disposable tip can be made to touch the tissue surface so that very little liquid is expelled, 
thus reducing the sampling area equal in diameter to that of the pipette tip. In the case of the 
capillary though, this did not allow the extraction of surface components and was thus not 
pursued. Despite of this, the capillary was able to produce liquid microjunction diameters as 
small as 1200 m from 0.2 L of solvent dispensed (Figure 15). This corresponds to a 30% 
decrease in the diameter of the surface extracted, when compared to the liquid microjunction 
produced by pipette tips in the conventional LESA set-up ((Quanico, Franck et al. 2013), see 
Figures 2 & 4).  
 
Figure 15. Liquid microjunction sizes as a function of dispensed volume. 
The capillary in the FAMOS autosampler is capable of dispensing 0.2 L solvent, in contrast to 
the Triversa Nanomate where the tip can only dispense up to a minimum of 0.6 L. 
Consequently, the size of the liquid microjunction formed is reduced. 
 
Aside from reducing the size of the extracted area, the size of the microdigested area was also 
decreased. This was achieved by setting the CHIP 1000 microspotter to discrete mode, allowing 
the user to change the number of spots that will be microspotted per region specified. As such, 
the number of spots was set to 1 x 1, yielding only one spot on the marked region. The volume 
spotted was then set to 20 picoliters per spot. The number of droplets and waiting time were set 
depending on the preexisting conditions of the experiments and thus vary depending on the 
feasibility of forming the microdroplet prior to commencing the spotting. Figure 16 shows an 
example of microdigested regions on the rat brain tissue section, showing that the diameter of 
microdigested spots can be decreased down to approximately 150 m following this approach. 
This corresponds to about 78% reduction in microdigested region diameter. As in the LESA 
experiment, comparison of the extracts obtained from digested and undigested regions on the 
same position in a coronal rat brain section was performed, where it can be seen once again that 
1211.37 m 1312.73 m 1611.87 m
0.2 L 0.3 L 0.4 L
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extraction only occurs in the digested region as shown by the very low number of tryptic peptide-
based protein identifications in the undigested region (Figure 17). Examination of each 
extraction cycle by running them separately in nanoLC-MS showed that majority of the protein 
IDs (88%) were obtained from the first extraction alone. Successive extractions only contributed 
about 5 additional new identifications each time (Figure 18). In both experiments, only a 25-min 
gradient was employed for chromatographic separation, hence the low number of protein 
identifications even on the digested region. To determine if this indeed could be the case, the size 
of the microdigested area was increased in the succeeding experiment back to approximately 650 
m and the extracts ran in 1.5 and 4 h gradients using the same data acquisition parameters.  
Increasing the gradient separation, as expected, led to concomitant increases in the number of 
protein identifications (Figure 19).  
 
Figure 16. Sample microdigested regions reduced in diameter up to 150 µm. 
Digestion was done by setting the number of spots in the digestion area (parameter required by 
the microspotter) to 1x1, corresponding to one droplet only.  
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Table 4. Parameters used for comparing microextraction using the TriVersa NanoMate 
(LESA) and the FAMOS autosampler. 
 
Results show that, in both gradients, more proteins were identified with the online approach than 
with the conventional LESA instrument (Figure 20). The number of identifications was 
significantly lower compared when using an Orbitrap Elite instrument, as expected. Although 
0.1% FA does not extract as much components compared when an organic modifier is present in 
the solvent, the former is still sufficient to provide about 500 protein identifications using the 
FAMOS, given the acquisition limitations of the LTQ Orbitrap instrument. It is to be noted too 
that the volume of extracting solvent is almost 70% smaller when using the FAMOS; this not 
only reduces the size of the extraction area but also improves the extraction efficiency. Finally, 
elimination of sample pretreatments prior to injection to the nanoLC could also contribute to the 
higher protein identification yield. Although it is beneficial to desalt samples as it improves 
column lifetimes, minimizes adduct formation and leads to high protein recovery (Salplachta, 
Rehulka et al. 2004), desalting can also be a setback as small hydrophilic peptides can elute with 
0.1% TFA leading to protein losses (Tannu, Wu et al. 2004). This also greatly shortens the 
sample preparation time as the drying steps using the speedvac were eliminated.  
Parameter LESA FAMOS
Extraction solvent 80% ACN/0.1% TFA 0.1% FA
Dispensed solvent volume per cycle 0.6L 0.2L
Number of Extraction Cycles 5 5
Microjunction contact time 15s 15s
Ziptip? Yes No
Trypsin Concentration 20ug/mL 20ug/mL
CHIP Digestion size* 674m 648m
*Refers to diameter of digested spot
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µm loop, the authors report extraction times up to 8 minutes, given a flow rate of 25 L/min. This 
implies however that the size of the sample loop will limit the volume of solvent containing the 
extracted material that can be collected. Meanwhile, to ameliorate the extraction efficiency, 
multiple cycles of extraction are performed on the discrete droplet-type microextraction. Several 
reports (Eikel, Vavrek et al. 2011; Walworth, ElNaggar et al. 2011) indicate that repeated cycles 
could lead to increase in the size of the microextracted area, and that the small size of the droplet 
limits the dissolution of compounds to the liquid interface. Results of this bottom-up proteomics 
approach indicate that the latter is not the case, since close to a thousand proteins were in fact 
identified from just five cycles of extraction on a sample surface as small as 650 µm. Also with 
this approach, increases in the size of the microextracted area are not critical because the 
microdigested region ultimately determines the size of the extractable area. Perhaps the 
advantage that can be gleaned from the use of smaller microjunction areas then is that the volume 
of solvent used will also be small, thus, more cycles of extraction can be performed, if really 
desired. In the experiments, up to 5 cycles of extraction were done, using 0.2 L of solvent each 
time. They were dispensed in a sample reservoir containing 13 L of 0.1% FA, and after all 
cycles of extraction have been completed, 13 L was injected into a 25 L-sample loop. Note 
that the loop was not filled to capacity. During sample loading, the missing liquid was 
compensated for by solvent A (0.1% FA) and then injected to the column. If the need arises, 
additional extraction cycles can be done further since there is still an excess of the loop volume 
that needs to be filled. Even though the volume is very small and can thus limit the solubility of 
peptides, this was overcome because the repeated cycles of extraction leads to wetting of the 
sampling surface and thus improves the extraction efficiency with each consecutive cycle. 
Perhaps the biggest limitation of the current bottom-up, liquid junction microextraction approach 
is the efficiency of the digestion process. Compared to conventional sample digestion techniques, 
in situ digestion has its distinct challenges. For instance, proteins in situ present structural 
conformations that render them less susceptible to proteolysis compared when they are in 
solution. Also, the amount of proteins on micrometer-thick tissue sections is significantly lower 
compared to whole organs (McDonnell, Corthals et al. 2010); their amounts can therefore be 
easily overwhelmed by successive addition of proteolytic enzymes leading to autolysis. Also, 
successive deposition of the proteolytic enzyme can easily lead to loss of spatial resolution 
because of the diffusion of the solvent dependent on the properties of the surface. 
Supplementary Figure 1 (see Annex) shows a full MS survey scan from t= 56.28 min of the 
  126 
1.5h gradient run using the FAMOS autosampler previously shown in Figure 20. The MS scan 
shows isotopic patterns of intact proteins, suspiciously corresponding to ubiquitin, an abundant 
protein. The presence of undigested proteins is indicative of incomplete digestion, which is 
expected given the short digestion time (1h), unregulated temperature, and small volume of 
trypsin in contact with the surface. Inspection of the sequence coverage of the proteins identified 
also indicates, in general, low coverage and number of peptides identified per protein, with an 
average of 47% having sequence coverage of less than 5% and having only 1 peptide. In fact, if 
the number of peptides is set to 2, the number of protein identifications is greatly reduced to 253 
for the sample ran in a 4h gradient using the FAMOS autosampler. This is also unsurprising, 
since no antigen retrieval, chaotrope, or reducing agent was used to improve the digestion. The 
extent of digestion depends on a variety of factors. The presence of disulfide bonds between two 
adjacent cysteine residues plays an important role in protein stability, as it renders them less 
susceptible to denaturation and subsequently degradation (Betz 1993). As such, reduction of 
these bonds by reducing agents such as DTT, beta-mercaptoethanol, or TCEP is often 
incorporated in conventional protein digestion protocols, coupled with cysteine capping using 
iodoacetamide to prevent the re-oxidation of these residues. Introduction of chaotropes by heating 
to denaturing temperatures, addition of high concentrations of urea or guanidinium 
hydrochloride, addition of organic solvents, etc. is also imperative in the development of protein 
digestion protocols as the denaturation of proteins allows for the exposure of otherwise buried 
lysine and arginine residues thereby facilitating their cleavage.  
Performing efficient digestion at the least possible time still remains a challenge not just for this 
approach but for comprehensive proteomics in general, and it has been examined extensively 
(Hustoft, Reubsaet et al. 2011). The authors finally concluded that none of the methods 
accelerating digestion (such as infrared energy, microwave energy, aqueous/organic systems or 
filter-aided sample preparation (FASP)) are as efficient as performing in-solution digestion for 
12-16h (overnight). For in situ digestion, recent developments have been reported, namely by 
Harris et al and Jiao et al (Harris, Nicklay et al. 2013; Jiao, Miao et al. 2013). Harris et al used 
preformed, sub-millimeter-sized hydrogels with trapped trypsin to facilitate surface digestion 
once it is deposited on the tissue section. Although the approach provides a means to allow the 
use of multiple successive experimental workflows on the same tissue section, only 212 proteins 
were reportedly identified given that the hydrogel was incubated for extended periods of time (6-
12h) at 50C. Meanwhile Jiao et al immobilized trypsin on graphene oxide and deposited the 
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particles in situ prior to matrix deposition and MALDI MSI. Compared to other supports, 
graphene oxide presents notable structure and chemical features that improves protein digestion 
efficiency and makes it amenable to MALDI MSI. 
Perhaps the most promising approach is by performing digestion under pressure such as in on-
line digestion systems like the FOLDS set-up (Lopez-Ferrer, Petritis et al. 2010). High pressure 
causes proteins to get denatured, making them more susceptible to proteolysis. Coupling of on-
tissue extraction with high-pressure digestion systems can be done, for instance, by performing 
intact protein extraction and then injecting them into an immobilized pepsin column interfaced 
with a nanoLC-MS instrument. This brings about the question of whether it is possible to perform 
intact protein extraction using the liquid junction extraction approach. Initial attempts were done 
by loading 1% SDS on the tips for LESA extraction, however, it was difficult to accurately 
aspirate or dispense the solution because it is highly viscous. Once the solution is dispensed, it 
rapidly spreads on the tissue thus creating a larger spot extracted. Furthermore, removal of the 
detergent is impossible without having to subject the extract to SDS-PAGE separation, FASP, or 
tube-gel clean-up and digestion (Lu and Zhu 2005; Wisniewski, Zougman et al. 2009). 
Protein extraction in the sub-millimeter scale has its advantages and disadvantages. On the one 
hand it is possible to obtain a localized distribution of proteins up to a level of spatial resolution 
of about several cells. This is expected to provide a much better estimation of morphological 
changes in the tissue since a more homogeneous population of cells is sampled. The ultimate goal 
of on-tissue microextraction is to be able to sample single cells in situ, since it has been 
established that individual variation is apparent even for a population of what was otherwise 
perceived as homogeneous cells. However, this has its own unique consequences and limitations. 
For one, the number of DNA copies of a single protein is limited per cell. This means that the 
amounts of protein expressed per unit cell is significantly lower compared to those from a cell 
population. This imposes a much lower limit of detection to mass spectrometers. In the presence 
of more abundant proteins such as albumin, these lowly-expressed proteins become undetectable 
because of predominant ion suppression effect. Extensive work by Sweedler’s group and others 
(Nemes, Rubakhin et al. 2013) on the metabolomic profiling of a single cell have shown that 
even with sophisticated instrumentation, one is able to monitor only a small portion of the 100-
1000 small molecules that are expected to be produced in single cells, mainly because these 
molecules are detected in their natural abundances (ie., without the use of amplification 
procedures such as those employed in DNA quantification). In this regard, it might be ideal to 
  128 
restrict spatial resolution up to a certain limit so that there still remains a certain degree of protein 
enrichment that will be sufficient for detection. This limitation will be imposed by the nature of 
the tissue that is being studied, and will vary depending on its extent of homogeneity. Note that 
this should be similar in principle to laser capture microdissection, where enrichment is done by 
collecting thousands of cells of identical phenotype at the expense of losing localization because 
of the need to collect them in several places on the tissue. Also, it might be ideal to continue with 
this approach because, in contrast to single cell analysis, the cell microenvironment is being 
considered when following this approach.  
The other complication is the complexity of proteins owing to their bigger sizes relative to other 
types of biological molecules. Because current mass spectrometers are designed to detect masses 
within the low mass range, there is a bias against high-molecular weight proteins, although this is 
currently being overcome with the design of new generation mass spectrometers. Although it is 
desirable to do protein identification on the basis of their in source decay fragmentation alone as 
in bottom-up proteomics approaches, current in-source decay instruments lack precursor ion 
detection which renders them useless for comprehensive proteomics analysis. 
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Conclusions – Part 1 
Develop alternative methods to ameliorate MSI protein identification strategies. 
This can be achieved by developing a localized protein extraction method based on the liquid 
microjunction approach. The approach is similar in principle to the generation of protein ID 
databases that are then used for matching with peaks in MSI spectra. In contrast though, the 
protein database will be obtained from localized regions on the tissue section. This will be done 
by performing in situ tryptic digestion on those regions, followed by extracting the peptides using 
the liquid microjunction approach, then subjecting the extracts to shotgun nanoLC MS. 
 
This section demonstrated the applicability of the liquid microjunction for localized 
microproteomics analysis directly on tissue, highlighting its advantages and disadvantages in this 
context. Coupled with on-tissue microdigestion, the liquid microjunction strategy provides a 
robust means to examine proteins of limited abundance by extracting and identifying them from 
individual regions of the tissue. In return, the identified low abundance proteins were used to 
discern the distinct regions from each other, showing also the applicability of this strategy for 
tissue profiling. In spite of the small region (and consequently low number of cells) sampled, the 
liquid microjunction strategy can provide a large number of protein identifications. As such, it 
can serve as a suitable alternative to whole tissue/organ protein extraction for database generation 
in MSI back-correlation methods.  
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Résumé en français 
La technique d’imagerie par spectrométrie de masse (MSI) MALDI fut présentée comme une 
bonne stratégie pour identifier les régions présentant des phénotypes spécifiques basés sur les 
différences de profils moléculaires. Les protéines présentes dans différentes régions peuvent être 
identifiées in situ mais le nombre de protéines identifiables reste très faible comparé aux 
approches protéomiques basées sur la MS. Pour outrepasser ce problème, une nouvelle stratégie 
impliquant la microdissection manuelle de régions de sections de tissus montés sur des lames 
histologiques recouvertes de parafilm M, fut étudiée dans cet article. L’extraction et le 
fractionnement de protéines à partir de régions d’intérêts a permis d’identifier plus de 1000 
protéines venant de chacune des microdissections. L’intérêt de cette approche réside dans son 
faible coût et la facilité d’exciser des zones de l’ordre du millimètre. Ainsi il possible d’identifier 
des protéines venant de cellules de phénotype spécifique mis en évidence par la classification 
moléculaire à partir d’expérience de MALDI-MSI. Cette approche peut être appliquée à 
l’ensemble d’une coupe de tissu afin de générer des images moléculaire de protéines basée sur la 
quantification sans marquage. Cette approche a été appliquée sur une coupe de tissu monté sur 
une lame recouverte de parafilm M, qui a ensuite été découpée en  morceaux réguliers. 
L’identification et la quantification relative des peptides selon la stratégie du comptage de 
spectres obtenus par nanoLC MS & MS/MSa permis de reconstruites des images de protéines. 
Cette stratégie de MSI basée sur la quantification offre la possibilité de pouvoir cartographier un 
grand nombre de protéines, qu’elles soient en grande ou en faible abondance. 
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QUANTIFICATION BASED MASS SPECTROMETRY IMAGING OF PROTEINS BY 
PARAFILM ASSISTED MICRODISSECTION 
 
Julien Franck1, Jusal Quanico1,2, Maxence Wisztorski1, Robert Day2, Michel Salzet1 and 
Isabelle Fournier1* 
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de Médicine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, J1H 
5N4, Canada 
 
ABSTRACT  
MALDI-MSI was presented as a good strategy to highlight regions presenting specific 
phenotypes based on molecular content. The proteins present in the different areas can be 
identified by MALDI MSI, however, the number of protein identifications remains low in 
comparison with classical MS-based proteomics approaches. To overcome this, a new strategy, 
involving the microdissection of tissue sections mounted on parafilm M-covered glass slides is 
presented. Extraction and fractionation of proteins from a specific region of interest was 
investigated, leading to the identification of more than 1000 proteins from each microdissected 
piece. The strength of this cheap technique lies in the facile excision of millimeter-sized portions 
from the tissue allowing for the identification of proteins from cells of a specific phenotype 
obtained from the MALDI MS imaging based molecular classification using hierarchical 
clustering. This approach can be extended to whole tissue sections in order to generate images of 
the section based on label-free quantification obtained from identification data. As a proof of 
concept we have studied a tissue mounted on a parafilm M-covered glass slide, cut it into regular 
pieces and submitted each piece to identification and quantification according to the developed 
PAM method. Images were then reconstructed by relative quantification of identified proteins 
based on spectral counting of the peptides analyzed by nanoLC-MS & MS/MS. This strategy of 
quantification-based MSI offers new possibilities for mapping a large number of high and low 
abundance proteins. 
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INTRODUCTION 
To date, MALDI Mass Spectrometry Imaging (MALDI-MSI) is widely used to map the 
distribution of compounds within tissue sections. Different classes of endogenous or exogenous 
molecules are detected namely drugs (Drexler, Tannehill-Gregg et al. 2011; Kallback, 
Shariatgorji et al. 2012; Shanta, Kim et al. 2012), metabolites (Trim, Francese et al. 2009; 
Sugiura and Setou 2010; Shanta, Kim et al. 2012), lipids (Hankin, Farias et al. 2011; Landgraf, 
Garrett et al. 2011; Murphy, Hankin et al. 2011), peptides (Goodwin, Pennington et al. 2008; 
Sole-Domenech, Johansson et al. 2010; Bruand, Sistla et al. 2011) and proteins (Grey, Chaurand 
et al. 2009; Franck, Longuespee et al. 2010; Clemis, Smith et al. 2012) from organs or even 
whole body animals (WBA). The strength of MALDI MSI lies in the detection and localization 
of hundreds of compounds without any labeling in one acquisition step. The technique is now 
widely used in many fields of research for various applications such as DMPK or ADME studies 
in pharmacology (Prideaux, Staab et al. 2010; Goodwin, Iverson et al. 2012; Takai, Tanaka et al. 
2012), and biomarker investigation in oncology (Lemaire, Menguellet et al. 2007; Elsner, Rauser 
et al. 2012; Longuespee, Gagnon et al. 2013) or brain disorders such as Parkinson and Alzheimer 
diseases (Stoeckli, Staab et al. 2002; Stauber, Lemaire et al. 2008; Strobel, Haerle et al. 2009). It 
has been shown to be a well-suited tool to highlight changes in biomolecule regulation as the 
organisms undergo alterations in their physiological state. If corresponding molecules are 
identified, valuable information can be obtained on the signaling pathways involved which can 
then be used to deduce the underlying biological mechanisms. Identification of imaged molecules 
is, thereof, essential for the understanding of biological phenomena.  
 
Since several years many groups have developed strategies allowing the direct identification from 
tissue sections of the different classes of molecules. This has been successfully demonstrated for 
drugs, lipids and peptides (Cerruti, Benabdellah et al. 2012; Gagnon, Franck et al. 2012). For 
proteins, however, conventional ion activation methods failed to produce fragmentation in 
MALDI from singly-charged state ions. By performing In-Source Decay (ISD), a single-step 
Top-Down strategy has been developed for protein identification using 1,5-Diaminonaphthalene 
(1,5-DAN) as matrix (Bonnel, Longuespee et al. 2011; Debois, Smargiasso et al. 2013). 
Likewise, a Bottom-Up strategy employing in situ enzymatic digestion based on the deposition of 
a proteolytic enzyme on the surface of the whole section or on discrete regions has been 
developed (Franck, El Ayed et al. 2009; Gustafsson, Oehler et al. 2011). However, in both cases, 
  135 
only the major proteins are identified because the signal from less abundant proteins is hampered 
by the complexity of the sample. To overcome this, proteins can be in situ-digested and the 
resulting peptides microextracted prior to their analysis by nanoLC-MS & MS/MS minimizing 
the ion suppression effects by addition of a separation step and concentrating the peptides. This 
strategy allows the identification of many proteins including the less abundant ones, but the 
localization is lost. This can be regained by doing a back correlation of the m/z of the off-tissue 
identified peptides to those of the tryptic peptides detected by MALDI-MSI. This strategy was 
described in the case of oncology (El Ayed, Bonnel et al. 2010) and neurodegenerative 
diseases(Stauber, Lemaire et al. 2008). However, the inaccurate mass measurement from the two 
different instruments used could be detrimental. Recently, Schober et al. have updated this 
strategy by using a high accuracy mass spectrometer (Schober, Schramm et al. 2011). 
Nevertheless, even if the procedure is now very attractive due to the accurate mass measurement 
available, the analysis is still limited mainly by the extent of the digestion efficiency on the tissue 
section in imaging mode and by the dominating presence of abundant proteins which tend to 
suppress the signal of the low abundant ones.  
 
An alternative strategy would consist of extracting all proteins on a restricted region of interest 
(ROI of around several hundred µm2) allowing for their identification in a complete proteomics 
approach involving enzymatic digestion and nanoLC-MS/MS. In this strategy, many proteins 
could be highlighted and their localization maintained. To date, Laser Capture Microdissection 
(LCM) is largely used to study proteins from cells of a defined phenotype which are 
automatically or manually selected according to morphology criterion. However, LCM requires a 
relatively large number of cells in order to reach the sufficient amount of proteins needed for a 
conventional proteomics investigation (1500-2500 proteins identified from 50 000-60 000 cells 
collected) (Wisniewski, Dus et al. 2012). This makes the technique meticulous and time-
consuming especially if the cell collection has to be performed manually. On gross tissues, the 
morphological changes are also observable and often, a single histological analysis to discern 
between normal and diseased tissues is sufficient especially when dealing with multiple samples. 
However, gross tissue analysis can be unspecific especially if only restricted areas are affected by 
the disease. Thus, a compromise between the highly specific LCM and gross tissue analysis can 
be performed. One possible approach would be the use of liquid microjunction-microextraction, 
which was already presented as an efficient strategy to identify proteins from discrete locations 
on a tissue section (Quanico, Franck et al. 2013; Wisztorski, Fatou et al. 2013). In this approach, 
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proteins were first digested in situ using a microspotter and the resulting peptides were extracted 
by liquid microjunction prior to their analysis using nanoLC-HRMS & MS/MS. From a region of 
approximately 600-700 µm in diameter, up to 1500 proteins were identified showing the great 
interest in this new strategy for biomarker hunting and understanding of physiopathological 
processes. This strategy was applied to Formalin Fixed and Paraffin Embedded 
(FFPE)(Wisztorski, Fatou et al. 2013) tissues for studying the fimbria region of tubo-ovarian 
cancer samples allowing the identification of 983 and 792 non-redundant proteins in the benign 
and cancer regions, respectively.  
 
Recently, Kristiansen and coworkers (Kristiansen 2010) have presented an approach where 
samples are manually microdissected under microscope using a needle and the dissected tissue 
was then soaked in a cell lysis buffer. This strategy has presented good results in a very short 
time while maintaining the localization within the tissue. Unlike LCM, this procedure allows the 
analysis of cells and also their micro-environment in a high throughput mode and different class 
of biomolecules could be analyzed.  
 
Here is presented another strategy where tissue sections are mounted on a parafilm M-covered 
glass slide allowing for their manual microdissection under microscope using a scalpel. In 
parallel, a consecutive section is subjected to MALDI-MSI for hierarchical clustering (HC), 
providing information on the molecular content of groups of cells. It is then possible to 
distinguish ROIs that can be manually microdissected and the small pieces of parafilm M that 
contain the ROIs are then soaked in buffer followed by digestion of the proteins. The resulting 
peptides are then analyzed using nanoLC-HR MS & MS/MS providing very accurate mass 
measurement allowing for high confidence identification of thousands of proteins. The complete 
sequence of this new procedure called Parafilm-Assisted Microdissection (PAM) is presented in 
Figure 1. Because simple identification does not provide any information on protein abundance 
variations, we have examined protein quantification based on a label-free strategy using spectral 
counting. By combining all these in an integrated approach, we present a new concept of 
molecular imaging by MS where images of each identified proteins can be reconstructed based 
on label-free quantification data.  
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EXPERIMENTAL 
Reagents 
Reagents used for the experiments are listed and accessible in Supplementary information file. 
 
Tissue preparation & MS Imaging 
Detailed protocols for tissue dissection, sectioning and preparation for MALDI MS Imaging as 
well as statistical analysis (Hierarchical clustering) of MS imaging can be found in 
Supplementary Information. 
 
Microextraction & digestion 
The consecutive 10-µm sections of the rat brain adjacent to the one subjected to MALDI MS 
imaging were mounted on a polylysine glass slide covered with a layer of parafilm M (Pechiney 
Platic Packaging, Chicago, Illinois). For this, the parafilm M was manually stretched and placed 
on the surface of the polylysine glass slide. According to the hierarchical clustering, regions of 
interest were then selected and cut using a scalpel. The pieces of parafilm M containing the tissue 
were then placed in a tube containing 20 µL of a solution of DTT (50 mM) in NH4HCO3 buffer 
(50 mM) (pH=8) and heated for 15 min at 55°C (incubation temperature was limited to 55 C 
only to prevent the parafilm M from melting). After cooling, 20 µL of a solution of IAA (100 
mM) in NH4HCO3 buffer (50 mM) were added and the mixture was incubated for 15 min at room 
temperature in the dark. 25 µL of a solution of trypsin (20 µg/mL) in NH4HCO3 (50 mM) were 
then added and the sample was incubated overnight at 37 °C. 
 
Intact Protein Extraction and SDS-PAGE 
Intact proteins from the PAM pieces were extracted by incubating the pieces in 20 L of 50 mM 
bicarbonate buffer containing 50 mM DTT and 1% SDS at 55 C for 15 min. The extracts were 
then loaded on an 11.5% polyacrylamide gel and separated at 70 V for 15 min and then 150 V 
until the dye front reaches the other end of the gel. After migration, the gel was incubated in the 
gel fixative solution for 20 min and stained with colloidal Coomassie brilliant blue overnight. 
The stain was then removed by washing the gel three times with distilled deionized water.  
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NanoLC-MS/MS 
Samples were desalted on a C-18 Ziptip (Millipore,Saint-Quentin-en-Yvelines, France), dried 
under vacuum and then resuspended in AcN/0.1% FA, 5:95, v/v). The samples were separated by 
online reversed-phase chromatography using a Thermo Scientific Proxeon Easy-nLC system 
equipped with a Proxeon trap column (100 μm ID x 2 cm, Thermo Scientific) and C18 packed tip 
column (100 μm ID x 15 cm, NikkyoTechnos Co. Ltd). Elution was carried out using an 
increasing gradient of AcN (5% to 40% over 110 minutes) and a flow rate of 300 nL/min. A 
voltage of 1.7 kV was applied via the liquid junction of the nanospray source. The 
chromatography system was coupled to a Thermo Scientific Orbitrap Elite mass spectrometer 
programmed to acquire in a data-dependent mode. The survey scans were acquired in the 
Orbitrap mass analyzer operated at 120,000 (FWHM) resolving power. A mass range of 400 to 
2000 m/z and a target of 1E6 ions were used for the survey scans. Precursor ions observed with 
an intensity over 500 counts were selected “on the fly” for ion trap collision-induced dissociation 
(CID) fragmentation with an isolation window of 2 u. and a normalized collision energy of 35%. 
A target of 5000 ions and a maximum injection time of 200 ms were used for MS2 spectra. The 
method was set to analyze the top 20 most intense ions from the survey scan and a dynamic 
exclusion was enabled for 20 s. 
 
Tandem mass spectra were processed with Thermo Scientific Proteome Discoverer software 
version 1.3. Spectra were searched against UniprotKB/Swiss-Prot (version January 2012) filtered 
with Rattus norvegicus (41604 sequences) taxonomy using the SEQUEST® algorithm (version 
1.3.0.339). The search was performed choosing trypsin as the enzyme with one missed cleavage 
allowed. Precursor mass tolerance was 10 ppm and fragment mass tolerance was 0.5 Da. N-
terminal acetylation, phosphorylation of tyrosine, serine and cysteine, methionine oxydation and 
arginine deamidation were set as variable modifications. Peptide validation was performed with 
the Percolator algorithm by filtering based on a q-value below 0.01, which corresponds to a false 
discovery rate (FDR) of 1%. The proteins identified using Sequest were then further examined 
using Scaffold version 3.6.2 (Proteome Software Inc., Portland, Oregon). Scaffold uses the 
Peptide Prophet algorithm (Keller, Nesvizhskii et al. 2002) to validate the peptide identifications 
and the Protein Prophet algorithm (Nesvizhskii, Keller et al. 2003) to validate protein 
identifications. Peptide and protein identifications were accepted if they can be established at a 
confidence level greater than 95.0% and 99.0%, respectively, as specified by these algorithms. 
Proteins sharing the same peptides and for which the peptide IDs cannot be discerned were 
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grouped together to satisfy the principles of parsimony. Only protein IDs containing 2 or more 
peptides were considered.  
 
Quantification-based MS Imaging approach 
A 10-µm rat brain tissue section was mounted on a parafilm M covered glass slide and half of the 
tissue was microdissected manually using a scapel under microscope to produce 60 equal 
portions of approximately 1.5 mm2 in size. The section was then scanned and each piece 
numbered on the scanned photo so that they can be used later for mapping the proteins on the 
tissue. Each tissue piece on the scanned picture was also measured for use in data normalization. 
Tissue pieces were then excised and labeled with their corresponding number on the scanned 
photo. From each piece, intact proteins were digested as described before, and the obtained 
tryptic peptides were desalted using C18 Ziptips. Samples were separated using a Thermo 
Scientific Proxeon Easy-nLC system equipped with a Proxeon trap column (100 μm ID x 2 cm, 
Thermo Scientific) and C18 packed tip column (75 μm ID x 15 cm, Acclaim Pepmap 300 
Thermo Scientific). Additional information regarding the separation and identification of the 
proteins can be found in the Supplementary Information. After loading the MSF files for all the 
parafilm M-mounted samples in Scaffold, normalized total spectrum counts based on the total 
number of spectra associated with the protein inclusive of the spectra from the group members 
(as generated by clustering), were obtained for each piece. In Microsoft Excel software version 
2007, the resulting values were then tabulated to the numbers that corresponds to the positions of 
the PAM pieces on the tissue section. Additionally, the Excel cells were selected in order to 
reconstruct the shape of tissue section. To generate maps for each identified protein, the Excel 
cells were subjected to the Conditional Formatting tool using the Three-Color Gradient Scale 
function following a coloring scheme with gray corresponding to the lowest value (0 spectral 
counts), yellow to the 50% value, and orange to the maximum value. This scaling method was 
done individually for each protein being mapped, so that the yellow and orange colors always 
correspond to the 50% and maximum values of the spectrum counts of that protein. 
 
RESULTS & DISCUSSION 
MALDI-MSI & molecular histology of rat brain 
Classification of molecular profiles by molecular histology provided by a MALDI MSI 
experiment after hierarchical clustering (HC) will highlight cells of different phenotypes. Since 
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we are interested in studying proteins we should logically perform HC from MALDI MSI protein 
data. However, MALDI MSI of proteins requires specific preparation procedures that can be time 
consuming such as tissue washing (Lemaire, Wisztorski et al. 2006) and matrix deposition. In 
fact, due to their high molecular weight, protein signals can often be masked by abundant lipid 
signals. More important than experimental time, since proteins require true incorporation into 
matrix crystals during the crystallization process for MALDI, contrary to small molecules such as 
lipids, they also require a matrix deposition method where a minimum volume of solvent is 
spotted or sprayed. This makes impossible the use of systems allowing very fine and 
homogenous crystal layer deposition where spray is very dry. This also as consequence impairs 
the spatial resolution of experiments. On the other hand, for lipids, the matrix can be deposited in 
various ways (spray coating (Gustafsson, Oehler et al.)) or even solvent-free methods (Murphy, 
Hankin et al. 2011)) generating a gain in spatial resolution and do not require tissue treatment 
prior to matrix deposition allowing for a gain of time. Because MALDI MSI of lipids can be 
performed under simpler preparation methods and under higher spatial resolution conditions, 
lipid expression variations was examined to determine whether it correlates to protein expression 
variations. For this, two consecutive sections were subjected to MALDI-MSI experiments for the 
detection of lipids on one hand and proteins on the other. Based on the detection of both classes 
of biomolecules, hierarchical clustering (HC) was established. HC results for lipids and proteins 
are presented in Figure 2. Using the same algorithm for both lipids and proteins allowed the 
classification of the hippocampus, corpus callosum and thalamus regions. However, the 
ventromedial hypothalamic nuclei can only be discerned in the cluster for the lipids; in the case 
of protein clustering, these regions are indistinguishable from the thalamus. This could be 
attributed to the slight delocalization of proteins on the section after washing or even matrix 
deposition. Indeed, as presented in Figure S-1, the m/z 810.7 present a distribution in the corpus 
calosum, thalamus, ventromedial hypothalamic nuclei and mediodorsal nuclei while m/z 772.6 is 
localized within the hypothalamus, brain stem, hippocampus and amygdala, and m/z 769.6 is 
localized in the primary and secondary motor cortex and hypothalamus. This clearly shows that 
according cell phenotypes there are clear changes in the molecular content that affect drastically 
various biomolecule classes (including most abundant ones) with a correlation between them. 
This gives similar classification by HC whatever the classification is based on (lipids, peptides or 
proteins). We can even observe that classification is more precise based on lipid data due to the 
preparation of sample. Thus, ROIs can be determined based on lipids and used further for 
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proteins. Therefore, based on the lipid clusters, 3 ROIs were selected for protein analysis using 
the PAM strategy. 
 
Microextractions from rat brain 
In order to establish the efficiency of the new microextraction strategy based on the PAM 
approach, the three different ROIs selected from HC data were excised under the microscope 
from an adjacent rat brain section (Figure 3A). ROI1 corresponds to the CA3 and dentate gyrus 
of the hippocampus, the ROI2 is more focused to the external capsule of the corpus callosum 
while the ROI3 is dedicated to the lateral globuspallidus and the caudate putamen (striatum) 
(Figure 3B). The dimensions of the ROIs are shown in Figure 3A allowing calculation of the 
corresponding areas, respectively (ROI1 = 3.4 mm2, ROI2 = 2.86 mm2, ROI3 = 1.77 mm2). 
Proteins from these ROIs were then reduced, alkylated and digested overnight by trypsin and the 
generated peptides were separated using a nanoLC device coupled to a HR mass spectrometer. 
MS/MS allows the identification of approximately 1140 proteins when the IDs from all the 
regions are summed up (Figure 3C). Moreover, 36 proteins were only detected in ROI1, 31 in 
ROI2 while 40 proteins where detected in ROI3 as shown in the Venn diagram in Figure 3C. The 
corresponding base peak chromatograms and the detailed list of protein IDs can be found on the 
Figure S-2 and Supplementary Information-2 respectively. It must be noted that the ROIs don’t 
have the same size; this was intentional to demonstrate the versatility in the size and shape of the 
regions that can be sampled. For comparative studies it is recommended to analyze ROIs of the 
same sizes so that the variation in protein content will be reflective of the type of cells present 
and consequently of the variation in protein expression. This implies that it is not necessary to 
obtain regions of uniform cell content. In tissues where there is innate heterogeneity of cells or 
induction of such when the tissue is in a disease state, it is important not only to show the 
variation in protein expression but also to show that there is a change in cell phenotype. This is 
evident for example in the case of prostate adenocarcinomas where the progression from the early 
to late stages of the disease is concomitant with the increase of cancer cells and their invasion of 
nearby glands leading to loss of cell differentiation (Tomlins, Rubin et al. 2006).  
 
With minimal amount of starting materials, more than 1000 protein IDs are still obtainable and 
very specific proteins can be highlighted on localized regions. For instance, examination of the 
protein IDs from ROI1 shows proteins specifically expressed in this region, such as gamma-
synuclein (found in the cerebellar cortex, thalamus, hypothalamus, and the CA1, CA2, CA3 and 
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CA4 regions of the hippocampus) (Buchman, Hunter et al. 1998), and protein unc-13 homolog B 
(found predominantly in the cerebral cortex, hippocampus and striatum) (Augustin, Betz et al. 
1999) for example. From ROI3, diacylglycerol kinase beta (confined to the caudate putamen, the 
accumbens nucleus and the olfactory tubercle) (Hozumi, Fukaya et al. 2008) and cAMP and 
cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (detected in striatum and testis at the 
protein level) (Fujishige, Kotera et al. 1999). However, in a biological investigation, experiments 
would have to be repeated at least 3 times in order to improve the accuracy on the quantified 
proteins by label-free quantification. 
 
Moreover, the technique is very easy to implement. Indeed, in comparison with MSI of proteins 
that requires specific instrumentation for sample preparation, user’s skills and is generally time 
consuming, no sample pretreatments such as lipid and peptide removal are necessary. This 
strategy only requires the transfer of a thin layer tissue section on a parafilm M-covered glass 
slide, materials which are readily available in the laboratory. In traditional proteomics 
approaches, entire organs are homogenized and interesting proteins that are generally expressed 
in a limited number of cells are diluted, limiting their detection, and even if they were detected, 
their localization within the tissue is lost. Here the strategy offers many advantages including 
reduced sample preparation time, extraction from restricted regions that minimize dilution of less 
abundant proteins, and high throughput capabilities. Moreover, digestion of proteins is well 
controlled and additional steps including reduction and alkylation of cysteine residues to improve 
protein detection can be done, both of which remain difficult to implement directly on a tissue 
section in the case of a MALDI-MSI experiment.  
 
This procedure allows a high throughput analysis of samples but with regards to the 
hydrophobicity of the solution of trypsin, digestion of hydrophobic proteins such as membrane 
proteins is limited. Extraction of proteins with detergents such as Triton X, CTAB, SDS, BAC, 
CHAPS and OGP was thus performed, using microdissected portions coming from the symmetric 
regions of three adjacent tissue sections. These detergents have specific features including 
differences in charge (zwitterionic, neutral, negative or positive). The samples were incubated 
with each detergent solution and the resulting extracts were submitted to SDS-PAGE separation 
and stained with Coomassie blue, as shown in Figure-S3. According to the limit of detection of 
this staining procedure (50-100ng of proteins) (Miller, Crawford et al. 2006), it can be seen that 
whatever the detergent used, many proteins are detected up to 250 kDa with a high sensitivity. 
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Extraction of intact proteins from the micro-dissected samples can be advantageous to increase 
the number of identified proteins since this approach will provide access to more hydrophobic 
proteins and also enables to add a dimension of fractionation prior to the shot-gun analysis. 
Indeed proteins are firstl separated by 1D SDS PAGE, then the gels are divided into several 
bands and subjected to in-gel digestion followed by LC MS & MS/MS analysis. 
 
PAM from entire tissue sections 
Since proteins can be identified from specific regions of interest using the PAM approach, this 
strategy can be extended to an entire section. Then, the extracted proteins from each piece of 
tissue can be digested and analyzed by nanoLC-MS & MS/MS. After identification, proteins can 
be then quantified by label free quantification such as spectral counting. It is then possible to 
assimilate each PAM piece as an image pixel and use these quantification data for image 
reconstruction in order to provide protein imaging based on quantification data.. This approach 
was thus applied to the individual analysis of 60 PAM pieces (Figure 4) of approximately 
identical size (~1.5 mm2) from an entire rat brain tissue section cut in half along the axis of 
symmetry. For further use in image reconstruction, the positions where the PAM pieces have 
been obtained were noted. The tryptic peptides were then separated on a 2-h gradient 
chromatographic separation and analyzed by MS & MS/MS on an LTQ Orbitrap XL instrument. 
The generated spectra were then subjected to Sequest querying followed by verification with 
Scaffold. Then, label-free quantification by spectral counting, available on Scaffold, was used to 
normalize the spectra and provide quantitative information per protein per PAM piece. The 
images were then constructed by plotting in Excel the normalized spectral count of each protein 
as observed for each PAM sample with the corresponding position on the tissue. Thus, each grid 
represents one PAM piece, and its color depends on the value of the spectral count. Figure 4 
shows representative images for some of the proteins identified using this approach. Despite the 
poor spatial resolution of these images compared to conventional MALDI MSI, it can still be 
gleaned that there is preferential distribution of the proteins across the analyzed sections with 
certain proteins showing highly localized distribution. In the strategy we were able to identify 
1066 unique proteins with a 1% FDR, 2 peptides minimum, all of these being available for 
quantification-based imaging. It appears that the PAM strategy applied to entire tissue section 
allows the detection and localization of high abundant proteins as well as less abundant ones. 
Validation of the spatial mapping of protein abundances performed in this study was confirmed 
by the presence of oxytocin and vasopressin peptides in media preoptic area, in the 
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paraventricular nucleus of the hypothalamus and the anterior hypothalamus which are known to 
contain these peptides (Theodosis 2002). In this context, we focus our attention on neuropeptide 
precursors and detect in thalamus or hypothalamus area chromogranins (chromogranin B, 
chromogranin C), granulins, proenkephalins as well as a specific enzyme involved in their 
catabolism, the angiotensin-converting enzyme in the thalamus area. For molecules involved in 
immune response (IL16, macrophage migration factor) or neurotrophic molecules (glia 
maturation factor beta, pleiotrophin, basigin), their localization is specific to the protein 
concerned. IL16 is localized in the supraoptic nucleus. Pleiotrophin is found in the optical area 
and also in corpus callosum. The tumor suppressor factors CD82 or leucine-rich glioma 
inactivated factor (LGI1) also have specific localization which are in line with previous data (Wu, 
Orozco et al. 2009). LGI1 is known to be produced in the prefrontal cortex and amygdala. All 
these data reflect that the PAM procedure for protein quantification is in line with 
immunocytochemical data but bring now quantification of these molecules into the tissue. More 
protein distributions are found in Figure-S4. All proteins identified are listed in a table presented 
in Supplementary Information-2. 
 
Spatial mapping of protein abundances by voxelation was previously demonstrated by Petyuk 
and coworkers (Liu and Smith 2003; Petyuk, Qian et al. 2007). In their strategy, they have 
adapted a bladder-based voxelation device for gene expression to study protein expression and 
compared gene and protein expression. Using this mechanical voxelation device they were able 
to produce 1 mm3 (1 mm x 1mm x 1mm) voxels. For quantification of the identified proteins they 
used 18O isotope labeling of tryptic digestion products. The 18O labeling was performed from the 
consecutive tissue slice to the one used for voxelation, and spiked in each voxelation sample for 
use as reference for quantification. By PAM of tissue sections we have developed a strategy of 
higher spatial resolution using a much easier and straightforward approach. Indeed, we are able to 
produce 0.0225 mm3 (1.5 mm x 1.5 mm x 10 µm) voxels which is 44.4% fold less. Moreover, 
using micro-dissection of thin tissue sections we can possibly even manually reach 1mm x 1mm 
x 10 µm voxels (i.e. 0.01 mm3) which is 100 fold less in volume and 100 fold higher in 
resolution. The present approach also offers the advantage of being compatible with all types of 
samples including FFPE samples and thereof easily usable on hospital library samples.  
 
The PAM strategy presented here provides some new interesting features for MSI of proteins as 
it offers the possibility to identify and localize directly proteins on tissue without the need of in 
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situ MS/MS which has revealed certain limitations in the number and dynamic range of identified 
proteins. Neither does it require back correlation which is based on the construction of in-house 
tryptic peptide databanks (Lemaire, Desmons et al. 2007; Schober, Schramm et al. 2011), nor an 
adjacent section to be in situ digested for comparison with image data, which is, for the moment, 
difficult to control with automatic devices which might lead to irreproducible digestion and 
cannot guarantee a similar cell content. The back correlation strategy can also suffer from ion 
suppression effect indirectly because the localization of the proteins is based on tryptic peptide 
detection by MALDI-MSI. Given the complex nature of the tissue, the ionization efficiency can 
be greatly decreased, thus leading to less number of peptide signals that can be correlated to 
protein identification generated by LC-MS & MS/MS. Indeed, it was previously shown that 
around 300-400 tryptic peptides could be detected using a MALDI-LTQ-orbitrap instrument on 
one pixel of a tissue section subjected to an in situ enzymatic digestion (Quanico, Franck et al. 
2013). However, after micro extraction of these tryptic peptides by liquid micro-junction, 25,000 
MS/MS were performed when the extract was analyzed by nanoLC-HR MS & MS/MS leading to 
the identification of approximately 3800 unique tryptic peptides. Here the proteins are identified 
off tissue, minimizing the ion suppression effect. Their distribution is based on spectral counting 
and as such, several identified peptides were used to map them out. This is in stark contrast to 
MS imaging, where the protein mapping is usually based on single peptides (Seeley and Caprioli 
2008). Additionally, here, the proteins are not only identified based on more than one single 
peptide but are also localized using the same criteria. This means that if a protein is not detected 
on a PAM region, it is possible to assume that it is not due to the ion suppression effect coming 
from the tissue but rather because the protein is not present or with intensity beyond the limit of 
detection of the instrument. 
 
CONCLUSION 
The technique presented here provides a cheap, convenient and rapid microdissection method that 
can be used to probe protein expression changes in discrete, localized regions of the tissue 
defined by molecular histology. Although first developed on a rat brain tissue section only, the 
strategy is expected to find broader applications, especially when dealing with multiple samples 
as in the field of biomarker hunting. It was also introduced here that the PAM procedure can be 
extended to a whole section in order to do indirect molecular imaging based on the identification 
and subsequent quantification by label-free method of proteins out of the tissue. This new 
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strategy offers many advantages including the identification and localization of more than a 
thousand proteins in contrast to MS-based imaging strategies where ion suppression effect greatly 
limits the back correlation. The strength of the approach is its capability to identify and localize 
proteins simultaneously based on the identification of more than 2 unique peptides. For the 
moment, the distribution of the proteins was done using spectral counting as label free 
quantification. In order to get a more precise distribution of the intensity of a protein, an 
alternative quantitative approach based on isotopic tags (Gygi, Rist et al. 1999) can be 
implemented prior to nanoLC-MS & MS/MS. This will allow a more accurate relative 
quantification of the proteins region by region and thus of the entire section.  
 
The new concept of protein imaging constructed based on protein quantification is expected to 
give a better description of protein distribution and abundance because more proteins can be 
identified with high confidence and imaged from a single tissue section. Such a different way of 
performing MSI can bring important improvement for biological and clinical applications in the 
understanding of regulation pathways in physiological and physiopathological contexts.  
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FIGURE CAPTIONS 
Figure 1: Microdissection strategy used for identification of proteins from discrete location of a 
tissue section 
 
Figure 2: (A) Cluster image obtained the MALDI MSI of proteins on a rat brain section at 
300µm and (B) the corresponding dendrogram. (C) Cluster image obtained the MALDI MSI of 
lipids on the consecutive section at 300µm and (D) the corresponding dendrogram. 
 
Figure 3: (A) Optical image of a rat brain section after PAM, showing the 3 ROIs. (B) The 
positions based the rat brain atlas. (C) Venn diagram of the protein IDs from the 3 ROIs after 
Sequest interrogation Scaffold validation. 
 
Figure 4: Optical image of the rat brain tissue section (right panel), half of which was subjected 
to PAM (left panel) and reconstructed distribution of representative proteins based on the spectral 
count provided by nanoLC-MS/MS analysis. 
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acid (2,5-DHB), DL-dithiothreitol (DTT), iodoacetamide (IAA), cetrimonium bromide (CTAB), 
benzalkonium chloride (BAC), octyl -D-glucopyranoside (OGP) and  3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) were obtained from Sigma 
(Saint-Quentin Fallavier, France). Tetramethylethylenediamine (TEMED), ammonium persulfate 
(APS), sodium dodecyl sulfate (SDS) and Triton-X 100 were purchased from Bio-Rad (Marnes 
La Cocquette, France). Sequencing grade, modified porcine trypsin was obtained from Promega 
(Charbonnieres, France). 
 
Rat Brain Dissection 
Male Wistar rats were used and were treated in accordance to the guidelines of the Institutional 
Animal Care and Use Committee (IACUC) of University of Lille 1. Extraction of the brain was 
performed as described previously (Fournier, Day et al. 2003). Briefly, the rats were anesthetized 
with carbon dioxide and the collected brains snap-frozen in isopentane (50C). The frozen 
tissues were then stored at 80C until use. 
 
Mass Spectrometry Imaging (MSI) 
10-m sections were cut using a cryostat (Leica Microsystems, Nanterre, France) and subjected 
to lipid MSI as described previously (Meriaux, Franck et al. 2010). These were finger-thawed on 
ITO-coated slides (BrukerDaltonics, Bremem, Germany) and dried for 15 min in a dessicator. 
2,5-DHB (20 mg/mL, dissolved in 7:3 EtOH/0.1% TFA, v/v) was then sprayed on the tissue 
surface as micro droplets using an electrospray nebulizer attached to a 500-L syringe and the 
flow rate set to 2.5 µL/min. The nebulizer was moved uniformly throughout the tissue surface for 
10 min to ensure uniform matrix deposition. MS spectral images were acquired using an 
Ultraflex II mass spectrometer equipped with a Smart beam (Nd:YAG, 355nm) laser having a 
repetition rate up to 200 Hz (BrukerDaltonics, Bremen, Germany). The images were acquired in 
positive reflector mode at 100 or 300-m resolution at a mass range of m/z 200-2000, and the 
obtained spectra were averaged from 500 laser shots per pixel. Images obtained were analyzed 
using Fleximaging 2.1 (BrukerDaltonics, Bremen, Germany). For the imaging of intact rat brain 
proteins, consecutive 10-m rat brain sections were subjected to a series of washing steps using 
70% and 95% EtOH/H2O then with CHCl3 to deplete abundant proteins, endogenous peptides 
and lipids. Matrix deposition was performed using ImagePrep (Bruker Daltonics, Bremen, 
Germany), as described previously using sinapinic acid/aniline liquid ionic matrix (Franck, 
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Arafah et al. 2009). Uniform deposition of the matrix on the tissue was ensured by monitoring the 
tension of each deposition step online with a computer attached to the ImagePrep instrument. 
Using UltraFlex II, images were acquired in positive mode at 100 or 300-m resolution at a mass 
range of m/z 300-20000, with each spectra being an average of 500 shots per pixel. 
 
Hierarchical clustering 
For statistical analysis, the data set obtained from the rat brain samples by FlexImaging was 
loaded in ClinProTools 2.2 software (BrukerDaltonics, Bremen, Germany) to conduct 
hierarchical clustering. The spectra were initially prepared by setting the resolution to 800 and the 
m/z range from 200 to 900 (for lipids) and 3000 to 17000 (for proteins). Savitsky-Golay 
smoothing was employed using 2.0 m/z spectral width and 5 cycles. The signal-to-noise (S/N) 
ratio of the total average spectrum was set 3.0. Unsupervised clustering was selected with 
Correlation as distance method and Average as linkage method. Results of the hierarchical 
clustering were exported to FlexImaging 2.1 software to reconstruct the areas with different 
profiles.  
 
NanoLC MS/MS Parameters for Quantification-based MS Imaging Approach 
The samples were separated by online reversed-phase chromatography using a Thermo Scientific 
Proxeon Easy-nLC system equipped with a Proxeon trap column (100 μm ID x 2 cm, Thermo 
Scientific) and C18 packed tip column (100 μm ID x 10 cm, NikkyoTechnos Co. Ltd). Elution 
was carried out using an increasing gradient of AcN (5% to 30% over 230 minutes) and a flow 
rate of 300 nL/min. A voltage of 1.6 kV was applied to the needle of the nanospray source. The 
chromatography system was coupled to a Thermo Scientific LTQ Orbitrap XL mass spectrometer 
programmed to acquire in data dependent mode. The survey scans were acquired in the Orbitrap 
mass analyzer operated at 60 000 (FWHM) resolving power. A mass range of 300 to 1600 m/z 
and a target of 1E6 ions were used for the survey scans. Precursor ions observed with an intensity 
over 500 counts were selected “on the fly” for ion trap collision-induced dissociation (CID) 
fragmentation with an isolation window of 2 a.m.u. and a normalized collision energy of 35%. A 
target of 5000 ions and a maximum injection time of 200 ms were used for MS2 spectra. The 
method was set to analyze the top 20 most intense ions from the survey scan and a dynamic 
exclusion was enabled for 30s. SEQUEST was used for database querying as was done 
previously. For peptide and protein validation Scaffold version 4.0.5 was used, taking advantage 
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of the new local FDR-based scoring algorithm and the clustering feature, the latter allowing the 
grouping of proteins sharing similar peptide evidence (Searle 2010). As previously, default 
parameters were used.  
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FIGURE SUPPLEMENTS 
 
 
Figure S-1: Lipid molecular images of a rat brain tissue section, ∑ being the composite image of 
m/z 769.6, 772.6 and 810.7. 
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Figure S-4: Example of identified proteins distributions reconstructed based on spectral counting 
label free quantification method. 
 
 
 
Additional supplementary data (Supplementary Information-2) can be found in the online version 
of the article at: http://pubs.acs.org/doi/suppl/10.1021/ac4009397 
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Chapter 4 
Parafilm-Assisted Microdissection: Application to Prostate Cancer 
 
The early diagnosis of prostate cancer remains a challenge because of the lack of reliable 
biomarkers that can effectively describe this disease independent of sample heterogeneity due to 
genetic variation and environmental exposure. Current methods for prostate cancer detection 
comprised of digital rectal exam (DRE), prostate-specific antigen (PSA) measurement, and 
investigation by transrectal ultrasound (TRUS, (Stavridis, Saidi et al. 2010)) are being used for 
routine screening prior to undergoing more invasive follow-up procedures such as a biopsy. 
However, the use of these screening methods has been controversial because overdiagnosis of 
insignificant tumors led to unnecessary treatment and known harms associated with the 
diagnostic tests (Dijkstra, Mulders et al. 2014; Saman, Lemieux et al. 2014). Also, DRE 
screening often detects prostate cancer only at advanced stages. Although PSA is already a US 
FDA-approved protein biomarker for prostate cancer, nonetheless, increasing evidence suggests 
that it is not cancer-specific as elevated PSA levels are also observed during prostatitis, prostatic 
intraepithelial neoplasia (PIN), benign prostatic hypertrophy, or even recent ejaculation (Brawer 
2005; McVary 2007; Xia, Cui et al. 2012; Rajaei, Momeni et al. 2013; Stephan, Ralla et al. 
2014). Furthermore, although elevated PSA levels correlate with prostate cancer incidence, PSA 
alone or in tandem with other screening methods cannot be used to provide reliable prognostic 
indicators on which decisions to undergo treatment despite of its deleterious effects heavily rely 
on (Wolf, Wender et al. 2010). Clearly, there is a need for the establishment of biomarkers that 
can discern prostate cancer in its aggressive stages, in order to discriminate patients requiring 
immediate therapy from those whose likelihood of benefit from treatment is low. 
 
To this end, mass spectrometry (MS) is increasingly becoming a method of choice for protein 
biomarker discovery. Specifically, MS-based shotgun proteomics has been demonstrated to allow 
the nearly complete characterization of large proteomes by taking advantage of robust 
developments in rapid data acquisition, high resolution MS, increased sensitivity and rapid duty 
cycle. To date, for example, it has been demonstrated on the yeast proteome (Mann, Kulak et al. 
2013), and it is expected that full characterization of the human proteome will soon follow 
(Wilhelm, Schlegl et al. 2014). MS-based shotgun proteomics is a powerful tool to detect 
differences in protein expression levels at low-attomole detection limits particularly when using 
Q Exactive systems. Its major limitation for screening purposes though is that it is low-
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throughput, because of extensive purification procedures during sample clean-up, as well as long 
chromatographic gradients required for efficient separation, and rigorous interpretation of large 
datasets that are generated. Direct MS-based methods such as liquid extraction surface analysis 
(LESA, (Quanico, Franck et al. 2013)) and desorption electrospray ionization (DESI, (Liu and 
Ouyang)) to name a few, as well as matrix-assisted laser desorption/ionization mass spectrometry 
(MALDI MS, (Anderson and Kodukula 2014)) in both profiling and imaging modes, have been 
developed to minimize sample preparation and allow mapping of protein distributions but these 
methods are restricted at best to tissue profiling studies rather than discovery of candidate 
biomarkers because of their limited sensitivity and/or protein identification capabilities 
considering that they were not aimed at complete proteome characterization. 
 
To be able to analyze more samples at a much faster rate using the MS-based shotgun proteomics 
approach, we have recently developed the parafilm-assisted microdissection technique (PAM) in 
order to sample regions of interest (ROIs) directly from tissue sections, the ROIs having been 
identified from the MALDI MSI analysis of an adjacent section (Franck, Quanico et al. 2013). 
With this method, we were able to analyze multiple samples in a sequential manner, allowing us 
to generate heat maps of protein distributions across an entire tissue section by assigning each 
PAM piece as a voxel of that image. The PAM approach provided a means to obtain millimeter-
sized portions that can be easily subjected to protein extraction and digestion procedures without 
the use of additional rigorous sample purification steps. This time we exploit the advantage of 
using the PAM approach in profiling mode to analyze prostate tumor samples, with the objective 
of finding candidate protein biomarkers that can be further validated on a larger cohort of 
samples. 
Materials and methods 
Tissue Specimens 
Fresh frozen tumors embedded on OCT polymer were retrieved from archived specimens of a 
previous study (D'Anjou, Routhier et al. 2011). These specimens have been obtained with 
informed consent from patients in the Centre Hospitalier of University of Sherbooke and the 
tumor and benign regions have been identified by an experienced pathologist. These were 
confirmed, upon receipt of the samples, by dissecting 10-µm sections using a cryomicrotome 
(Leica Microsystems, Nantere, France), subjecting them to HES staining, and verifying the actual 
positions of the regions. 
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MALDI-MSI Analysis 
The consecutive 10-µm section adjacent to the one subjected to HES staining was used for 
MALDI MSI analysis of lipids. The section was mounted on an ITO-coated conductive slide and 
dried under vacuum for 5 min. 2,5-Dihydroxybenzoic acid (DHB) was used as matrix and 
prepared at a concentration of 20 µg/mL in 70 :30 ethanol/0.1 % TFA. The matrix solution was 
sprayed uniformly throughout the entire tissue section using a discarded electrospray nebulizer. 
The nebulizer is attached to a 500-µL syringe that is driven by a pump at a flow rate of 2.5 
µL/min. The fine mist generated by the spray head ensures the deposition of micrometer-sized 
matrix droplets onto the tissue surface. Spraying was performed for 10 min and the formation of 
matrix crystals was confirmed by examination under a light microscope. 
 
The prepared sections were examined using an UltraFlex II instrument equipped with a Smart 
beam (Nd:YAG, 355nm) laser having a repetition rate up to 200 Hz (BrukerDaltonics, Bremen, 
Germany). The images were acquired in positive reflector mode at 100-m resolution at a mass 
range of m/z 200-1500, and the obtained spectra were averaged from 500 laser shots per pixel. 
Images obtained were analyzed using Fleximaging 2.1 (BrukerDaltonics, Bremen, Germany) to 
map the entre section. Regions of interest (ROIs) were defined on the benign and tumor regions 
basing from the HES optical images, and the spectra from these regions were exported to ClinPro 
Tools version 3.0 (Bruker Daltonics, Bremen, Germany). A limit of less than 1000 spectra was 
exported per region. These representative spectra were used for the hierarchical clustering 
analysis using the following parameters. The spectra were initially prepared by setting the 
resolution to 800 and the m/z range from 200 to 900. Savitsky-Golay smoothing was employed 
using 2.0 m/z spectral width and 5 cycles, and the signal-to-noise (S/N) ratio of the total average 
spectrum was set 3.0. Unsupervised clustering was selected with Correlation and Average as 
distance and linkage methods, respectively. The results were then exported back to FlexImaging 
and the spectra of the branches of the dendrogram overlapped with the optical image of the tissue 
section. This method verifies the visually-defined benign and tumor regions as well as made them 
more precise. 
Protein Extraction and nanoLC-MS 
The consecutive section adjacent to the one subjected to MALDI MSI was used for the 
proteomics experiments. These sections were mounted on parafilm-covered glass slides, dried 
under vacuum, and subjected to the PAM procedure previously described (Franck, Quanico et al. 
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2013). The approximately 1.5 mm2 pieces were incubated in 25 µL of 50 mM dithiothreitol 
(DTT) for 15 min at 55C and then 25 µL of 150 mM iodoacetamide (IAA) for 15 min in the 
dark. The entire mixture was digested overnight using 20 µL of 20 µg/mL sequencing grade 
modified trypsin (Promega, Lyon, France) at 37C. The extracts were then dried in vacuo and 
reconstituted with 10 µL 0.1% TFA for desalting using C18 Ziptips (Millepore, Saint-Quentin-
en-Yvelines, France). These were again dried and resuspened in 5% ACN/0.1% FA prior to 
injecting to the nanoLC-MS instrument. 
 
Separation of the sample components was done using an online reversed-phase chromatographic 
system (Thermo Scientific Proxeon Easy-nLC II) equipped with a Proxeon trap column (100 μm 
ID x 2 cm, Thermo Scientific) and C18 packed tip column (100 μm ID x 15 cm, NikkyoTechnos 
Co. Ltd). Elution was carried out using an increasing gradient of AcN (5% to 40% over 110 
minutes) and a flow rate of 300 nL/min. A voltage of 1.7 kV was applied via the liquid junction 
of the nanospray source. This was interfaced to a Thermo Scientific Orbitrap Elite mass 
spectrometer programmed to acquire in data-dependent mode. The survey scans were acquired in 
the Orbitrap mass analyzer operated at 120,000 (FWHM) resolving power. A mass range of 400 
to 2000 m/z and a target of 1E6 ions were used for the survey scans. Precursor ions observed 
with an intensity over 500 counts were selected “on the fly” for ion trap collision-induced 
dissociation (CID) fragmentation with an isolation window of 2 u and a normalized collision 
energy of 35%. A target of 5000 ions and a maximum injection time of 200 ms were used for 
MS2 spectra. The method was set to analyze the top 20 most intense ions from the survey scan 
and a dynamic exclusion was enabled for 20 s. 
Protein Identification 
The MS/MS spectra were analyzed with Sequest (Thermo Fisher Scientific, San Jose, CA, USA) 
version 1.4.1.14. Spectra were searched against the Uniprot database (version November 2013) 
filtered with Homo sapiens (122786 sequences) taxonomy using trypsin as digestion enzyme (one 
missed cleavage). Sequest was searched with a fragment ion tolerance of 0.100 Da and a parent 
ion tolerance of 10.0 ppm. Carbamidomethylation of cysteine and oxidation of methionine were 
set as fixed and variable modifications, respectively.  
 
Scaffold (version 4.0.5, Proteome Software Inc., Portland, OR, USA) was used to validate 
MS/MS-based peptide and protein identifications. Peptide identifications were accepted if they 
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could be established at a given probability to achieve an FDR less than 5.0 % by the Scaffold 
Local FDR algorithm. Protein identifications were accepted if they could be established at a 
given probability to achieve an FDR less than 2.0 % and contained at least 2 identified peptides.  
Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii, Keller et al. 
2003). Proteins that contained similar peptides and could not be differentiated based on MS/MS 
analysis alone were grouped to satisfy the principles of parsimony . 
 
The protein IDs for each sample were loaded into Perspectives version 1.0.3 (Proteome Software 
Inc., Portland, Oregon) using the same FDR thresholds used in Scaffold and the decoys were 
removed from the final list. Clustering was performed to group together proteins with any shared 
evidence and for which the peptide IDs cannot be discerned. Doing so produced 1221 and 1227 
protein groups for data generated by the Orbitrap Elite and Q-Exactive instruments, respectively. 
The total weighted spectral counts of the protein groups were then obtained and subjected to 
Fisher’s Exact Test. Only proteins with p<0.05 were considered to have significant differential 
expression between the benign and tumor group datasets. The protein list was then exported in 
Excel and the log2 fold change was computed from the weighted spectral counts (tumor/benign). 
The protein list was further filtered by removing IDs with log2 fold change = 0 and selecting IDs 
which were detected in at least 60% of the benign or tumor samples (for samples with replicates, 
the spectral count was averaged). For the dataset obtained using the Orbitrap Elite instrument, 
this corresponds to detection in at least 3 of 4 benign or tumor samples, while for the dataset 
obtained using the Q-Exactive, this corresponds to at least 6 out of 9 benign or tumor samples.  
Protein-Protein Interaction (PPI) Network 
The differentially expressed protein list identified from the two datasets were combined and used 
as seed terms for the construction of the PPI network using STRING (Search Tool for the 
Retrieval of Interacting Genes) version 9.1. String is a database that generates and scores both 
physical and functional PPIs from various sources based on their neighborhood, gene fusions, co-
occurrence, co-expression, experiments and literature mining. The extended network was 
constructed from the list using a confidence score = 0.7, corresponding to high level of 
confidence. 
Network Construction and Analysis 
The PPI network was visualized using Cytoscape network visualization software version 3.1.1 
(Shannon, Markiel et al. 2003) and analyzed using the Network Analyzer plug-in (Assenov, 
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Ramirez et al. 2008). The topology of the network was visualized by mapping the Degree and 
Betweenness centrality parameters, corresponding to node size and node color, respectively. 
Degree pertains to the number of edges that links a given node, so that nodes possessing a high 
Degree value may represent hub genes. Betweenness centrality, on the other hand, reflects the 
importance of a node based on the number of shortest path lengths that passes this node. 
Meanwhile, the thickness of the edges was depicted using the edge betweenness values.  
 
The constructed network was then subjected to Markov Clustering (MCL) algorithm using the 
ClusterMaker plug-in to determine the major clusters. The granularity parameter was set to 
default value (2.5) and the EdgeBetweenness parameter was used as the source for array data. 
With this parameter, the edge cut-off was set to 73.042. Major clusters identified in this manner 
were visualized using Betweenness centrality for node size and expression value for node color. 
For the expression values, a binary scale was used to represent the log2 fold change values: 0 for 
log2 fold change less than 0 (underexpressed), and 1 for those greater than 0 (overexpressed). 
Gene Ontology Analysis 
The differentially expressed proteins identified from the two datasets were uploaded to the 
ClueGO application (version 2.1.2, (Bindea, Mlecnik et al. 2009)) to check for enriched pathways 
in the benign and tumor regions. Functionally-grouped annotated networks were generated using 
the following settings. The organism was set to Homo sapiens. The gene ontology (GO, 
(Consortium 2010)) terms were accessed from the following ontologies/pathways : 
GO_Biological Process, GO_Molecular Function, GO_Cellular Component and GO_Immune 
System Process (ontology updated 5/23/2014), Kyoto Encyclopedia of Genes and Genomes 
(KEGG, updated 5/24/2014), Reactome Pathway database (updated 5/24/2014), and 
WikiPathways (updated 5/24/2014). All types of evidence were used (see 
http://www.geneontology.org/GO/evidence.shtml). The Use GO Term Fusion option was 
selected, and only pathways with pV ≤ 0.05 were accepted. The significance of each term or 
group was calculated using the right-sided hypergeometric test corrected using Bonferroni step-
down correction. The kappa score was set to 0.5 and for network specificity, the GO tree levels 
were restricted at 6-13 (medium-detailed specificity) and for each cluster a minimum of 5 genes 
and 7% of the gene population was set. GO terms were grouped with an initial group size of 3 
and 50% for group merge. The remaining parameters were set to default.  
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The gene identifiers of the major clusters identified by MCL clustering during network analysis 
were also examined using the Cancer Gene Index feature available in the Reactome FI plug-in 
(Milacic, Haw et al. 2012). The tree of National Cancer Institute (NCI) disease terms was loaded 
and the term “neoplasm” was selected to highlight gene identifiers that have been annotated for 
this term and its sub-terms. To map selected over-represented pathways to Reactome events, The 
Pathway Analysis tool was used. 
 
Results 
Identification of ROIs by MALDI MSI 
In this study, MALDI MSI was used to define regions of interest (ROI) on both the benign and 
tumor regions of the prostate tissue sections that can then be subjected to the PAM technique. 
Although the spatial resoluton used was only 100 µm, it was sufficient to provide images with 
discernible localized tumors that coincide very well with those identified by HES staining 
(Figure 21a and b). But more than just providing optical images, the data generated are actually 
molecular images. By subjecting the mass spectral information of these molecules to HC analysis 
and creating images from the resulting clusters (Figure 21c and d), it is possible to produce more 
simplified images where ROIs are defined based on statistical inference gained from the 
similarity of the cellular contents of neighboring cells. This greatly simplifies the selection 
criteria used to identify ROIs, in contrast to looking at cell morphologies which can at times be 
subjective or misleading and depend on the experience of the experimenter. In the case of 
prostate tissue, the latter task easily becomes complicated because of the innate heterogeneity of 
the tissue.  
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It has previously been shown that lipid MS images are sufficient alternatives to protein MS 
images as both show similar component localization but with lipid imaging being done much 
faster and at better spatial resolution (Franck, Quanico et al. 2013). Lipids, in contrast to proteins, 
do not need to be incorporated into the matrix crystals for them to be desorbed in MALDI. Thus, 
it is possible to generate smaller matrix crystals without compromising the efficiency of the 
ionization/desorption process. Hence, lipid imaging was employed for ROI identification. Sample 
MS composite and peak intensity images for four prostate sections are shown in Figure 22, 
where it can be seen that for each sample, different peaks were used to localize the tumor regions. 
There is almost no consensus in the peaks observed in both regions in all samples, and yet HC 
analysis (Figure 22, bottom images) clearly shows that the regions are distinct from each other 
once the entire spectra of the molecular contents were taken into account. This suggests that 
despite of the heterogeneous nature of individual tissues (whose molecular expression profiles are 
dependent not only on the individual genetic factors but also on environmental exposure), their 
overall molecular make-up nonetheless distinguishes healthy tissues from those under disease 
states. 
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mechanisms and the selection of druggable targets depend on the reliability of this stage. 
Specifically, the major problem is in the assessment of individual variability within a sample set. 
To this end, Scaffold and Perspective are complementary software that can provide a means to 
evaluate protein expression levels in terms of spectral counts, and introduce statistics into the 
dataset. Scaffold is used to validate protein IDs obtained from initial Sequest interrogations. Its 
LFDR algorithm allows one to maximize the number of protein IDs at an optimal false discovery 
rate. Perspective is then used to deal with large protein datasets and to allow the user to 
categorize the samples further depending on pre-existing information. Emphasis is given on this 
added categorization feature, as it provides control over the grouping of the datasets needed when 
implementing a statistical method. For datasets of small number of replicates, the Fisher’s exact 
test provides a means to compute exactly the significance of a deviation from the null hypothesis. 
It can be used to compute the p value of each protein across sample categories. To further screen 
the differentially expressed protein candidates, only those with non-zero spectral counts in at 
least 60% cases in at least one sample group were selected, and only those with fold change ≥ 2 
or ≤ 0.5 were used for network analysis. 
 
Initial nanoLC-MS analysis of four prostate tissue samples subjected to the PAM technique and 
using an Orbitrap Elite instrument yielded 1221 protein identifications, 374 of which have 
Fisher’s Test p-values ≤ 0.05. A total of 122 proteins were identified to have differential 
expression after filtering using the fold change and detectability across samples criteria, 79 of 
which were classifed as over-expressed and 43 as under-expressed. In this experiment, single 
PAM pieces were taken from the benign and tumor regions. In the succeeding experiment using  
the Q-exactive, two PAM pieces from each region were taken from 8 prostate tissue samples and 
one from a sample of limited size. This yielded 1251 protein IDs, 485 of which fit the Fisher’s 
test criterion. Applying the filtering parameters yielded 208 differentially expressed proteins of 
which, 135 were overexpressed and 73 underexpressed. Thus, a total of 273 differentially 
expressed proteins are reported in this work (Table 5).  
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Table 5. Over- and under-expressed proteins and their fold change values. 
 
Negative values denote under-expression. Cells are color-coded so that the most intense colors 
represent 16 to 32-fold change, medium shades represent 4 to 8-fold change, while the lightest 
shades represent 2-fold change. 
Protein Name Log2 Fold Protein Name Log2 Fold Protein Name Log2 Fold Protein Name Log2 Fold
GOLM1 4 RPSA 1 ECH1 1 COL6A2 -1
PRKDC 4 FASN 1 PTBP1 1 C3 -1
POSTN 4 PGLS 1 ANXA3 1 COL18A1 -1
RPL23 4 LAMP1 1 RPS19 1 GNAI2 -1
GDF15 4 FSTL1 1 RPS27A 1 CP -1
HYOU1 4 SUB1 1 MDH2 1 ACPP -1
CTNNA1 4 SRSF3 1 RPS4X 1 OGN -1
PSME2 3 HSPD1 1 CKAP4 1 CRYZ -1
PARP1 3 DBNL 1 RPLP2 1 VTN -1
HADHA 3 TTN 1 RPL15 1 FGG -1
DAK 3 NPM1 1 PSAP 1 LMOD1 -1
TRIM28 3 COPG 1 MT1G 1 PALLD -1
ST13 2 UBA1 1 RPL18 1 HMGB1 -1
RPL31 2 CCT2 1 P4HB 1 DPYSL2 -1
RPN1 2 S100A9 1 LTF 1 FGA -1
LAMP2 2 PPP2CA 1 IQGAP2 1 APOH -1
DECR1 2 RPL18A 1 DHRS7 1 CORO1A -1
LAP3 2 SET 1 PRDX3 1 LAMB2 -1
DYNC1H1 2 VCP 1 PHB 1 EMILIN1 -1
ANXA6 2 COPA 1 DDAH2 1 SERPINA1 -1
GAA 2 HSPE1 1 MAOB 1 PTRF -1
CIRBP 2 FAM129A 1 LMNA 1 GDI1 -1
ATIC 2 TXN 1 H3F3B 1 LAMA4 -1
GRHPR 2 AHNAK 1 LCP1 1 HSPB1 -1
C1QBP 2 TPI1 1 CDC42 1 CFH -1
FBP1 2 FUCA1 1 RPS27A 1 NID1 -1
ETFB 2 HSD17B4 1 ALDH6A1 1 ELN -1
puf 2 CANX 1 HNRNPM 1 HSPB6 -1
PPP2R4 2 GPI 1 COPB2 1 EHD2 -1
RPL13 2 RPL7A 1 RPS13 1 LASP1 -1
UQCRC1 2 NCL 1 ECHS1 1 SERPINC1 -1
MCCC2 2 RBMX 1 CALR 1 C4B -1
ASAH1 2 RPL14 1 TLN1 1 PTGR1 -1
ANP32A 2 RNPEP 1 RAN 1 CLU -1
PRDX5 2 PRKCSH 1 PDIA6 1 AMBP -1
RPL8 2 XRCC5 1 ATP1A1 1 HRG -1
C4A 2 ACAT1 1 YWHAZ 1 CAV1 -1
NUMA1 2 PARK7 1 PCBP1 1 A1BG -1
TKT 2 LPP 1 EIF4A1 1 CCT8 -1
APEX1 2 CPE 1 HSPA8 1 EPHX2 -1
NACA 2 COL12A1 1 RDH11 1 FHL1 -1
SEPT9 2 TAGLN 1 GLUD1 1 FBLN1 -1
DHX9 2 GOT2 1 ANXA1 -1 CFB -1
TGFBI 2 RPS12 1 SYNPO2 -1 ARMC5 -1
MARCKS 2 DDX39B 1 SORBS1 -1 COL14A1 -1
NANS 1 RPS8 1 CSRP1 -1 SYNE1 -1
TPP1 1 HMGN2 1 MYO1C -1 VWA1 -1
PRDX6 1 HNRNPC 1 APOA1 -1 SERPINA3 -1
IQGAP1 1 VCL 1 DPYSL3 -1 LAMA5 -1
EEF2 1 ERP29 1 CALD1 -1 DSP -1
HEXB 1 HNRNPU 1 TNS1 -1 PLG -2
CTSD 1 LTA4H 1 IGL@ -1 KNG1 -2
PDIA4 1 H2AFY 1 PHGDH -1 FN1 -2
PTMS 1 PABPC1 1 GC -1 DCN -2
SCARB2 1 TNC 1 LGALS3BP -1 EFEMP1 -2
S100A8 1 RPL6 1 APOA2 -1 CAPG -2
NDUFS1 1 EEF1G 1 SYNM -1 FBLN5 -2
ACLY 1 UGDH 1 RSU1 -1 KANK2 -2
PDLIM5 1 CMPK1 1 TPSB2 -1 COL3A1 -2
COPB1 1 CORO1B 1 FERMT2 -1 TINAGL1 -2
RPL23A 1 TXNDC17 1 HSPG2 -1 F2 -2
XRCC6 1 GNB2L1 1 PDLIM7 -1 ADIRF -2
MSN 1 HSP90AA1 1 PPP2R1A -1 GSTM3 -3
RPS18 1 APRT 1 FBN1 -1 OLFML1 -3
DDX17 1 PHB2 1 GSTP1 -1 A2M -3
HNRNPK 1 ALDH7A1 1 ALDH4A1 -1 NID2 -3
UQCRC2 1 RPL12 1 FGB -1 MAP1B -5
PTGES3 1 AKR1A1 1 LAMC1 -1 MSMB -5
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Examination of the overexpressed proteins with 16-32 fold change identified previously reported 
proteins implicated in prostate cancer processes. This includes growth differentiation factor 15 
(GDF15), hypoxia upregulated protein 1 (HYOU1), periostin (POSTN) and poly(ADP-ribose) 
polymerase 1 (PARP1). GDF15 or prostate-derived factor (PDF) is a divergent member of the 
transforming growth factor- (TGF) superfamily that promotes androgen receptor (AR)-positive 
tumor progression by stimulating cell proliferation through the ERK1/2 signalling pathway 
(Chen, Karan et al. 2007). HYOU1, also known as oxygen regulated protein 150 (Orp150) is a 
heat shock protein involved in humoral response, whose secretion promotes cytoprotection by 
inducing macrophage-stimulated elaboration of endothelial cells and angiogenesis factors, as well 
as suppression of programmed cell death due to oxygen depravation, and facilitation of post-
translational transport and processing of the vascular endothelial growth factor (VEGF) through 
the endoplasmic reticulum (Miyagi, Hori et al. 2002; Stojadinovic, Hooke et al. 2007). POSTN is 
an extracellular matrix protein that can activate the Akt/PKB (protein kinase B) pathway to 
facilitate tumorigenesis (Gillan, Matei et al. 2002). PARP1, a nuclear enzyme, has a well-
documented role in DNA damage repair by catalyzing the poly(ADP-ribose) ylation 
(PARylation) of target substrates using NAD+ as a cofactor (Griffin, Curtin et al. 1995). By 
conferring resistance to genotoxic effects to cancer cells, PARP1 could thus decrease their 
sensitive towards DNA-damaging antitumor agents. In addition, PARP1 could also be recruited 
to sites of AR, restoring AR function in castration-resistant prostate cancer (Schiewer, Goodwin 
et al. 2012). 
 
Proteins implicated in other cancers were also identified, such as hydroxyacyl-coenzyme A 
(CoA) dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), 
alpha subunit (HADHA) and tripartite motif containing 28 (TRIM28). HADHA is a component 
of the mitochondrial trifunctional protein complex which is involved in the beta-oxidation cycle 
of long-chain acyl-CoAs. Its enzymatic activity is required in the beta-oxidation of 
polyunsaturated fatty acids, whose inhibitory effects on the growth of tumor cells are well-
documented (Dai, Shen et al. 2013). Thus, increased expression of HADHA has been implicated 
in cisplatin resistance via loss of polyunsaturated fatty acids in lung cancer cell lines (Kageyama, 
Nagashio et al. 2011). TRIM28 is a member of the tripartite motif family, an evolutionarily 
conserved family of transcription co-factors that have been implicated in various pathologies and 
cancers because of its pleotropic effects on both normal and tumor cells. It has been demonstrated 
to have dual roles in non-small cell lung cancer cells, playing a tumor-suppressor role in the early 
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stage of adenocarcinoma and contributing to the epithelial-to-mesenchymal transition (EMT) 
during cancer metastasis (Chen, Munoz-Antonia et al. 2014). Promotion of EMT by TRIM28 has 
also been reported for colorectal cancer (Fitzgerald, Sheehan et al. 2013). 
 
In addition, overexpression of DNA-dependent protein kinase catalytic subunit (DNA-PK or 
PRKDC) was also observed, in agreement with findings on the immunohistochemical staining of 
malignant epithelial cells of prostate carcinoma in situ and invasive prostate carcinoma (Moll, 
Lau et al. 1999). The overexpression, as well as underexpression, of PRKDC has also been 
reported in various other cancers (Hsu, Zhang et al. 2012), although the precise explanation for 
this variation and overexpression contradictory to its major function remains elusive. PRKDC is a 
member of the phophatidyl inositol 3-kinase related kinases (PIKK) superfamily, which is 
involved in the DNA double strand break response via non-homologous end joining during the 
G0 and G1 cell cycle stage (Shaheen, Znojek et al. 2011). As such, it is a critical regulator of 
DNA repair due to double strand breaks induced by ionizing radiation. Increased PRKDC levels 
in tumor cells could serve a protective role by rendering them less susceptible to radiation-based 
therapy. 
 
Proteosome activator complex 28 subunit beta (PA28 or PSME2) was also shown to exhibit 16-
fold overexpression in the tumor region. The PA28 activator complex is a member of the major 
histocompatibility complex (MHC) which enhances the generation of class 1 binding peptides by 
activating the catalytic complex containing -interferon (IFN-). In this sense, PA28 is important 
in the antigen presentation via MHC class 1 molecules and enhances antitumor activity and 
resorption; its impairement is thus beneficial for cancer cells, as has been demonstrated in the 
loss of human leukocyte antigen class 1 expression in human colon cancer cells (Miyagi, Tatsumi 
et al. 2003). Surprisingly though, proteasome activity is often higher in malignant tumors, 
suggesting that the absence of antitumor immune reaction might be due to the diminished 
function of the MHC class 1 itself (Kondakova, Spirina et al. 2014). It has been proposed that the 
high proteasome activity is either because of enhanced activity of cellular processes, many 
participants of which are proteasome subunits, or due to increased violations induced by cancer 
processes on the feedback between proteasome activity and transcription of their genes 
(Kondakova, Spirina et al. 2014). 
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Highly underexpressed proteins are also noted in the list. This includes the prostate cancer risk-
modulating factor glutathione S-transferase mu 3 (GSTM3), as well as -microseminoprotein 
(MSMB), one of the highly secreted proteins of the prostate whose function has not yet been 
elucidated (Xu, Valtonen-Andre et al. 2010; Hoogland, Dahlman et al. 2011; Haiman, Stram et 
al. 2012). GSTM3 is a member of the glutathione S-transferases, a multigenic family of enzymes 
that catalyzes the conjugation of reactive oxygen species (ROs) during oxidative damage in 
prostate carcinogenesis (Loktionov, Watson et al. 2001). Evidence shows that polymorphism of 
several genes encoding for GSTM3 leads to the production of inactive allelic variants, conferring 
variable efficiencies to carcinogen metabolism (Medeiros, Vasconcelos et al. 2004; Kesarwani, 
Singh et al. 2009). Also included are the serum protease inhibitor α-2-macroglobulin (A2M), 
whose decreased levels could indicate prostate cancer metastasis to the bone (Kanoh, Ohtani et 
al. 2001), nidogen 2 (NID2), whose hypermethylation has been implicated to favor invasion and 
tumor metastasis in oral cavity squamous cell carcinoma (Guerrero-Preston, Soudry et al. 2011)  
and has also been reported for lung, colon, and gastric cancers (Ulazzi, Sabbioni et al. 2007; 
Geng, Sun et al. 2012), and  α-catenin (CTNNA1), whose gene deletion supports its role as a 
recessive cancer gene (Bignell, Greenman et al. 2010; Majewski, Kluijt et al. 2013). 
Pathway and GO Analysis 
The differentially expressed proteins were examined further by establishing the predicted protein-
protein interactions (PPI) using STRING, plotting the PPIs using Cytoscape, analyzing the 
network parameters using NetworkAnalyzer, and performing MCL clustering and GO analysis 
using clusterMaker and ClueGO, respectively. This analysis was performed in order to determine 
which pathways were significantly perturbed in the tumor regions. This approach is in contrast 
with the differential expression analysis used previously, where individual protein markers were 
independently selected. The advantage is that the results are less prone to individual genetic 
heterogeneity that greatly decreases the discriminative power of individual markers (Dittrich, 
Klau et al. 2008; Lee, Chuang et al. 2008; Frohlich 2011). Also, proteins and their genes rarely 
act alone, thus, for their cellular functions to be understood, they have to be examined in the 
context of the pathways where their roles interplay with those of other proteins (Dittrich, Klau et 
al. 2008; Barrenas, Chavali et al. 2012; Yang, Daigle et al. 2012). The other advantage is that, 
with network analysis, we can perform MCL clustering to identify core modules and locate hubs 
(Nair, Ghatge et al. 2014). Hubs are large nodes in the network that have many connections with 
the smaller nodes; their centrality denotes that they have more functional relevance compared to 
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the other proteins/genes (Jeong, Mason et al. 2001; Ummanni, Mundt et al. 2011). It has been 
demonstrated, for example, that deletion of gene hubs could lead to increased frequency of 
occurrence of disease phenotypes compared to the deletion of less-connected ones (Barabasi and 
Oltvai 2004). Hubs are essential for keeping the integrity of networks because they are involved 
in the relay of information, thus, proteins occupying these positions become more promising 
biomarker candidates for more precise disease classification (Penrod and Moore 2014). 
 
To determine which pathways were enriched in the benign and tumor regions of the prostate 
samples, the differentially expressed protein list was analyzed using ClueGO. ClueGO can 
integrate GO terms, KEGG/BioCarta pathways, Reactome and WikiPathways terms and can 
create a functionally grouped GO/pathway network using kappa statistics for term linkage 
(Bindea, Mlecnik et al. 2009), in contrast to other GO analysis softwares, such as BiNGO or 
PIPE, which generate hierarchical trees based on assessment of overrepresented GO terms 
(Maere, Heymans et al. 2005; Ramos, Shannon et al. 2008). 
 
 
 

 Figure 23. Regulatory network plotted using Betweenness Centrality (node size) and 
log2Fold Change (color) using the differentially expressed protein dataset. 
Color scale: green = downregulation, red = upregulation. Color intensity denotes extent of down- 
or upregulation in the tumor region. 
 
Results of the network and GO analysis are summarized in Figure 23 and Supplementary Table 
1 (see Annex). After constructing the regulatory network using the PPIs and mapping using 
degree and betweenness centrality, the proteins were grouped according to the GO terms that they 
were used to identify. The node colors were then changed to log2Fold Change to show the 
distinctly perturbed pathways based not only on protein member overrepresentation, but also 
expression. As expected, distinct pathways were perturbed. Majority of the upregulated proteins 
in the tumor region are involved in cytoplasmic ribosomal protein synthesis and function, 
including 22 ribosomal proteins. The overexpression of cytoplasmic ribosomal proteins is 
concomitant with the increased metabolic activity necessary to drive the proliferation of 
neoplastic cells (Teng, Thomas et al. 2013). The amount of cell components must necessarily be 
increased in order to support the survival and proper functioning of daughter cells. In tumor cells, 
there is a close relationship between proliferation and ribosomal protein synthesis, because tumor 
suppressors and proto-oncogenes that stimulate proliferation also up-regulate ribosome synthesis 
in accordance with the altered cell cycle progression rate (Montanaro, Trere et al. 2008; Hein, 
Hannan et al. 2013). Ribosomal proteins have also been proposed to actively mediate certain 
aspects of tumorigenesis due to the extra-ribosomal cellular functions that they possess 
independent of protein biosynthesis (Ziemiecki, Muller et al. 1990; Naora 1999; Shenoy, Kessel 
et al. 2012; Teng, Thomas et al. 2013). Likewise, the enrichment of metabolism-related terms in 
the tumor region, such as valine, leucine and isoleucine degradation (KEGG:00280) and glucose 
metabolism (REACTOME:723), is correlated with increased cell proliferation. Such processes 
can be utilized by the tumor cells to drive energy production and to provide metabolites needed 
for cellular processes and protection against oxidative stress (Feron 2009; Vander Heiden, 
Cantley et al. 2009). Meanwhile, the ClueGO analysis of the underregulated terms showed 
enrichment of proteins involved in complement and coagulation pathways (WP:558, 
REACTOME:2051), essential components of the immune system used in the eradication of 
pathogens and clot formation; such diminished immune system activity is essential for continued 
survival of tumor cells. Laminin interactions (REACTOME:169262) and cytoplasmic membrane-
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bounded vesicle lumen (GO:0060205) were also underregulated, in accord with the alterations in 
the extracellular matrix to compromise the basement membrane that acts as a barrier for cancer 
cell invasion during EMT (Lu, Weaver et al. 2012). 
 
To identify the hubs in the network, MCL clustering was performed (Figure 24). Five modules 
were identified from the clusters and the hubs were pulled together and placed at the center of the 
regulatory network to highlight them (Figure 23 and Supplementary Figure 2, see Annex).  
Exploring further, the cancer gene indices (CGI) of the modules were loaded using Reactome. 
CGI contains data on 6,955 human genes, nearly 12,000 NCI Thesaurus cancer disease terms, 
and 2,180 unique pharmacological compounds from the NCI Thesaurus. The gene-disease and 
gene-compound associations were extracted from over 92 million analyzed sentences of nearly 
20 million abstracts. The resource was last updated in June, 2009 (Milacic, Haw et al. 2012). As 
shown in Figure 25, the highlighted nodes (yellow) indicate proteins that have been annotated 
with the term “neoplasm”. Neoplasms are abnormal growths of tissue that may or may  not 
necessarily produce a mass (Fragoso, de Coronado et al. 2004). Expectedly, majority of these 
hubs have well established roles in the regulation of cancer processes, as supported by their CGI 
annotations. For example, fibronectin 1 (FN1) is known for its role in suppressing prostate cancer 
cell migration via fibronectin matrix-mediated cohesion (Jia, Entersz et al. 2012). Nucleolin 
(NCL) is a multifunctional ubiquitously expressed protein that acts as a shuttle between the cell 
surface and the cytoplasm. Cell surface expressed NCL is overexpressed in various cancers, and 
its ligands, such as midkine and plieotrophin among others, have been implicated in 
tumorigenesis and angiogenesis (Hovanessian, Soundaramourty et al. 2010; Birmpas, Briand et 
al. 2012). PPP2R1A codes for the 65kDa subunit Aα isoform of serine/threonine-protein 
phosphatase 2A, a major serine/threonine phosphatase involved in various cellular processes such 
as metabolism, apoptosis, DNA replication, transcription and translation (Chen, Mai et al. 2013), 
and it has been reported that it is a target of missense mutations in high grade serious endometrial 
tumors as well as ovarian tumors but at lower frequencies (McConechy, Anglesio et al. 2011). 
Complement 1q-binding protein (C1QBP) can affect respiration in the mitochondria where it is 
predominantly expressed by shifting from oxidative phosphorylation to glycolysis (Amamoto, 
Yagi et al. 2011). This phenomenon, called the Warburg effect, is typical in carcinogenesis. In 
addition, inhibition of C1QBP leads to the shutdown of the mitochondrial membrane potential 
leading to the production of reactive oxygen species (ROs) that in turn can arrest the G1/S phase 
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of the cell cycle and lead to a succession of events leading to cell death, hence the supposition 
that C1QBP possesses anti-apoptotic activity (McGee, Douglas et al. 2011). 
 
 
Figure 24. Top MCL clusters obtained from the PPI network, showing the hubs where most 
nodes intersect. 
Betweenness centrality and normalized log2Fold change were used to plot the node size and 
color, respectively. Green and red nodes indicate under- and overregulated proteins, respectively. 
 
Of the five hubs identified, only glutamate oxaloacetate transferase 2 (GOT2) did not possess 
CGI annotations, suggesting that this protein is probably involved in non-neoplastic processes. 
GOT2 encodes for the mitochondrial isozyme of aspartate aminotransferase (AAT), and catalyzes 
the conversion of oxaloacetate to aspartate. GOT2, together with mitochondrial malate 
dehydrogenase 2 (MDH2), comprises the malate-aspartate shuttle of the glycolysis pathway. The 
malate-aspartate shuttle is known to be active in neoplastic cells of several tumor types and 
believed to account for about 20% of the total respiratory rate {Thornburg, 2008 #2760}.  
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Figure 25. Mapping of Cancer Gene Index-annotated proteins using the term “neoplasm” 
(nodes in yellow) in the modules. 
GOT2 is the only hub that does not have CGI annotations. 
 
In summary, the current work provided a simple means to evaluate protein expression data by 
making use of a combination of MSI, PAM and nanoLC-MS methods to sample and analyze 
regions directly from tissue specimens without extensive sample preparation or purification. A 
combination of rigid protein identification and spectral counting parameters followed by robust 
statistical methods were then applied to obtain high quality differential protein expression data. 
Examination of the differentially expressed proteins showed established biomarkers for prostate 
cancer diagnosis, as well as potential candidates for further verification. Apart from individual 
protein expression analysis, we also used network and GO analyses to identify FN1, GOT2, 
NCL, PPP2R1A and C1QBP as key regulators of prostate cancer among the hundreds of proteins 
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that we identified to have differential expression in the tumor region. This network-based 
approach supports existing evidence on the active roles of these proteins in carcinogensis, and 
allowed us to visualize the relative importance of the protein interactions based on well-defined 
topological parameters that may aid in the better understanding of the underlying mechanisms of 
the disease and provide avenues for specific protein therapeutic targets. Results of this work need 
to be further validated to realize their potential in the clinical setting. 
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Conclusions – Part 2 
 
This part described the development of the PAM approach for the examination of proteins 
directly on tissue sections. Simple mounting of tissue sections on parafilm made them amenable 
to direct manipulation, so that specific ROIs can easily be obtained and subjected to conventional 
proteomic analysis. The approach can be used in profiling and imaging modes. Profiling of 
regions in a rat brain section allowed for the identification of proteins of limited abundance in 
these regions. By extending the PAM approach to entire tissue sections, images can be generated 
based on spectral count data, so that the proteins mapped in this case were not imaged from only 
one or several peptide peaks as in conventional MSI, but from the same set of spectra that were 
used to identify the protein. The implication for imaging is two-fold. Now, we can map protein 
distribution with more confidence compared to back correlation-based MSI strategies because 
protein identification is done together with protein localization. Second, we can now obtain better 
inferences from imaging data, particularly for proteins, because we now look at localized 
differences based on protein expression changes themselves (which are quantifiable, by label-free 
methods and others), not just peak intensities (which only provide qualitative information). As 
the strategy is still in development, it remains to be demonstrated how the individual PAM pieces 
have to be decreased in size without compromising the protein identification yield. 
 
Profiling of prostate tumors using the PAM strategy made possible the detection of protein 
expression changes across the benign and cancerous regions of the samples. Results led to the 
identification of established diagnostic biomarkers for prostate cancer. Moreover, the analysis 
yielded potential biomarkers which warrant further examination. These experiments highlight the 
advantage of localized microproteomic analysis offered by the PAM strategy; we thus expect to 
find more applications of this strategy in our future proteomics studies. 
5DISCUSSION 
In the previous sections, it has been demonstrated that direct MS methods can be used in 
obtaining qualitative and quantitative information of proteins in tissue sections. This information 
ranges from protein identification, quantification, and localization. The idea of protein 
localization on tissue is a tenet of MS imaging. However, because of its inherent limitations, MS 
imaging can provide identification and quantification of only a limited set of compound species 
(small molecules, drugs, metabolites and lipids). Even if it has been applied to proteins also, still 
the information generated is restricted only to the most abundant proteins, which greatly limits its 
applicability in proteome-wide investigations. For instance its protein biomarker success fails in 
comparison to conventional proteomics approaches, where attomole protein expression changes 
can be routinely examined nowadays. Even then, MSI can provide localization information, 
which is often lost in conventional MS-based proteomics due to extensive sample purification.  
 
In order to address this limited protein identification by MSI, we constructed protein ID 
databases from adjacent sections and used this to increase protein identifcations on MSI data. 
This approach of using high-resolution data from LC-MS for correlation with high-resolution 
images in MSI is similar to what other groups have previously done. However, in contrast, our 
approach restricts database generation only to selected regions on the tissue sample. These 
localized protein datasets can potentially further refine correlation because it can detect proteins 
of low abundance in that region alone. But more importantly in these experiments, we have 
demonstrated that it is possible to obtain a huge set of protein identifications on localized regions 
at the sub-millimeter level. To date, this amount can only be matched using LCM-based 
proteomics methods, but with significantly more cells sampled. This approach deviates from our 
initial objective of improving protein identification in MSI-based platforms, but the promising 
result warrants further examination. Notably, the use of the liquid microjunction extraction 
approach in this study to extract proteins on localized regions in profiling mode can be extended 
to imaging mode, thus presenting the idea of being able to simultaneously identify and image a 
large set of proteins in a single analysis.  
 
Simultaneously performing imaging and protein identification is attractive because it eliminates 
the need of generating a database of identifications from adjacent sections, provides deeper 
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proteome coverage, and allows the generation of quantitative and distribution data in a single 
analysis. However, the major drawback of these approaches is the limited spatial information that 
can be obtained, which is reliant on the extent of decreasing the digestion spot size. Hence we 
resorted to microspotting of the proteolytic enzyme instead of performing digestion using the 
liquid microjunction, which is also possible, but provides lesser resolution and poor digestion 
efficiency (data not shown). To this end, alternatives that can produce smaller liquid 
microjunction spots were examined. Here, we used a capillary tubing with 100µm internal 
diameter to generate the liquid microjunction of smaller droplet sizes not attainable when using 
the current configuration of the TriVersa Nanomate. As the instrument can be directly interfaced 
with the nanoLC, we also examined the possibility of directly injecting the sample to the column 
even without sample clean-up. Results showed that this approach leads to more protein 
identifications, probably because a number of peptides have been lost in the stationary phase of 
ziptips. In this approach, the final spatial resolution was still determined by the size of the 
digested spot because the microjunction size attained was still large; we therefore are in the 
process of searching for alternatives to further decrease the size of the microjunction without 
compromising sensitivity. 
 
In parallel with the liquid microjunction approach, we also developed the PAM strategy to 
examine tissue sections directly. This is simply a facile method of sampling ROIs directly on 
tissue sections for in-solution processing with a nanoLC-MS instrument. Thus we can perform 
profiling experiments using this approach by determining ROIs through an MSI experiment on an 
adjacent section, and selectively sample through the section by PAM using the determined ROI. 
Perhaps the major advantage of this approach can be seen when it is performed in imaging mode, 
which is realized by processing all the individual PAM pieces. Here we demonstrate that 
simultaneous identification and quantification of proteins can be done by taking advantage of the 
label-free quantification method spectral counting. Using spectral data in place of peak intensities 
is advantageous because it provides a direct correlation of spectral information that has been used 
for protein identification with protein localization. This is in stark contrast with MSI approaches, 
where proteins are identified and localized based on individual peak assignments alone, whose 
tenability is largely dependent in the resolutive power of the mass spectrometer used. Multiple 
spectra not only provide reliable protein identification but in this case also confident localization. 
At the present, we only focused on the development of this concept, but in the future we expect to 
address the limited spatial resolution and reproducibility of this approach. In addition, we applied 
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Taken together, these developed on-tissue direct MS proteomics strategies presented data not 
previously achieved with related methods, sparking the interest in their further development. 
Their utitlity in real-life samples is expected to increase in the near future.
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3. Acknowledgement: If any part of the material to be used (for example, figures) has appeared in
our publication with credit or acknowledgement to another source, permission must also be sought
from that source.  If such permission is not obtained then that material may not be included in your
publication/copies. Suitable acknowledgement to the source must be made, either as a footnote or
in a reference list at the end of your publication, as follows:
“Reprinted from Publication title, Vol /edition number, Author(s), Title of article / title of chapter,
Pages No., Copyright (Year), with permission from Elsevier [OR APPLICABLE SOCIETY
COPYRIGHT OWNER].” Also Lancet special credit - “Reprinted from The Lancet, Vol. number,
Author(s), Title of article, Pages No., Copyright (Year), with permission from Elsevier.”
4. Reproduction of this material is confined to the purpose and/or media for which permission is
hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and illustrations may be
altered/adapted minimally to serve your work. Any other abbreviations, additions, deletions and/or
any other alterations shall be made only with prior written authorization of Elsevier Ltd. (Please
contact Elsevier at permissions@elsevier.com)
6. If the permission fee for the requested use of our material is waived in this instance, please be
advised that your future requests for Elsevier materials may attract a fee.
7. Reservation of Rights: Publisher reserves all rights not specifically granted in the combination of
(i) the license details provided by you and accepted in the course of this licensing transaction, (ii)
these terms and conditions and (iii) CCC's Billing and Payment terms and conditions.
8. License Contingent Upon Payment: While you may exercise the rights licensed immediately upon
issuance of the license at the end of the licensing process for the transaction, provided that you have
disclosed complete and accurate details of your proposed use, no license is finally effective unless
and until full payment is received from you (either by publisher or by CCC) as provided in CCC's
Billing and Payment terms and conditions.  If full payment is not received on a timely basis, then any
license preliminarily granted shall be deemed automatically revoked and shall be void as if never
granted.  Further, in the event that you breach any of these terms and conditions or any of CCC's
Billing and Payment terms and conditions, the license is automatically revoked and shall be void as
if never granted.  Use of materials as described in a revoked license, as well as any use of the
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publisher reserves the right to take any and all action to protect its copyright in the materials.
9. Warranties: Publisher makes no representations or warranties with respect to the licensed
material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and their
respective officers, directors, employees and agents, from and against any and all claims arising out
of your use of the licensed material other than as specifically authorized pursuant to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed, assigned,
or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in a writing signed
by both parties (or, in the case of publisher, by CCC on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms contained in any purchase
order, acknowledgment, check endorsement or other writing prepared by you, which terms are
inconsistent with these terms and conditions or CCC's Billing and Payment terms and conditions. 
These terms and conditions, together with CCC's Billing and Payment terms and conditions (which
are incorporated herein), comprise the entire agreement between you and publisher (and CCC)
concerning this licensing transaction.  In the event of any conflict between your obligations
established by these terms and conditions and those established by CCC's Billing and Payment
terms and conditions, these terms and conditions shall control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the permissions described in this
License at their sole discretion, for any reason or no reason, with a full refund payable to you. 
Notice of such denial will be made using the contact information provided by you.  Failure to
receive such notice will not alter or invalidate the denial.  In no event will Elsevier or Copyright
Clearance Center be responsible or liable for any costs, expenses or damage incurred by you as a
result of a denial of your permission request, other than a refund of the amount(s) paid by you to
Elsevier and/or Copyright Clearance Center for denied permissions.
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15. Translation: This permission is granted for non-exclusive world English rights only unless
your license was granted for translation rights. If you licensed translation rights you may only
translate this content into the languages you requested. A professional translator must perform all
translations and reproduce the content word for word preserving the integrity of the article. If this
license is to re-use 1 or 2 figures then permission is granted for non-exclusive world rights in all
languages.
16. Posting licensed content on any Website: The following terms and conditions apply as
follows: Licensing material from an Elsevier journal: All content posted to the web site must
maintain the copyright information line on the bottom of each image; A hyper-text must be included
to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx or the Elsevier homepage for books at
http://www.elsevier.com; Central Storage: This license does not include permission for a scanned
version of the material to be stored in a central repository such as that provided by Heron/XanEdu.
Licensing material from an Elsevier book: A hyper-text link must be included to the Elsevier
homepage at http://www.elsevier.com . All content posted to the web site must maintain the
copyright information line on the bottom of each image.
Posting licensed content on Electronic reserve:  In addition to the above the following clauses
are applicable: The web site must be password-protected and made available only to bona fide
students registered on a relevant course. This permission is granted for 1 year only. You may obtain
a new license for future website posting.
For journal authors:  the following clauses are applicable in addition to the above: Permission
granted is limited to the author accepted manuscript version* of your paper.
*Accepted Author Manuscript (AAM) Definition: An accepted author manuscript (AAM) is
the author’s version of the manuscript of an article that has been accepted for publication and which
may include any author-incorporated changes suggested through the processes of submission
processing, peer review, and editor-author communications. AAMs do not include other publisher
value-added contributions such as copy-editing, formatting, technical enhancements and (if
relevant) pagination.
You are not allowed to download and post the published journal article (whether PDF or HTML,
proof or final version), nor may you scan the printed edition to create an electronic version. A
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http://www.sciencedirect.com/science/journal/xxxxx. As part of our normal production process,
you will receive an e-mail notice when your article appears on Elsevier’s online service
ScienceDirect (www.sciencedirect.com). That e-mail will include the article’s Digital Object
Identifier (DOI). This number provides the electronic link to the published article and should be
included in the posting of your personal version. We ask that you wait until you receive this e-mail
and have the DOI to do any posting.
Posting to a repository: Authors may post their AAM immediately to their employer’s
institutional repository for internal use only and may make their manuscript publically available after
the journal-specific embargo period has ended.
Please also refer to Elsevier's Article Posting Policy for further information.
18. For book authors the following clauses are applicable in addition to the above:   Authors are
permitted to place a brief summary of their work online only.. You are not allowed to download
and post the published electronic version of your chapter, nor may you scan the printed edition to
create an electronic version. Posting to a repository: Authors are permitted to post a summary of
their chapter only in their institution’s repository.
20. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be
submitted to your institution in either print or electronic form. Should your thesis be published
commercially, please reapply for permission. These requirements include permission for the Library
and Archives of Canada to supply single copies, on demand, of the complete thesis and include
permission for UMI to supply single copies, on demand, of the complete thesis. Should your thesis
be published commercially, please reapply for permission.
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define how a reader may reuse their work: Creative Commons Attribution License (CC BY),
Creative Commons Attribution – Non Commercial - ShareAlike (CC BY NC SA) and Creative
Commons Attribution – Non Commercial – No Derivatives (CC BY NC ND)
Terms & Conditions applicable to all Elsevier Open Access articles:
Any reuse of the article must not represent the author as endorsing the adaptation of the article nor
should the article be modified in such a way as to damage the author’s honour or reputation.
The author(s) must be appropriately credited.
If any part of the material to be used (for example, figures) has appeared in our publication with
credit or acknowledgement to another source it is the responsibility of the user to ensure their reuse
complies with the terms and conditions determined by the rights holder.
Additional Terms & Conditions applicable to each Creative Commons user license:
CC BY: You may distribute and copy the article, create extracts, abstracts, and other revised
versions, adaptations or derivative works of or from an article (such as a translation), to include in a
collective work (such as an anthology), to text or data mine the article, including for commercial
purposes without permission from Elsevier
CC BY NC SA: For non-commercial purposes you may distribute and copy the article, create
extracts, abstracts and other revised versions, adaptations or derivative works of or from an article
(such as a translation), to include in a collective work (such as an anthology), to text and data mine
the article and license new adaptations or creations under identical terms without permission from
Elsevier
CC BY NC ND: For non-commercial purposes you may distribute and copy the article and
include it in a collective work (such as an anthology), provided you do not alter or modify the
article, without permission from Elsevier
Any commercial reuse of Open Access articles published with a CC BY NC SA or CC BY NC
ND license requires permission from Elsevier and will be subject to a fee.
Commercial reuse includes:
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·         Commercial exploitation ( e.g. a product for sale or loan)
·         Systematic distribution (for a fee or free of charge)
Please refer to Elsevier's Open Access Policy for further information.
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